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ABSTRACT
The characteristic ability of acetic acid bacteria to aerobically oxidize ethanol to acetic
acid has been harnessed for millennia to produce vinegar. Acetic acid permeates cell
membranes at low pH and generally inhibits bacterial growth at low millimolar
concentrations. The strains used for vinegar production, however, thrive in near-molar
concentrations. This remarkable resistance results from the combined contributions of
several molecular mechanisms. This study examines the inherent acid stability of proteins
from the industrial vinegar-production strain Acetobacter aceti 1023 and the process by
which cytoplasmic acetic acid is "overoxidized" to carbon dioxide.
Acetate overoxidation in A. aceti strain 1023 is catalyzed by a variant citric acid cycle
(CAC) that lacks succinyl-coenzyme A (CoA) synthetase. The acetic-acid-resistance
protein succinyl-CoA:acetate CoA-transferase (SCACT, AarC) circumvents this
deficiency and bypasses substrate-level phosphorylation and/or adenylation of acetate.
Moreover, continuous acetate dissimilation by this specialized CAC is dependent upon
only favorable oxidation of reduced cofactors.
Biphasic growth of A. aceti strain 1023 in yeast extract-peptone-dextrose-ethanol
medium is accompanied by distinct stages of acetate production, conservation, and
depletion. Acetate is initially accumulated as ethanol is oxidized in the first log phase,
transiently maintained in the first stationary phase, and ultimately consumed in the
second log phase. The high levels of AarC and SCACT activity present prior to the
acetate depletion phase suggest that regulation of CAC enzyme levels is not the only
mechanism by which premature acetate overoxidation is avoided. Acetate catabolism
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may be further minimized during ethanol oxidation by the maintenance of a low
cytoplasmic acetate concentration. A. aceti employs multiple means of active acetic acid
efflux which may be driven by the energetically favorable oxidation of ethanol.
Selective pressure to function in a primary metabolic role increased the specificity and
catalytic rapidity of AarC relative to other class I CoA-transferases. Catalysis relies upon
a novel oxyanion hole configuration composed partly of the distal amide nitrogen of
CoA to stabilize tetrahedral oxyanion intermediates. Structural alignments suggest this
mechanism is employed by all class I enzymes. Favorable hydrogen-bonding and
electrostatic interactions between the protein and the diphosphate moiety of CoA induce a
protein conformational change that was previously predicted to accelerate CoA transfer.
This motion is influenced by an auxiliary binding site that preconcentrates carboxylate
substrates.
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Chapter 1.
Background and introduction

PERSPECTIVE
Vinegar production. Acetic acid bacteria (AAB) are Gram-negative, acidophilic αproteobacteria that oxidize ethanol to acetic acid (1) using membrane-bound alcohol (2)
and aldehyde (3) dehydrogenases (Scheme 1.1). This characteristic ability has been
harnessed for millennia to produce vinegar (4). Cultures often progress through multiple
growth phases (5-7), accumulating acetate through the oxidation of ethanol in the first log
phase, conserving acetate during the first stationary phase, and then ultimately consuming
acetate in the second log phase. Ideal strains for vinegar production exhibit little acetic
acid consumption during the first log phase and an ability to tolerate high concentrations
of acetic acid during a prolonged conservation phase (7).
Acetic acid resistance. Acetic acid permeates the cell membrane at low pH and
generally inhibits bacterial growth at low-millimolar concentrations. Dissociation in the
relatively alkaline cytoplasm diffusively traps acetate while decreasing the intracellular
pH and poisoning the proton gradient (8, 9). Many AAB are nonetheless resistant to nearmolar concentrations of acetic acid (10, 11). Molecular mechanisms of resistance in the
AAB Acetobacter aceti include adaptation of cytoplasmic components (12-14) to internal
acidification (Figure 1.1) (15), active acetic acid efflux via the putative ABC transporter
AatA (16) and an unnamed acetic acid:proton antiporter (17), and production of acetic-

CH3CH2OH
ethanol

ADH
2e−, 2H+

H2 O

CH3CHO

CH3CH(OH)2

acetaldehyde

acetaldehyde
hydrate

ALDH
2e−, 2H+

CH3COOH
acetic acid

Scheme 1.1. Ethanol oxidation in the A. aceti periplasm. Membrane-bound alcohol (ADH) and
aldehyde (ALDH) dehydrogenases convert ethanol to acetic acid.
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Figure 1.1. Intracellular and extracellular pH in growing A. aceti cultures. (Left) Both intracellular
and extracellular pH decrease as ethanol is oxidized to acetic acid. Intracellular pH (closed squares),
extracellular pH (open squares), acetic acid (open triangles), and optical density (closed circles).
Intracellular pH was measured using [14C]-acetylsalicylic acid. (Right) A. aceti maintains a relatively
alkaline intracellular pH (pHi) as both the intracellular and extracellular pH (pHe) drop. Intracellular
pH was measured using [14C]-acetic acid. A similar plot was obtained using [14C]-benzoic acid.
Reprinted with permission from (15).

acid-inducible proteins, many with undefined biochemical roles, identified by proteomic
screens (9, 18).
Members of the AAB genus Acetobacter were historically differentiated from those of
Gluconobacter by a metabolic preference for ethanol and the ability to "overoxidize"
acetate to CO2, usually when ethanol was unavailable (19). Acetate overoxidation
implicates the oxidative decarboxylations performed by citric acid cycle (CAC)
dehydrogenases and suggests the presence of a complete CAC.
A. aceti strain 1023, an especially acetic-acid-resistant and comparatively
thermotolerant vinegar factory isolate (20, 21), requires acetic-acid-resistance genes
aarABC for growth on > 50 mM acetic acid at low pH (22). AarA is an NADHinsensitive hexameric form of citrate synthase (23). AarB is predicted to be a basic
protein of 154 amino acids with no homologues or known function (22). AarC is required
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for acetate overoxidation but is not acetyl-CoA synthetase and resembles several acylcoenzyme A (CoA):carboxylate CoA-transferases (24).
CoA-transferases. CoA-transferases catalyze the reversible transfer of CoA from acylCoA thioesters to free acids and play diverse metabolic roles in organisms from all lines
of descent. All three classes of CoA-transferase share mechanistic features, but only class
I and II enzymes appear to have a common ancestor (25).
Class I CoA-transferases are frequently involved in fatty acid metabolism and often use
acetyl-CoA and/or succinyl-CoA as a CoA donor (26, 27). Class I enzymes usually
possess heterotetrameric or homodimeric structures. The larger, identical subunits in the
homodimeric structures are composed of distinct N- and C-terminal domains that are
orthologous to the smaller, unique subunits in the heterotetrameric structures (27). CoA
transfer proceeds by a substituted-enzyme mechanism (28, 29) in which a catalytic
glutamate forms covalent mixed anhydride (30-32) and thioester (33) intermediates. The
carboxylate product characteristically dissociates before the carboxylate substrate binds
(Scheme 1.2).
Class III CoA-transferases are commonly involved in specialized anaerobic pathways
or activation of organic acids for subsequent decarboxylation (25). Class III enzymes
possess unique interlocked homodimeric structures (34). CoA transfer proceeds by a
ordered ternary mechanism in which a catalytic aspartate forms covalent mixed
anhydride and thioester intermediates analogous to those formed by class I CoAtransferases (35). The carboxylate product, however, characteristically dissociates after
the carboxylate substrate binds (Scheme 1.2).
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+

Class I

+

Class II

+

Class III

+

Scheme 1.2. Abbreviated class I and III CoA-transferase mechanisms. CoA-transferase reactions are
catalyzed by three classes of enzymes with distinct but related mechanisms. (Top) Class I CoAtransferase mechanism. (Bottom) Class III CoA-transferase mechanism. Both class I and III reactions
proceed through a series of mixed anhydride, tetrahedral oxyanion (not shown), and thioester
intermediates. The classes differ in the identity of the nucleophilic carboxylate (class I, glutamate;
class III, aspartate) and the order of substrate association and product dissociation (class I, ping-pong
Bi-Bi mechanism; class III, ordered Bi-Bi mechanism).
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Class II CoA-transferases function in the multiprotein complexes citrate lyase and
citramalate lyase, converting citrate (or citramalate) to oxaloacetate (or pyruvate) and
acetate. Citrate lyase and citramalate lyase possess heterooctadecameric structures
composed of unique transferase, lyase, and acyl-carrier-protein (ACP) subunits (36, 37).
An acetyl-dephosphoCoA prosthetic group is covalently attached to the ACP subunit
(25). Class II enzymes lack both a nucleophilic glutamate (class I) and a nucleophilic
aspartate (class III). Alternatively, the carboxylate substrate directly attacks the acetyldephosphoCoA-ACP thioester forming a free mixed anhydride intermediate and the
dephosphoCoA-ACP thiolate. Subsequent attack by dephosphoCoA-ACP thiolate at the

+

Class II
lyase
activity

Scheme 1.3. Abbreviated class II CoA-transferase mechanism. Class II CoA-transferases function in
the multiprotein complexes citrate lyase [R = -CH2COO− (citrate → oxaloacetate + acetate)] and
citramalate lyase [R = -CH3 (citramalate → pyruvate + acetate)]. Reactions proceed through a series
of mixed anhydride, tetrahedral oxyanion (not shown), and thioester intermediates. A retro-aldol
reaction completes the catalytic cycle. The recycled thioester is shuttled between lyase and transferase
active sites by a dephosphoCoA prosthetic group covalently anchored to acyl-carrier-protein (ACP).
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citryl (or citramalyl) carbonyl of the mixed anhydride produces the acyl-dephosphoCoAACP intermediate and acetate. A retro-aldol reaction catalyzed by the lyase subunit forms
the second carboxylate product (oxaloacetate or pyruvate) and regenerates the acetyldephosphoCoA prosthetic group (Scheme 1.3) (36).

PURPOSE
Chapter 2 defines the link between the CAC and acetic acid resistance in A. aceti. The
acetic-acid-resistance gene aarC encodes succinyl-CoA:acetate CoA-transferase (AarC,
SCACT). AarC reversibly catalyzes CoA transfer from succinyl-CoA to acetate forming
acetyl-CoA and succinate. Acetyl-CoA is then readily converted to carbon dioxide by the
specialized A. aceti CAC. Reannotation of the aarABC gene cluster revealed the presence
of a gene in the aarA-aarC intergenic region encoding the phosphoprotein phosphatase
SixA. SixA regulates the ArcA/ArcB two-component anoxic-redox-control system (38),
permitting high levels of CAC enzyme synthesis in the presence of high concentrations of
extracellular acetate. [The contents of Chapter 2 were published in E. A. Mullins et al.
(39).]
Chapter 3 examines the molecular mechanism(s) by which acetate overoxidation is
regulated in A. aceti. In yeast extract-peptone-dextrose-ethanol medium, A. aceti cultures
accumulate acetate in the first log phase, conserve acetate in the intervening stationary
phase, and ultimately deplete acetate in the second log phase. Despite moderately high
levels of AarA and AarC and correspondingly high levels of CS and SCACT activities,
little acetic acid is consumed prior to the second log phase. Premature acetate
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overoxidation may be minimized through the maintenance of a low cytoplasmic acetate
concentration.
Chapter 4 analyzes structure-function and structure-activity relationships in AarC.
Crystallography, molecular modeling, and molecular mechanics calculations were
combined to produce the first complete structural description of the ground-state
complexes and intermediates in a class I CoA-transferase reaction. AarC utilizes a novel
oxyanion hole configuration composed partly of the distal amide nitrogen of CoA to
stabilize tetrahedral intermediates. Structural alignments suggest this mechanism is
employed by all class I enzymes. Protein conformational dynamics, influenced by a
previously unidentified auxiliary carboxylate binding site, are integral to the acceleration
of CoA transfer.
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Chapter 2.
Explication of the specialized citric acid cycle of Acetobacter aceti
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INTRODUCTION
Acetic acid bacteria (AAB) are Gram-negative, acidophilic α-proteobacteria that
oxidize ethanol to acetic acid using membrane-bound alcohol dehydrogenase (ADH) and
aldehyde dehydrogenase (ALDH) enzymes. AAB are remarkably resistant to the
membrane-permeable toxins ethanol and acetic acid at low pH. Members of the AAB
genus Acetobacter were historically differentiated from those of Gluconobacter by a
metabolic preference for ethanol and the ability to "overoxidize" acetate to carbon
dioxide, usually when ethanol was unavailable (1). Acetate overoxidation implicates the
oxidative decarboxylations performed by citric acid cycle (CAC) dehydrogenases and
suggests the presence of a complete CAC.
Molecular mechanisms of acetic acid resistance in Acetobacter aceti include adaptation
of cytoplasmic components (2, 3) to internal acidification (4), active acetic acid efflux via
the putative ABC transporter AatA (5) and an unnamed acetic acid:proton antiporter (6),
and production of acetic-acid-inducible proteins, many with undefined biochemical roles,
identified by proteomic screens (7, 8).
A. aceti strain 1023, an especially acetic-acid-resistant and comparatively
thermotolerant vinegar factory isolate (9, 10), requires acetic-acid-resistance genes
aarABC for growth on > 50 mM acetic acid at low pH (11). AarA is an NADHinsensitive hexameric form of citrate synthase (12). AarB is predicted to be a basic
protein of 154 amino acids with no homologues or known function (11). AarC is required
for acetate oxidation but is not acetyl-CoA synthetase and resembles several acylcoenzyme A (CoA):carboxylate CoA-transferases (13).
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The apparent requirement of the A. aceti CAC for acetic acid resistance may indicate a
direct role in depleting cytoplasmic acetate by way of acetyl-CoA oxidation to carbon
dioxide or a general contribution to energy production. A. aceti requires vigorous
oxygenation at high acetate levels and low pH (14), consistent with either CAC role. A
draft genome sequence of A. aceti strain 1023 (3), however, lacks malate dehydrogenase
(Mdh) and succinyl-CoA synthetase (SCS) genes.
This study shows that A. aceti possesses a complete but modified CAC, enabling direct
acetate incorporation by an internal shunt. Mdh and SCS are functionally replaced by
malate:quinone oxidoreductase (Mqo) and succinyl-CoA:acetate CoA-transferase
(SCACT), respectively. SCACT is encoded by aarC. This biochemical function explains
genetic evidence for essential roles in acetic acid resistance and acetic acid metabolism
(11, 13).

MATERIALS AND METHODS
Reagents and general analytical methods. Chemicals were purchased from SigmaAldrich or Fisher in the highest purity available unless otherwise noted. DethiaacetylCoA was synthesized by H. Jiang as described previously (12). Oligodeoxynucleotide
(ODN) primers were obtained from Integrated DNA Technologies and used without
further purification. A. aceti citrate synthase with a C-terminal hexahistidine affinity tag
(AaCSH6) was purified by C. Z. Constantine as described previously (12). Restriction
enzymes, DNA modifying enzymes, and DNA size standards were purchased from New
England Biolabs. Protein quantitation by the method of Bradford and analytical gel-

14

filtration were performed as described previously (3). Absorbance measurements were
recorded on a Cary Bio 100 UV-visible spectrophotometer (Varian) or an 8453 UVvisible spectrophotometer (Agilent Technologies). Polymerase chain reaction (PCR)
products and plasmids were sequenced by the Washington University in St. Louis Protein
and Nucleic Acid Chemistry Laboratory. Protein mass was determined by electrosprayionization time-of-flight mass spectrometry (ESI-TOF-MS) by the Washington University
Mass Spectrometry Resource.
Sequence Analysis. A draft genome sequence for A. aceti strain 1023 (Table 2.1) was
assembled into several hundred contigs by T. J. Kappock using PCAP (15). Open reading
frames were identified using CRITICA, RBSFINDER, and GLIMMER 2.3.1 (16, 17).
The combined set of open reading frames was analyzed using LipoP 1.0 (18) and SigP
3.0 (19) to predict subcellular location and then annotated automatically with
InterProScan (20) and the KEGG (21) annotation server.
Propagation of A. aceti strains. Yeast extract-peptone-dextrose (YPD) plates
supplemented with 2% (v/v) ethanol (YPDE) were streaked from frozen glycerol stocks
(Table 2.1). After three days at 30 °C, single colonies were picked and transferred to 500mL YPDE (2%) solutions in 2.8-L Fernbach flasks. Cultures were propagated at 30 °C
with vigorous shaking (200 rpm) for 2 days, and cells were harvested by centrifugation
and stored at –80 °C for subsequent analysis.
Cloning and mutagenesis. DNA manipulations were performed using standard
molecular biology techniques (22). PCRs were performed using A. aceti strain 1023
gDNA isolated with 20/G genomic tips (Qiagen), appropriate ODN primers (Table 2.2),
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Table 2.1. Bacterial strains and plasmids used in this study
Descriptiona

Source

A. aceti 1023

Acetic-acid-tolerant factory strain

K. Kondob

A. aceti 2002

A. aceti type strain, DSM 2002

DSMZ

E. coli C41(DE3)

F′ ompT hsdSB(rB− mB−) gal dcm (DE3)

Avidisc

E. coli DH5α

F′ ϕ80lacZΔM15 Δ(lacZYA-argF)U169 deoR recA1 endA1
hsdR17(rK− mK+) phoA supE44 thi-1 gyrA96 relA1

Invitrogend

pET23a

T7 promoter expression vector, Apr

Novagen

pET23d

T7 promoter expression vector, Apr

Novagen

pET28a

T7 promoter expression vector, Kmr

Novagen

pJK286

Derivative of pET23a, encodes UctB

This study

pJK357

Derivative of pET23a, encodes AarC

This study

pJK358

Derivative of pET23a, encodes UctD

This study

pJK359

Derivative of pET23a, encodes UctA

This study

pJK360

Derivative of pET23d, encodes UctCe

This study

pJK361

Derivative of pET28a, encodes H6AarCf

This study

pJK385

Derivative of pJK357, encodes AarCH6g

This study

Strain or plasmid
Strains

Plasmids

a Ampicillin

resistant (Apr) and kanamycin resistant (Kmr). b Described in reference (9). c Described in
reference (60). d Described in reference (61). e Encodes a Thr2→Ala mutation as part of a unique
NcoI restriction site. f An upstream start codon adds MGSSHHHHHSSGLVPRGSH to the N-terminus
of AarC. g QuickChange mutagenesis was performed to introduce a Ter506→Ser mutation, adding
SLEHHHHHH to the C-terminus of AarC.

and Vent DNA polymerase. Mutagenesis reactions were performed using the QuikChange
II Site-Directed Mutagenesis kit (Stratagene), the indicated template plasmids (Table
2.1), and appropriate ODN primers (Table 2.2).
Expression of candidate SCACT genes. E. coli C41(DE3) cells transformed with
pJK286, pJK357, pJK358, pJK359, or pJK360 were propagated on Luria-Bertani (LB)
medium containing 0.1 g/L ampicillin (LB/Amp). Production cultures (50 mL LB/Amp)
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Table 2.2. ODN primers used in this study
ODN

Sequence (5′ → 3′)a

Product(s)

1022

CTG GTA AGC TTA GTC TCT CAA GAT GCA GTC

pJK286

1168

AGG TAG ACA TAT GGG CAC GAC

pJK286

1221

CAG GAA GCC CTC ATA TGA CAG AGC G

pJK357/pJK361

1223

TGG ACC AGA ACA TAT GAC AAA AGT TAA AAC

pJK358

1224

CTT GTT TGA ATT CGG CGG TAA TGT GTT AA

pJK358

1225

CCA AAG GAT CAC ATA TGT CAG ACA AAT TAC

pJK359

1226

AAA ATA AAT GAA TTC TAT AAT TAG GAG AGT AAT TCA CG

pJK359

1228

GAA TGT ATG AAT TCA GGC GTC ATT TTG CC

pJK360

1279

GGA CCC ATG GCT GAA ACC ACG C

pJK360

1280

GCA ATA CTC GAG TTA TGA TGG GAG C

pJK357/pJK361

1290

TGC TCC CAT CAT CAC TCG AGC ACC AC

pJK385

1291

GTG GTG CTC GAG TGA TGA TGG GAG CA

pJK385

a

Changes in the coding region relative to the genomic sequence are underlined.

were inoculated with overnight cultures at a 1:50 dilution and grown at 37 °C to an OD600
= 0.6. Production of recombinant protein was then induced by addition of isopropyl-βD-1-thiogalactopyranoside (IPTG) to 0.4 mM. Cells were grown at 15 °C an additional
16 h, harvested by centrifugation, and either used immediately or stored at –80 °C.
Purification of AarCH6. E. coli C41(DE3) cells transformed with pJK385 were
propagated on LB medium containing 0.1 g/L ampicillin (LB/Amp). Production cultures
(1 L LB/Amp) were inoculated with overnight cultures at a 1:500 dilution and grown at
37 °C to an OD600 = 0.6. Production of recombinant AarCH6 was then induced by
addition of IPTG to 0.4 mM. Cells were grown at 15 °C an additional 16 h, harvested by
centrifugation, and either used immediately or stored at –80 °C. All subsequent steps
were performed at 4 °C. Cells (typically 5 g/L culture) were resuspended in 5 mL/g TK
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buffer (50 mM Tris•HCl, pH 8.0, and 100 mM potassium chloride) and disrupted by three
cycles of sonication. Lysate was cleared by centrifugation at 30,000g for 30 min, addition
of streptomycin to 1% (w/v) from a 10% (w/v) stock, incubation for 15 min, and
additional centrifugation at 30,000g for 30 min. Solid ammonium sulfate was then added
to the cleared lysate to 35% saturation (208 g/L) over 30 min. After equilibrating an
additional 30 min, solids were removed by centrifugation at 30,000g for 10 min. Solid
ammonium sulfate was then added to the supernatant to 75% saturation (275 g/L) over 30
min. After equilibrating an additional 30 min, solids were collected by centrifugation at
30,000g for 10 min, dissolved in a minimal volume of TK buffer, and applied to a Ni2+charged nitrilotriacetic acid (Ni-NTA) agarose column (1.0 cm × 2.6 cm, 2.0 mL)
equilibrated in buffer A (50 mM Tris•HCl, pH 8.0, and 300 mM sodium chloride). The
column was washed with 10 column volumes of buffer A containing 10 mM imidazole
and then developed in a linear gradient of imidazole (10 → 500 mM, 30 mL × 30 mL).
Fractions containing AarCH6 were identified by sodium dodecyl sulfate polyacrylamide
gel electrophoresis (SDS-PAGE), pooled, and concentrated to > 5 mg/mL by
ultrafiltration (Amicon Ultra-15, 30,000 MWCO). Concentrated AarCH6 was exchanged
into TK buffer by several cycles of dilution and reconcentration. Single-use aliquots were
stored at –80 °C.
CAC enzyme activity assays. A. aceti cell pellets were resuspended in 5 mL/g 25 mM
HEPES, pH 8.0, and 100 mM sodium chloride and then disrupted by five cycles of
sonication. Half of the lysate was centrifuged at 16,100g for 20 min (fast-spin lysate),
while the other half of the lysate was centrifuged at 2,700g for 10 min (slow-spin lysate).
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Enzyme activity assays were performed by J. A. Francois at 25 °C (0.5-mL final volume).
In all cases, a unit (U) is defined as the amount of enzyme that forms 1 µmole of product
per minute.
Citrate synthase assays were performed as described previously (23) except that
reactions were initiated by the addition of fast-spin lysate (0.75 – 7.5 µg). Aconitase, αketoglutarate dehydrogenase, fumarase, and Mdh assays were performed using fast-spin
lysate as described previously (23). SCS assays, detecting thioester formation at 230 nm,
were performed using slow-spin lysate as described previously (24). Assays for the
opposite direction, coupling succinyl-CoA cleavage to consumption of 5,5'-dithiobis-(2nitrobenzoic acid) (DTNB) (23), gave unacceptably high background rates in cell-free
lysates. Succinate dehydrogenase assays were performed as described previously (25)
except that the reactions contained 50 mM potassium phosphate, pH 8.0, 100 mM
potassium chloride, 20 mM succinate, 50 µM phenazine methosulfate, 50 µM 2,6dichlorophenolindophenol, and 19 – 56 µg total cell lysate. Succinate-dependent dye
reduction was initiated by the addition of lysate (Δε578 = 18 mM−1 cm−1). Cell membranes
used for Mqo assays were obtained by J. A. Francois as described previously (26). Assay
mixtures contained 50 mM HEPES, pH 7.5, 10 mM potassium acetate, 10 mM calcium
chloride, 5 mM magnesium chloride, 5 mM (S)-L-malate, 50 µM 2,6dichlorophenolindophenol, and resupended A. aceti cell membranes (3 – 19 µg protein).
Malate-dependent dye reduction was initiated by the addition of membranes (Δε600 = 22
mM−1 cm−1).
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Citrate synthase-dependent SCACT assays. SCACT assays were performed at 25 °C
in 50 mM potassium phosphate, pH 8.0, 100 mM potassium chloride, the indicated
substrates, and enzyme to initiate the reaction (0.5-mL final volume). The source of
enzyme was 60 – 250 µg A. aceti fast-spin lysate, 1 – 250 µg recombinant E. coli lysate,
or 5 – 50 ng pure AarCH6. Forward-direction reaction mixtures (VisF assays) contained
350 mM potassium acetate, 0.5 mM succinyl-CoA, or varied amounts of one substrate.
Reverse-direction reaction mixtures (VisR assays) contained 20 mM succinate, 0.5 mM
acetyl-CoA, or varied amounts of one substrate. After 0.5 and 5 min, aliquots (50 µL)
were removed from the VisF/VisR reaction mixture and added to citrate synthase assays
(0.5-mL final volume) containing 0.4 mM DTNB, 0.3 mM oxaloacetate, and 2 U
AaCSH6, but lacking acetyl-CoA. The resulting burst of thionitrobenzene formation due
to CoA thiol formation was used to quantitate acetyl-CoA (Δε412 = 14.1 mM−1 cm−1) (27).
Fifteen carboxylates (oxalate, formate, malate, aspartate, ascorbate, alanine, citrate,
nicotinate, pyruvate, lactate, glycine, oxaloacetate, succinate, tartrate, and fumarate) were
screened as possible CoA-acceptors by J. A. Francois using a variant of the VisR assay.
The primary reaction (0.5-mL final volume) contained 50 mM Tris•HCl, pH 8.0, 20 mM
potassium chloride, 50 mM carboxylate, pH 8.0, 50 µM acetyl-CoA, and 100 µg fast-spin
lysate (passed through a prepacked PD-10 column containing Sephadex G-25M) added to
initiate the reaction. After fixed times (0.5 – 30 min), aliquots (50 µL) from the primary
reaction were added to citrate synthase assays (0.5-mL final volume) containing 0.4 mM
DTNB, 0.3 mM oxaloacetate, and 0.01 U AaCSH6, but lacking acetyl-CoA.
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High performance liquid chromatography (HPLC)-coupled SCACT assays.
SCACT assays were performed at 25 °C in 50 mM potassium phosphate, pH 8.0, 100
mM potassium chloride, the indicated substrates, and 5 – 50 ng pure AarCH6 used to
initiate the reaction (0.5-mL final volume). Forward-direction reaction mixtures (LCF
assays) contained 350 mM potassium acetate, 0.2 mM succinyl-CoA, or varied amounts
of one substrate. Reverse-direction reaction mixtures (LCR assays) contained 20 mM
succinic acid, 1 mM acetyl-CoA, or varied amounts of one substrate. After 0 and 5 min,
aliquots (0.1 mL) of the reaction mixture were transferred into 6.25% trichloroacetic acid
(0.4 mL), vortexed briefly, and centrifuged at 16,100g for 3 min. The soluble portion was
then transferred to an autosampler vial and analyzed by HPLC.
Velocities were determined by referencing the product acyl-CoA peak area to an acetylCoA calibration curve (ε260 = 16.4 mM−1 cm−1) (28). Velocities are averages of three or
four determinations unless otherwise noted. Kinetic constants were determined using
Prism (GraphPad) to fit equations for Michaelis-Menten kinetics, competitive inhibition,
or substrate inhibition (29). A sum-of-squares F test was used to discriminate between
alternative kinetic models.
HPLC analysis. CoA and CoA thioesters were resolved on a Breeze HPLC system
(Waters) equipped with a Symmetry C18 column (4.6 mm × 75 mm, 3.5 µm; Waters) by
a modified literature method (30). Elution was performed at ambient temperature and a
flow rate of 0.8 mL/min with detection at 260 nm. A mixture of 100 mM sodium
phosphate and 75 mM sodium acetate, pH 4.6, was used in a water/methanol solvent
system. The gradient program was 0 – 5 min, 9% methanol (isocratic); 5 – 15 min, 9 →
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15% methanol (linear gradient); 15 – 17 min, 15% methanol (isocratic); 17 – 22 min, 15
→ 9% methanol (linear gradient); and 22 – 27 min, 9% methanol (isocratic). Injections
(25 – 100 µL) were performed by a 717plus autosampler (Waters).
Under these conditions, peaks corresponding to CoA (8.0 min), succinyl-CoA (15.2
min), and acetyl-CoA (16.7 min) were well resolved from each other in mixtures. All
peaks, including those of dethiaacetyl-CoA (10.2 min) and acetoacetyl-CoA (16.4 min),
were identified by comparison to pure standards. In all cases, (acyl-)CoA peak areas were
computed as the sum of the major peak and a trailing (acyl-)isoCoA peak. The latter are
2'-phosphoryl isomers that are common contaminants in commercial (acyl-)CoA
preparations (31).
Covalent inactivation of AarCH6. AarCH6 (0.5 µg) was incubated for 10 min at 25
°C in a 0.5-mL mixture containing 50 mM potassium phosphate, pH 8.0, 100 mM
potassium chloride, and 100 µM acetyl-CoA. Sodium borohydride was added to 10 mM
from a 500 mM stock solution and incubated an additional 10 min. An aliquot (5 µL) of
the enzyme solution was then immediately added to an otherwise complete LCR assay to
measure residual enzymatic activity. Control reactions lacked sodium borohydride,
acetyl-CoA, or both. The remainder of the protein solutions were flash-frozen, stored at –
80 °C, and subsequently analyzed by ESI-TOF-MS.
Fluorescence titrations. Fluorescence emission spectra were recorded by T. J.
Kappock at 20 °C using a Cary Eclipse fluorescence spectrophotometer (Varian) with
excitation at 285 nm (1.5 nm slit width) and detection at 300 – 420 nm (5 nm slit width).
Intrinsic protein fluorescence emission spectra of a stirred solution of 1 µM AarCH6 in
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50 mM potassium phosphate, pH 8.0, and 100 mM potassium chloride were acquired 1
min after the addition of each aliquot of dethiaacetyl-CoA. Succinate was then added to
the AarCH6•dethiaacetyl-CoA complex. The effect of dethiaacetyl-CoA addition on Nacetyltryptophanamide fluorescence emission spectra was used to assess inner filter
effects.
Nucleotide sequence accession numbers. The sequences reported herein have the
following GenBank accession numbers: uctA, DQ668371; uctB-oxc-uctC-duf1275,
DQ668372; uctD, DQ668373; aarA-sixA-tyrA-orf1-aarC, DQ631551; and mqo,
DQ674275.

RESULTS
Reannotation of genes in the aarABC gene cluster. Conditionally essential aceticacid-resistance (aar) genes were identified in mutant A. aceti strain 1023 derivatives that
could not survive exposure to 50 mM acetic acid at low pH but were able to grow at an
equivalent pH generated by the membrane-impermeant mineral acid HCl (11). Insertional
inactivation experiments were used to define the aarABC genes and an apparently
essential gene X (Figure 2.1) (32).
New gene annotations predicted three ORFs on the opposite strand: orf1, encoding a
putative metallophosphoesterase; tyrA, encoding chorismate mutase; and sixA, encoding a
transcriptional regulator involved in a phosphohistidine relay system. Gene synteny in
other AAB genomes supports the new assignments (3, 33, 34) (http://genome.jgi-psf.org/
finished_microbes/acicr/acicr.home.html). AAB have a collinear orf1-sixA-gltA
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Figure 2.1. Revised annotation of the aar region in A. aceti strain 1023. The ORFs from the original
gene assignment were determined using kanamycin cassette insertional inactivation at restriction sites
indicated with vertical arrows (11). Insertion points were characterized as resistant to 50 mM acetic
acid (open triangles), sensitive (filled triangles), or apparently essential (shaded triangles). Original
assigned functions were aarA, citrate synthase; aarB, unknown; X, unknown; and aarC, possible
CoA-transferase or acyl-CoA-hydrolase. Neither aarB nor X has significant similarity to other
inferred protein sequences. The new assigned functions are orf1, putative metallophosphoesterase;
tyrA, chorismate mutase; and sixA, phosphoprotein phosphatase affecting the ArcA/ArcB twocomponent regulator. The revised assignment includes a single-base insertion in the aarC region that
lengthens the ORF slightly. The scale bar is in units of bp.

arrangement (gltA, citrate synthase, is the equivalent of A. aceti aarA), except in
Acidiphilium cryptum, which has the putative phosphatase orf1 located elsewhere. In A.
aceti strain 1023 and Gluconobacter oxydans, tyrA is inserted between orf1 and sixA,
while Granulibacter bethesdensis has two genes inserted between sixA and gltA. In the
revised assignment, aarC is divergently transcribed from all other genes in the aar gene
region.
Annotation of genes involved in acetate metabolism. A draft 3-Mb A. aceti strain
1023 genome (3) contains all genes needed for six of the eight canonical CAC enzymes.
Genes for SCS, Mdh, and glyoxylate shunt enzymes were not identified. A gene encoding
membrane-bound Mqo, a functional replacement for Mdh found in diverse bacteria (26,
35), is present. Genes encoding enzymes needed to convert acetate to acetyl-CoA,
allowing for acetate dissimilation by the CAC, are also present: acetyl-CoA synthetase
(Acs) or acetate kinase (AckA) and phosphotransacetylase (Pta).
Five CoA-transferase genes, four with unassigned functions (uctA − D) and aarC, were
annotated in the draft genome sequence. The originally reported aarC gene (GenBank
accession number D13291) encodes a protein with 496 residues. The revised aarC gene
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encodes a protein with 505 residues. The only coding region sequence difference is an
insertion of a G after nucleotide 178 in the original sequence report (G210 in the revised
sequence). The revised AarC has a different sequence in residues 1 − 54 (residues 1 − 40
in the original AarC).
Expression and screening of candidate SCACT genes. All five CoA-transferase
genes (uctA − D and aarC) were cloned into pET vectors and overexpressed in E. coli
C41(DE3) (Figure 2.2). Only UctD and AarC possessed detectable SCACT activity in
VisR assays. Despite the dramatically lower solubility of AarC, the specific activity of the
AarC-containing lysate was 333-fold higher than that of the UctD-containing lysate.
N- and C-terminally hexahistidine-tagged AarC (H6AarC and AarCH6, respectively)
were examined in parallel overproduction experiments. While AarCH6 exhibited slightly
lower solubility than AarC, H6AarC was completely insoluble. AarCH6 was purified and
characterized as described below.
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Figure 2.2. Overproduction of candidate SCACTs in E. coli C41(DE3). Lysates were cleared by
centrifugation (16,100g for 10 min), analyzed by SDS-PAGE, and screened for SCACT activity using
the VisR assay. The relative activity of each protein in the same culture volume is expressed as a
percentage of AarC activity (a vector-only control had 0.008% relative activity). Lane 1: UctA (41.5
kDa expected, 0.007%); lane 2: UctB (47.6 kDa expected, 0.01%); lane 3: UctC (41.8 kDa expected,
0.01%); lane 4: UctD (55.5 kDa expected, 0.3%); lane 5: AarC (54.8 kDa expected, 100%); and lane
6: AarC, total lysate (insoluble protein and cellular debris were not removed by centrifugation). All
lanes contain comparable amounts of lysate. Size standard positions are indicated.
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Detection and quantitation of enzyme activities. Congruent with genome sequence
data, six of eight canonical CAC enzyme activities were found in A. aceti cell lysates
(Table 2.3). No activity was detected for SCS, Mdh, or the glyoxylate shunt enzymes
isocitrate lyase and malate synthase [J. A. Francois]. SCACT and Mqo activities,
however, were detected [J. A. Francois]. SCACT activity was initially identified using a
variant of the VisR assay, measuring succinate-dependent decomposition of acetyl-CoA.
Of the 15 carboxylic acids screened, only succinate supported activity.
Previously published "single-pot" CoA-transferase assays using citrate synthase to
quantitate acetyl-CoA would allow kinetic characterization in only the biosynthetic
direction (succinyl-CoA + acetate → acetyl-CoA + succinate) and were deemed
inadequate for use in this study. Discontinuous VisF/VisR methods, which allow SCACT
activity to be assayed in both the biosynthetic direction and the nonbiosynthetic direction,
were developed for use with complex cell lysates. HPLC-based LCF/LCR assays were
created to quantitate individual (acyl-)CoAs and allow for discrimination between acylCoA-hydrolase and CoA-transferase activities (Figure 2.3A). Reaction quenching
conditions that minimized but did not eliminate acyl-CoA decomposition over a timescale
of hours were identified (Figure 2.3B/C). Replicate experiments were performed such
that the mean velocity at each concentration was determined with the same average delay.
Velocity corrections based on the observed rates of acyl-CoA decomposition would
increase the reported kcat values by less than 10%.
Purification of AarCH6. AarCH6 was purified by ammonium sulfate fractionation
and immobilized metal affinity chromatography. Purity was assessed after each stage of
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Table 2.3. CAC enzyme activities in A. aceti strainsa

Step

Enzyme

Sp. activity (nmol product formed/min/mg protein)
in A. aceti strain:
1023

2002

Assay
directionb

pH

1

citrate synthase

1200 ± 60

1050 ± 80

F

8.0

2

aconitase

2200 ± 200

5460 ± 4

H

8.0

3

isocitrate dehydrogenase

1280 ± 10 (NAD+)
590 ± 20 (NADP+)

530 ± 80 (NAD+)
520 ± 50 (NADP+)

F

8.0

4

α-ketoglutarate dehydrogenase

28 ± 4

98 ± 2

F

7.0

5

succinyl-CoA synthetase

NDc

ND

R

7.2

5′

succinyl-CoA:acetate CoA-transferase

170 ± 4
80 ± 20

114 ± 2
53 ± 5

F
R

8.0

6

succinate dehydrogenase

22 ± 3

21 ± 2

F

8.0

7

fumarase

600 ± 100

700 ± 100

R

7.0

8

malate dehydrogenase

ND

ND

R

8.0

8′

malate:quinone oxidoreductase

46 ± 2

69 ± 3

F

7.5

a

Succinyl-CoA:acetate CoA-transferase activity was measured using VisF/VisR assays. All other enzyme activities were assayed as described in the
Materials and Methods. J. A. Francois assayed the canonical CAC enzymes and Mqo. b F, biosynthetic; R, nonbiosynthetic; H, half-reaction
(citrate→aconitate). c Not detected.
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A

acetyl-CoA

succinyl-isoCoA
succinyl-CoA
CoA

acetyl-isoCoA

isoCoA

B

C

Figure 2.3. HPLC analysis of CoA, acetyl-CoA, and succinyl-CoA. (A) Conversion of acetyl-CoA to
succinyl-CoA using pure AarCH6. Aliquots were removed from an LCR assay and quenched at t = 0
(red), 5 (blue), and 40 min (green). A small increase in the CoA peak area is evident. (B/C)
Decomposition of acyl-(iso)CoAs in quenched reaction mixtures incubated at 22 °C. The solid lines
represent fits of each dataset to the single-exponential decay function [A]t = [A]0 exp(−kt). (B) AcetylCoA half-life determination. The fitted parameters are [A]0 = 86 µM and k = 0.0075 ± 0.0001 h−1 (92
h half-life). (C) Succinyl-CoA half-life determination. The fitted parameters are [A]0 = 98 µM and k =
0.00202 ± 0.00003 h−1 (343 h half-life). At pH 8, both acetyl-CoA and succinyl-CoA have ~10 h halflives.

the isolation by SDS-PAGE (Figure 2.4) and specific activity (Table 2.4). ESI-TOF-MS
analysis of AarCH6 was consistent with a 513-residue protein lacking Met1 (55,846 ± 2
Da observed; 55,847 Da expected; Figure A.1). Analytical gel-filtration produced a single
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Table 2.4. AarCH6 purification charta
Protein (mg)

Activity (U)b

Sp. activity (U/mg)

Fold purification

Yield (%)

Clarified lystate

570

3500

6.1

1.0

100

35 − 75% (NH4)2SO4

460

2900

6.3

1.0

83

Ni-NTA

9.5

710

75

12

20

Stage

a AarCH6

was purified from 8 1-L production cultures (~40 g cell paste). b SCACT activity was measured using the VisR assay.
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kDa
116
97
84
66

1

2

3

55
45
36
29

Figure 2.4. Purification of AarCH6. Purity was assessed throughout the purification by SDS-PAGE
and specific activity (Table 2.4). Lane 1: clarified lysate, lane 2: 35 − 75% ammonium sulfate, and
lane 3: Ni-NTA. Each lane contains 5 µg protein. Size standard positions are indicated.

peak with a molecular mass of 160 kDa, congruent with a dimeric or trimeric solution
state [C. M. Starks].
Kinetic characterization of AarCH6. The determination of accurate kinetic
parameters for AarCH6 was complicated by apparent acetate substrate inhibition (Figure
2.5A) and the presence of CoA, a common contaminant in commercial acyl-CoAs (~5%
in acetyl-CoA, ~10% in succinyl-CoA) that hinders substrate saturation. Accurate acid
substrate kinetic constants for class I CoA-transferases require saturation of the enzyme
with the acyl-CoA substrate. LCF/LCR assays allowed simultaneous determination of
CoA levels and enzyme activity. Similar kinetic parameters were obtained using both
LCF/VisF and LCR/VisR assays (Figure 2.5A/C).
Steady-state kinetic analysis was performed for each substrate at a single, saturating,
but minimally inhibitory concentration of the second substrate (Table 2.5). LCR assays
spiked with CoA showed that CoA is an effective competitive inhibitor versus acetylCoA (Figure 2.6B). A plot of velocity versus [acetyl-CoA] is only satisfactorily fit if
inhibition due to residual CoA is taken into account (Figure 2.5D). The increased scatter
in velocities determined with succinyl-CoA (LCF assay) gave fits that were not improved
30

by correcting for CoA inhibition (Figure 2.5B). If CoA is an equally potent competitor for
each acyl-CoA substrate, the values given underestimate the succinyl-CoA Km and kcat
values by ~15% but have a negligible effect on Keq.

A

B

C

D

Figure 2.5. Kinetic characterization of AarCH6. (A) Acetate saturation data at pH 8.0 (red circles),
pH 6.0 (blue squares), and pH 5.0 (green triangles) obtained with the LCF (solid symbols) and the
VisF (open symbols) assays using a fixed concentration of succinyl-CoA (0.2 mM). Substrate
inhibition was observed under all pH conditions examined. (B) Succinyl-CoA saturation data at pH
8.0 obtained with the LCF assay using a fixed concentration of acetate (350 mM). (C) Succinate
saturation data at pH 8.0 obtained with the LCR (red circles) and VisR (blue squares) assays using a
fixed concentration of acetyl-CoA (1.0 or 0.5 mM, respectively). (D) Acetyl-CoA saturation data at
pH 8.0 obtained with the LCR assay using a fixed concentration of succinate (20 mM). The red solid
line is a fit of the data accounting for competitive inhibition due to CoA contamination (determined
using LCR assays spiked with additional CoA). The blue dashed line is a simulation using the fitted
parameters, representing the expected acetyl-CoA saturation curve without the influence of CoA
contamination ([CoA] = 0).
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Table 2.5. AarCH6 kinetic constantsa
Substrate or inhibitor

Parameter

Value

acetate (pH 8.0)b

kcat (s−1)

280 ± 40

Km (mM)

70 ± 20

kcat/Km (M−1 s−1)

(4 ± 1) × 103

Ki,acetate (mM)

1600 ± 800

kcat (s−1)

147 ± 9

Km (mM)

50 ± 10

kcat/Km (M−1 s−1)

(2.9 ± 0.6) × 103

Ki,acetate (mM)

1100 ± 300

kcat (s−1)

49 ± 6

Km (mM)

29 ± 8

kcat/Km (M−1 s−1)

(1.7 ± 0.5) × 103

Ki,acetate (mM)

500 ± 100

kcat (s−1)

201 ± 8

Km (µM)

22 ± 4

kcat/Km (M−1 s−1)

(9 ± 2) × 106

kcat (s−1)

71 ± 2

Km (mM)

0.9 ± 0.1

kcat/Km (M−1 s−1)

(7.9 ± 0.9) × 104

kcat (s−1)

75 ± 2

Km (µM)

22 ± 2

kcat/Km (M−1 s−1)

(3.4 ± 0.3) × 106

Ki,CoA (µM)e

16 ± 2

---

Keqf

0.14 ± 0.05

acetoacetated

kcat (s−1)

37 ± 3

Km (mM)

130 ± 10

kcat/Km (M−1 s−1)

(2.8 ± 0.4) × 102

Ki (µM)g

17 ± 3

Kd (µM)

0.8 ± 0.2

acetate (pH 6.0)b

acetate (pH 5.0)b

succinyl-CoAb

succinatec

acetyl-CoAc

dethiaacetyl-CoA

a

Assays were performed at 25 °C and pH 8.0 unless otherwise noted. Turnover numbers were (cont.)
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calculated assuming one active site per 55.8 kDa subunit (1 s−1 = 1.07 U/mg). b LCF assays were
performed using a fixed concentration of either succinyl-CoA (0.2 mM) or acetate (350 mM) and a
variable concentration of the other substrate. c LCR assays were performed using a fixed
concentration of either acetyl-CoA (1.0 mM) or succinate (20 mM) and a variable concentration of the
other substrate. d Modified LCF assays were performed using a fixed concentration of succinyl-CoA
(0.2 mM) and a variable concentration of acetoacetate (1 − 100 mM). e Modified LCR assays were
performed using a variable concentration of acetyl-CoA (5 − 1,200 µM) and fixed concentrations of
succinate (20 mM) and CoA (unadjusted or adjusted to a final concentration of 40, 70, or 100 µM). f
The equilibrium constant was calculated using the Haldane relationship [Keq = (kcat/Km,succinyl-CoA × kcat/
Km,acetate)/(kcat/Km,acetyl-CoA × kcat/Km,succinate)] (62). g Modified LCR assays were performed using a
variable concentration of acetyl-CoA (10 − 300 µM) and fixed concentrations of succinate (20 mM)
and dethiaacetyl-CoA (0, 5, 25, or 50 µM).

Acetoacetate is a cosubstrate for several CoA-transferases that convert succinyl-CoA to
succinate (36, 37). LCF assays containing acetoacetate instead of acetate showed that
AarCH6 is also able to use acetoacetate as a CoA-acceptor. [The product peak had the
same HPLC retention time as an authentic acetoacetyl-CoA standard.] The acetoacetate
kcat/Km, however, is only 7% of that of acetate assayed under the same conditions (Table
2.5).
Preliminary mechanistic analysis of AarCH6. A previously published sequence
alignment of active-site residues from several class I CoA-transferases (38) suggests that
AarC(H6) is a class I enzyme. Class I CoA-transferases first bind the acyl-CoA substrate
forming a glutamyl-CoA thioester intermediate and a carboxylate product (39, 40). The
carboxylate product is then released before the carboxylate substrate is bound, accounting
for the observed ping-pong kinetics (41) and susceptibility to borohydride inactivation
(40, 42, 43). Sodium borohydride treatment of AarCH6 that had been incubated with
acetyl-CoA caused near-complete loss of enzyme activity (0.7% relative activity) with
respect to a control lacking both acetyl-CoA and sodium borohydride (100% relative
activity, 79 U/mg), consistent with reduction of the glutamyl-CoA thioester intermediate
to 5-hydroxynorvaline. ESI-TOF-MS analysis of the borohydride-treated enzyme
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complex was also consistent with the anticipated –14 Da change (55,832 ± 2 Da
observed; 55,833 Da expected; Figure A.2). Sodium borohydride treatment of AarCH6 in

A

B

C

Figure 2.6. Further kinetic characterization of AarCH6. (A) Parallel lines indicative of ping-pong
kinetics were observed in a modified LCR assays containing a variable concentration of succinate
(0.3 – 13 mM) and a fixed concentration of acetyl-CoA [10 (red circles), 19 (blue squares), 60 (green
triangles), or 300 µM (black diamonds)]. (B) CoA was determined to be a competitive inhibitor in
modified LCR assays containing a variable concentration of acetyl-CoA (5 – 1200 µM) and fixed
concentrations of succinate (20 mM) and CoA [unadjusted (red circles) or adjusted to a final
concentration of 40 (blue squares), 70 (green triangles), or 100 µM (black diamonds)]. (C)
Dethiaacetyl-CoA was determined to be a competitive inhibitor in modified LCR assays containing a
variable concentration of acetyl-CoA (10 – 300 µM) and fixed concentrations of succinate (20 mM)
and dethiaacetyl-CoA [0 (red circles), 5 (blue squares), 25 (green triangles), or 50 µM (black
diamonds)]. In all panels, the solid lines illustrate linear regressions to datasets of the same color and
were not used in the determination of enzyme kinetic parameters. Kinetic parameters and error
estimates (Table 2.5) were determined by global nonlinear fitting as described in the Materials and
Methods. Velocities in panels A and C are averages of two determinations.
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the absence of acetyl-CoA caused partial inactivation (71% relative activity), which may
indicate that a portion of the enzyme was isolated as the covalent AarCH6-CoA adduct.
Steady-state kinetic experiments produced nonintersecting lines in double-reciprocal
plots (Figure 2.6A), congruent with ping-pong kinetics and a modified-enzyme
mechanism.

DISCUSSION
Genetic screens identified two categories of Acetobacter genes affecting acetic acid
resistance: (i) those that improve the acetic acid resistance of A. aceti strains when
introduced or overexpressed, including the aarABC gene cluster (11) and the aconitase
gene (44), and (ii) those that improve the acetic acid resistance of E. coli, including the
RecG (45) and AatA genes (5). This study further defines the mechanism by which the
aarABC gene cluster confers acetic acid resistance and assesses the potential role of the
CAC and related pathways in acetic acid dissimilation.
The A. aceti CAC converts acetate to carbon dioxide, a characteristic ability of
members of the genus Acetobacter. A prerequisite is efficient conversion of acetate to
acetyl-CoA, which can be performed by AckA/Pta or Acs. Pta and Acs activities increase
in A. aceti during acetate oxidation (46). Sustained acetyl-CoA oxidation requires a
complete CAC. SCS genes, however, are not present in a draft A. aceti strain 1023
genome sequence, and SCS activity was not detected in A. aceti strain 1023 lysate.
When grown in the presence of glucose, A. aceti is able to assimilate carbon from
acetate (5) or ethanol (47). [Ethanol is presumably oxidized to acetate in the course of
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assimilation.] Isocitrate lyase and malate synthase activities have been reported in A.
aceti cells grown on acetate as the sole carbon source (48), which would be consistent
with acetate assimilation by the glyoxylate shunt. However, genes for the glyoxylate
shunt enzymes are not present in a draft A. aceti strain 1023 genome sequence (3). A.
aceti may assimilate acetate by a different route. Alternative pathways are present in
several other α-proteobacteria that lack isocitrate lyase (49).
The findings described herein show that A. aceti contains a complete but unorthodox
CAC in which the acetic-acid-resistance protein AarC (SCACT) converts succinyl-CoA
and acetate to succinate and acetyl-CoA. This bypass facilitates the metabolic activation
and oxidation of acetate and constitutes part of a conditionally essential detoxification
pathway required for survival at high acetic acid concentrations.
Potential advantages of SCACT. The use of SCACT bypasses a nucleotide
requirement in the CAC and the need for initial acetate phosphorylation or adenylation
(Figure 2.7), decreasing the sensitivity of flux through the CAC to the energy state of the
cell. The metabolic demand for free CoA is similarly reduced. Moreover, sustained acetic
acid detoxification by irreversible oxidation would require only the favorable
regeneration of reduced pathway cofactors.
AarC homologues in other AAB. Southern hybridization experiments indicated that
sequences homologous to aarC are widely present in AAB of the genus Acetobacter (13).
Examination of three genome sequences from more diverse AAB revealed a close match
to AarC in only A. cryptum (YP_001234564, E = 1 × 10−132), which also contains SCS
genes (http://genome.jgi-psf.org/finished_microbes/acicr/acicr.home.html). Genes
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Figure 2.7. Acetate oxidation by an unorthodox A. aceti CAC. Gray lines indicate CAC genes that are
not found in a draft A. aceti strain 1023 genome sequence (3). Each has a functional replacement.
Using periplasmic dehydrogenases, A. aceti produces large quantities of acetic acid from ethanol and
must contend with a constant influx of the former. Together with a complete oxidative
phosphorylation pathway, this variant CAC functions in the eight-electron oxidation of acetic acid:
CH3COOH + 2 O2 → 2 CO2 + 2 H2O. This pathway skips AckA, Acs, and SCS (sucCD), the only
steps that would be directly influenced by cytoplasmic nucleotide pools, and reduces the number of
enzymes that have free CoA substrates from two to one. The initial electron acceptors, two NAD+,
one FAD, and one ubiquinone (presumed to be Q9 in A. aceti), would give a lower energy yield than
the canonical CAC but have an additional irreversible step, the Mqo-mediated quinone reduction.
Genes for the glyoxylate shunt enzymes isocitrate lyase and malate synthase are not found in A. aceti
strain 1023.

homologous to aarC were not found in the complete genome sequences of the AAB G.
bethesdensis CGDNIH1 (33) or G. oxydans (34). G. bethesdensis CGDNIH1, however,
does possess SCS genes. Only G. oxydans lacks the genes necessary for a complete CAC.
Comparison with other CAC bypasses. Helicobacter pylori lacks several typical
CAC components (26, 50), including Mdh, which is replaced by Mqo, and SCS, which is
replaced by succinyl-CoA:acetoacetate CoA-transferase (36). AarC is also able to support
succinyl-CoA:acetoacetate CoA-transferase activity, albeit with a substantially lower kcat/
Km than that of either acetate or succinate (Table 2.5). Given the likelihood that the
concentration of acetate is much greater than the concentration of acetoacetate in the A.
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aceti cytoplasm and that genetic experiments associate aarC with acetate metabolism (11,
13), AarC is likely to function principally as SCACT.
Mycobacterium tuberculosis lacks both α-ketoglutarate dehydrogenase and SCS, which
are replaced by α-ketoglutarate decarboxylase and succinic semialdehyde dehydrogenase
(23). [Neither of these activities was detected in A. aceti lysates (J. A. Francois).] Like the
A. aceti SCACT bypass, the succinic semialdehyde bypass avoids CoA- and nucleotidedependent steps in the CAC.
All three bypasses preserve the typical cyclic course of the CAC and thereby differ
from the "branched" CAC variants in facultative and obligate anaerobes (51).
Metabolic flux. The kinetic and mechanistic parameters of SCACT delineate potential
effect(s) on metabolic flux. A. aceti strain 1023 tolerates > 0.5 M acetic acid, but aardisrupted strains are unable to survive 50 mM acetic acid (11). Since there is likely no
difference in acetate permeation, removal of cytoplasmic acetate appears to become
critical at ~10−2 M. The observed acetate Km values are in this range (Table 2.5),
consistent with a conditionally essential detoxification role for AarC. At lower pH, the
acetate Km decreases, possibly increasing the rate of acetate oxidation during intense
acetic acid stress.
The thiotransesterification reactions performed by CoA-transferases tend to have small
|ΔG| values. The slightly unfavorable SCACT reaction (Keq = 0.14; ΔG = +1.2 kcal/mol)
would be mitigated at high acetate levels or when acetyl-CoA is rapidly consumed by the
CAC, i.e., during vigorous aeration. Additionally, the near-thermoneutrality of the
SCACT reaction is likely to be maintained in A. aceti as the cytoplasmic pH drops (4).
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Acetate dissimilation. Reliance on a complete CAC for acetate removal might explain
the vigorous oxygenation requirements of A. aceti cultures, which become critical at high
acetic acid levels (14, 52). Together with ADH-mediated ethanol oxidation, the CAC
supplies energy for many cellular processes, including the maintenance of a proton
gradient. Transient oxygen deprivation sharply decreases cell viability within minutes
(14), which is not consistent with energy loss due to a slow collapse of the
transmembrane pH gradient. Instead, evidence presented here indicates that a complete
CAC, including AarC, supports the overoxidation of acetate to carbon dioxide (Figure
2.7). Cytoplasmic acetate would rapidly accumulate if cofactor reoxidation slows, which
is consistent with the observed rapid loss of cell viability during inadequate culture
aeration.
In many Gram-negative bacteria, NADH limits CAC flux under anaerobic conditions.
Citrate synthase (53) and Mdh (54) are susceptible to allosteric and product inhibition,
respectively. However, both the acid-tolerant H. pylori and the acidophilic A. aceti
contain citrate synthase forms that are insensitive to NADH (12, 50). Additionally, Mdh
is replaced by Mqo in both organisms. Ubiquinone reduction by Mqo is more favorable
than NAD+ reduction by Mdh and is largely independent of the [NADH]/[NAD+] ratio.
Both properties would tend to favor the production of oxaloacetate. In A. aceti, these
adaptations may avoid suppression of acetate dissimilation during periods of acetic acid
stress.
Acetate secretion by bacteria is often due to activation of the carbon overflow pathway
during anaerobiosis or when the central metabolic pathways are overtaxed (55). NAD+
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and CoA are recovered as acetyl-CoA is converted to CoA and acetate, a diffusible
compound that leaves the cytoplasm but can be recovered in the stationary phase. In
AAB, vigorous periplasmic ethanol oxidation ensures that the acetate concentration
gradient is always directed inward, precluding the diffusive loss of excess cytoplasmic
acetate. Oxidation of acetate to carbon dioxide by the AarC-modified A. aceti CAC
allows diffusive carbon loss, since carbon dioxide is favored over bicarbonate at low pH
and can traverse bacterial cell membranes (56).
A CAC regulator in the aarA-aarC intergenic region. New assignments in the A.
aceti aarA-aarC intergenic region explain several previously confusing observations,
including the singular gene X and aarB sequences that are apparently unique to A. aceti.
The gene X region was reannotated as tyrA (chorismate mutase). Chorismate mutase
performs a key step in aromatic amino acid biosynthesis, suggesting that the inviability of
strains disrupted in the X/tyrA region (11) may have resulted from a nutritional
deficiency. Additionally, the aarB region was reannotated as sixA (phosphoprotein
phosphatase). SixA regulates the ArcA/ArcB anoxic-redox-control system, one of a small
number of global regulatory systems in E. coli that represses the synthesis of aerobic
metabolic enzymes during anaerobic conditions (57, 58). The observed increase in CAC
enzyme activities in an ArcA-knockout (59) suggests that SixA-dependent suppression of
the ArcA/ArcB anoxic-redox-control system would stimulate flux through the CAC.
Reassignment of the conditionally essential aarB region to sixA is congruent with known
AarA and AarC functions.
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Conclusion. The functional assignment of AarC (SCACT) reconciles the apparent need
for a complete CAC for acetic acid resistance and the absence of SCS genes in a draft A.
aceti strain 1023 genome sequence. AarC forms an internal shunt that enables direct
incorporation of acetate into the CAC and facilitates the dissimilation of diffusively
trapped cytoplasmic acetate.

FUTURE DIRECTIONS
The specialized CAC described herein has obvious significance for acetic acid
resistance and dissimilation but somewhat ambiguous implications for acetate
assimilation. Unlike the glyoxylate shunt enzymes isocitrate lyase and malate synthase,
AarC does not bypass the two oxidative decarboxylations performed by CAC
dehydrogenases. The ability of A. aceti to utilize acetate as a sole carbon source is
contentious (13, 48). This phenotypic discrepancy may be indicative of genotypic
variance among members of a genetically unstable genus (32). Sequencing of the A. aceti
strain 2002 genome would allow for comparison of the type strain and a vinegarproduction strain. Two such strains should be representative of the significant genetic
diversity found within A. aceti.
Suppression of acetate catabolism during ethanol oxidation is critical for efficient
vinegar production and requires that the dissimilatory nature of the A. aceti CAC be
curtailed. The molecular manner in which acetate overoxidation is regulated is unknown.
Measuring levels of aarC (mRNA), AarC, and SCACT activity as a function of medium
composition (ethanol, acetate, and glucose concentrations) and pH could provide
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information that would ultimately allow the design of more effective industrial vinegarproduction strains. Initial findings are presented in Chapter 3.

REFERENCES
1.

Bergey, D. H., Krieg, N. R., and Holt, J. G. (1984) Bergey's manual of systematic
bacteriology, Williams & Wilkins, Baltimore, MD.

2.

Constantine, C. Z., Starks, C. M., Mill, C. P., Ransome, A. E., Karpowicz, S. J.,
Francois, J. A., Goodman, R. A., and Kappock, T. J. (2006) Biochemical and
structural studies of N5-carboxyaminoimidazole ribonucleotide mutase from the
acidophilic bacterium Acetobacter aceti, Biochemistry 45, 8193-8208.

3.

Francois, J. A., and Kappock, T. J. (2007) Alanine racemase from the acidophile
Acetobacter aceti, Protein Expr. Purif. 51, 39-48.

4.

Menzel, U., and Gottschalk, G. (1985) The internal pH of Acetobacterium wieringae
and Acetobacter aceti during growth and production of acetic acid, Arch. Microbiol.
143, 47-51.

5.

Nakano, S., Fukaya, M., and Horinouchi, S. (2006) Putative ABC transporter
responsible for acetic acid resistance in Acetobacter aceti, Appl. Environ. Microbiol.
72, 497-505.

6.

Matsushita, K., Inoue, T., Adachi, O., and Toyama, H. (2005) Acetobacter aceti
possesses a proton motive force-dependent efflux system for acetic acid, J. Bacteriol.
187, 4346-4352.

7.

Lasko, D. R., Schwerdel, C., Bailey, J. E., and Sauer, U. (1997) Acetate-specific
stress response in acetate-resistant bacteria: an analysis of protein patterns,
Biotechnol. Prog. 13, 519-523.

8.

Steiner, P., and Sauer, U. (2001) Proteins induced during adaptation of Acetobacter
aceti to high acetate concentrations, Appl. Environ. Microbiol. 67, 5474-5481.

9.

Ohmori, S., Arima, K., Beppu, T., and Masai, H. (1980) Isolation and identification
of acetic acid bacteria for submerged acetic acid fermentation at high temperature,
Agric. Biol. Chem. 44, 2901-2906.

10. Ohmori, S., Uozumi, T., and Beppu, T. (1982) Loss of acetic acid resistance and
ethanol oxidizing ability in an Acetobacter strain, Agric. Biol. Chem. 46, 381-389.

42

11. Fukaya, M., Takemura, H., Okumura, H., Kawamura, Y., Horinouchi, S., and Beppu,
T. (1990) Cloning of genes responsible for acetic acid resistance in Acetobacter
aceti, J. Bacteriol. 172, 2096-2104.
12. Francois, J. A., Starks, C. M., Sivanuntakorn, S., Jiang, H., Ransome, A. E., Nam, J.
W., Constantine, C. Z., and Kappock, T. J. (2006) Structure of a NADH-insensitive
hexameric citrate synthase that resists acid inactivation, Biochemistry 45,
13487-13499.
13. Fukaya, M., Takemura, H., Tayama, K., Okumura, H., Kawamura, Y., Horinouchi, S.,
and Beppu, T. (1993) The aarC gene responsible for acetic acid assimilation confers
acetic acid resistance on Acetobacter aceti, J. Ferment. Bioeng. 76, 270-275.
14. Muraoka, H., Watabe, Y., and Ogasawara, N. (1982) Effect of oxygen deficiency on
acid production and morphology of bacterial cells in submerged acetic fermentation
by Acetobacter aceti, J. Ferment. Technol. 60, 171-180.
15. Huang, X., Wang, J., Aluru, S., Yang, S. P., and Hillier, L. (2003) PCAP: a wholegenome assembly program, Genome Res. 13, 2164-2170.
16. Badger, J. H., and Olsen, G. J. (1999) CRITICA: coding region identification tool
invoking comparative analysis, Mol. Biol. Evol. 16, 512-524.
17. Delcher, A. L., Harmon, D., Kasif, S., White, O., and Salzberg, S. L. (1999)
Improved microbial gene identification with GLIMMER, Nucleic Acids Res. 27,
4636-4641.
18. Juncker, A. S., Willenbrock, H., Von Heijne, G., Brunak, S., Nielsen, H., and Krogh,
A. (2003) Prediction of lipoprotein signal peptides in Gram-negative bacteria,
Protein Sci. 12, 1652-1662.
19. Bendtsen, J. D., Nielsen, H., von Heijne, G., and Brunak, S. (2004) Improved
prediction of signal peptides: SignalP 3.0, J. Mol. Biol. 340, 783-795.
20. Mulder, N. J., Apweiler, R., Attwood, T. K., Bairoch, A., Bateman, A., Binns, D.,
Bradley, P., Bork, P., Bucher, P., Cerutti, L., Copley, R., Courcelle, E., Das, U.,
Durbin, R., Fleischmann, W., Gough, J., Haft, D., Harte, N., Hulo, N., Kahn, D.,
Kanapin, A., Krestyaninova, M., Lonsdale, D., Lopez, R., Letunic, I., Madera, M.,
Maslen, J., McDowall, J., Mitchell, A., Nikolskaya, A. N., Orchard, S., Pagni, M.,
Ponting, C. P., Quevillon, E., Selengut, J., Sigrist, C. J., Silventoinen, V., Studholme,
D. J., Vaughan, R., and Wu, C. H. (2005) InterPro, progress and status in 2005,
Nucleic Acids Res. 33, D201-D205.

43

21. Kanehisa, M., Goto, S., Hattori, M., Aoki-Kinoshita, K. F., Itoh, M., Kawashima, S.,
Katayama, T., Araki, M., and Hirakawa, M. (2006) From genomics to chemical
genomics: new developments in KEGG, Nucleic Acids Res. 34, D354-D357.
22. Ausubel, F. M., Brent, R., Kingston, E., Moore, D. D., Siedman, J. D., Smith, J. A.,
and Struhl, K. (2000) Current protocols in molecular biology, John Wiley & Sons,
New York, NY.
23. Tian, J., Bryk, R., Itoh, M., Suematsu, M., and Nathan, C. (2005) Variant
tricarboxylic acid cycle in Mycobacterium tuberculosis: identification of αketoglutarate decarboxylase, Proc. Natl. Acad. Sci. USA 102, 10670-10675.
24. Ramaley, R. F., Bridger, W. A., Moyer, R. W., and Boyer, P. D. (1967) The
preparation, properties, and reactions of succinyl-coenzyme A synthetase and its
phosphorylated form, J. Biol. Chem. 242, 4287-4298.
25. Fernandes, A. S., Pereira, M. M., and Teixeira, M. (2001) The succinate
dehydrogenase from the thermohalophilic bacterium Rhodothermus marinus: RedoxBohr effect on heme bL, J. Bioenerg. Biomembr. 33, 343-352.
26. Kather, B., Stingl, K., van der Rest, M. E., Altendorf, K., and Molenaar, D. (2000)
Another unusual type of citric acid cycle enzyme in Helicobacter pylori: the
malate:quinone oxidoreductase, J. Bacteriol. 182, 3204-3209.
27. Riddles, P. W., Blakeley, R. L., and Zerner, B. (1979) Ellman's reagent: 5,5'dithiobis(2-nitrobenzoic acid)--a reexamination, Anal. Biochem. 94, 75-81.
28. Dawson, R. M. C. (1986) Data for biochemical research, 3rd ed., Clarendon Press,
Oxford, United Kingdom.
29. Cleland, W. W. (1979) Statistical analysis of enzyme kinetic data, Methods Enzymol.
63, 103-138.
30. Demoz, A., Garras, A., Asiedu, D. K., Netteland, B., and Berge, R. K. (1995) Rapid
method for the separation and detection of tissue short-chain coenzyme A esters by
reversed-phase high-performance liquid chromatography, J. Chromatogr. B Biomed.
Appl. 667, 148-152.
31. Burns, K. L., Gelbaum, L. T., Sullards, M. C., Bostwick, D. E., and May, S. W.
(2005) Iso-coenzyme A, J. Biol. Chem. 280, 16550-16558.
32. Beppu, T. (1993) Genetic organization of Acetobacter for acetic acid fermentation,
Antonie Van Leeuwenhoek 64, 121-135.

44

33. Greenberg, D. E., Porcella, S. F., Zelazny, A. M., Virtaneva, K., Sturdevant, D. E.,
Kupko, J. J., 3rd, Barbian, K. D., Babar, A., Dorward, D. W., and Holland, S. M.
(2007) Genome sequence analysis of the emerging human pathogenic acetic acid
bacterium Granulibacter bethesdensis, J. Bacteriol. 189, 8727-8736.
34. Prust, C., Hoffmeister, M., Liesegang, H., Wiezer, A., Fricke, W. F., Ehrenreich, A.,
Gottschalk, G., and Deppenmeier, U. (2005) Complete genome sequence of the
acetic acid bacterium Gluconobacter oxydans, Nat. Biotechnol. 23, 195-200.
35. Goldie, A. H., Narindrasorasak, S., and Sanwal, B. D. (1978) An unusual type of
regulation of malate oxidase synthesis in Escherichia coli, Biochem. Biophys. Res.
Commun. 83, 421-426.
36. Corthesy-Theulaz, I. E., Bergonzelli, G. E., Henry, H., Bachmann, D., Schorderet, D.
F., Blum, A. L., and Ornston, L. N. (1997) Cloning and characterization of
Helicobacter pylori succinyl CoA:acetoacetate CoA-transferase, a novel prokaryotic
member of the CoA-transferase family, J. Biol. Chem. 272, 25659-25667.
37. Hersh, L. B., and Jencks, W. P. (1967) Coenzyme A transferase. Kinetics and
exchange reactions, J. Biol. Chem. 242, 3468-3480.
38. Mack, M., and Buckel, W. (1997) Conversion of glutaconate CoA-transferase from
Acidaminococcus fermentans into an acyl-CoA hydrolase by site-directed
mutagenesis, FEBS Lett. 405, 209-212.
39. Rochet, J. C., and Bridger, W. A. (1994) Identification of glutamate 344 as the
catalytic residue in the active site of pig heart CoA transferase, Protein. Sci. 3,
975-981.
40. Solomon, F., and Jencks, W. P. (1969) Identification of an enzyme-γ-glutamyl
coenzyme A intermediate from coenzyme A transferase, J. Biol. Chem. 244,
1079-1081.
41. Heider, J. (2001) A new family of CoA-transferases, FEBS Lett. 509, 345-349.
42. Hersh, L. B., and Jencks, W. P. (1967) Coenzyme A transferase. Isolation and
properties of an enzyme-coenzyme A intermediate, J. Biol. Chem. 242, 3481-3486.
43. Hersh, L. B., and Jencks, W. P. (1967) Isolation of an enzyme-coenzyme A
intermediate from succinyl coenzyme A-acetoacetate coenzyme A transferase, J.
Biol. Chem. 242, 339-340.
44. Nakano, S., Fukaya, M., and Horinouchi, S. (2004) Enhanced expression of
aconitase raises acetic acid resistance in Acetobacter aceti, FEMS Microbiol. Lett.
235, 315-322.
45

45. Steiner, P., and Sauer, U. (2003) Overexpression of the ATP-dependent helicase
RecG improves resistance to weak organic acids in Escherichia coli, Appl.
Microbiol. Biotechnol. 63, 293-299.
46. Saeki, A., Matsushita, K., Takeno, S., Taniguchi, M., Toyama, H., Theeragool, G.,
Lotong, N., and Adachi, O. (1999) Enzymes responsible for acetate oxidation by
acetic acid bacteria, Biosci. Biotechnol. Biochem. 63, 2102-2109.
47. Rao, M. R., and Stokes, J. L. (1953) Utilization of ethanol by acetic acid bacteria, J.
Bacteriol. 66, 634-638.
48. Stouthamer, A. H., van Boom, J. H., and Bastiaanse, A. J. (1963) Metabolism of C2
compounds in Acetobacter aceti, Antonie van Leeuwenhoek 29, 393-406.
49. Alber, B. E., Spanheimer, R., Ebenau-Jehle, C., and Fuchs, G. (2006) Study of an
alternate glyoxylate cycle for acetate assimilation by Rhodobacter sphaeroides, Mol.
Microbiol. 61, 297-309.
50. Pitson, S. M., Mendz, G. L., Srinivasan, S., and Hazell, S. L. (1999) The
tricarboxylic acid cycle of Helicobacter pylori, Eur. J. Biochem. 260, 258-267.
51. Cronan, J. E., Jr., and Laporte, D. (1996) Tricarboxylic acid cycle and glyoxylate
bypass, in Escherichia coli and Salmonella: cellular and molecular biology
(Neidhardt, F. C., Curtiss III, R., Ingraham, J. L., Lin, E. C. C., Low, K. B.,
Magasanik, B., Reznikoff, M., Riley, M., Schaechter, M., and Umbarger, H. E., Eds.)
2nd ed., pp 202-216, American Society for Microbiology, Washington, DC.
52. Mesa, M. M., Caro, I., and Cantero, D. (1996) Viability reduction of Acetobacter
aceti due to the absence of oxygen in submerged cultures, Biotechnol. Prog. 12,
709-712.
53. Nguyen, N. T., Maurus, R., Stokell, D. J., Ayed, A., Duckworth, H. W., and Brayer,
G. D. (2001) Comparative analysis of folding and substrate binding sites between
regulated hexameric type II citrate synthases and unregulated dimeric type I
enzymes, Biochemistry 40, 13177-13187.
54. Wise, D. J., Anderson, C. D., and Anderson, B. M. (1997) Purification and kinetic
characterization of Haemophilus parasuis malate dehydrogenase, Arch. Biochem.
Biophys. 344, 176-183.
55. Wolfe, A. J. (2005) The acetate switch, Microbiol. Mol. Biol. Rev. 69, 12-50.
56. Merlin, C., Masters, M., McAteer, S., and Coulson, A. (2003) Why is carbonic
anhydrase essential to Escherichia coli?, J. Bacteriol. 185, 6415-6424.

46

57. Bauer, C. E., Elsen, S., and Bird, T. H. (1999) Mechanisms for redox control of gene
expression, Annu. Rev. Microbiol. 53, 495-523.
58. Iuchi, S., and Lin, E. C. (1988) arcA (dye), a global regulatory gene in Escherichia
coli mediating repression of enzymes in aerobic pathways, Proc. Natl. Acad. Sci.
USA 85, 1888-1892.
59. Perrenoud, A., and Sauer, U. (2005) Impact of global transcriptional regulation by
ArcA, ArcB, Cra, Crp, Cya, Fnr, and Mlc on glucose catabolism in Escherichia coli,
J. Bacteriol. 187, 3171-3179.
60. Miroux, B., and Walker, J. E. (1996) Over-production of proteins in Escherichia coli:
mutant hosts that allow synthesis of some membrane proteins and globular proteins
at high levels, J. Mol. Biol. 260, 289-298.
61. Laboratories, B. R. (1986) BRL pUC host: E. coli DH5α competent cells, Focus 8, 9.
62. Cleland, W. W. (1982) An analysis of Haldane relationships, Methods Enzymol. 87,
366-369.

47

Chapter 3.
Propagation of Acetobacter aceti and preliminary analysis of the aar gene cluster

INTRODUCTION
The characteristic ability of acetic acid bacteria (AAB) to aerobically oxidize ethanol to
acetic acid has been harnessed for millennia to produce vinegar (1). This process is often
accompanied by diauxic growth (2-4). Cultures accumulate acetate in the first log phase
as ethanol is oxidized, maintain acetate during the first stationary phase, and then deplete
acetate in the second log phase. Ideal strains for vinegar production exhibit little acetic
acid consumption during the first log phase and an ability to tolerate high concentrations
of acetic acid during a prolonged conservation phase (4).
A genetic screen of the industrial vinegar-production strain Acetobacter aceti 1023
identified a gene region that was essential for acetic acid resistance (5). The aar gene
cluster contains five genes, of which three have roles in acetic acid resistance: aarA
encodes citrate synthase (CS, AarA) (5, 6), sixA encodes a phosphoprotein phosphatase
(SixA) that modulates synthesis of citric acid cycle (CAC) enzymes (7), and aarC
encodes succinyl-CoA:acetate CoA-transferase (SCACT, AarC) (Chapter 2). AarA and
AarC constitute part of a specialized CAC that provides acetic acid resistance by
catalyzing the "overoxidation" of cytoplasmic acetic acid to carbon dioxide. AarC
facilitates this process by circumventing substrate-level phosphorylation and/or
adenylation of acetate.
The glyoxylate shunt enzymes isocitrate lyase and malate synthase, which bypass the
oxidative decarboxylations performed by CAC dehydrogenases, are absent from A. aceti
strain 1023 (Chapter 2). The lack of a glyoxylate shunt suggests that rapid acetate
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depletion in the second log phase occurs primarily, if not exclusively, by dissimilatory
(catabolic) means, and not by assimilatory (anabolic) means as suggested previously (8).
This study seeks to correlate transcriptional and translational levels of aar products
with acetate levels during biphasic growth and to identify the molecular mechanism(s) by
which acetate overoxidation is regulated.

MATERIALS AND METHODS
Reagents and general analytical methods. Chemicals were purchased from SigmaAldrich or Fisher in the highest purity available unless otherwise noted.
Oligodeoxynucleotide (ODN) primers were obtained from Integrated DNA Technologies
and used without further purification. A. aceti citrate synthase (AaCS or AarA) and AaCS
with a C-terminal hexahistidine affinity tag (AaCSH6) were isolated by C. M. Starks and
C. Z. Constantine, respectively, as described previously (6). Restriction enzymes, DNA
modifying enzymes, and DNA size standards were purchased from New England
Biolabs. Protein quantitation by the method of Bradford was performed as described
previously (9). Absorbance measurements were recorded on an 8453 UV-visible
spectrophotometer (Agilent Technologies). Polymerase chain reaction (PCR) products
and plasmids were sequenced by the Purdue University Genomics Core Facility. Protein
mass was determined by matrix-assisted laser-desorption/ionization time-of-flight mass
spectrometry (MALDI-TOF-MS) by the Purdue Proteomic Facility.
Cloning and mutagenesis. DNA manipulations were performed using standard
molecular biology techniques (10). PCRs were performed using A. aceti strain 1023
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(Table 3.1) gDNA isolated with 20/G genomic tips (Qiagen), appropriate ODN primers
(Table 3.2), and Vent DNA polymerase. Mutagenesis reactions were performed using the
QuikChange II Site-Directed Mutagenesis kit (Stratagene), the indicated template
plasmids (Table 3.1), and appropriate ODN primers (Table 3.2).
Propagation of A. aceti strains. Yeast extract-peptone-dextrose (YPD, Sigma) plates
supplemented with 2% (v/v) ethanol (YPDE) were streaked from frozen A. aceti glycerol
stocks (Table 3.1). After three days at 30 °C, single colonies were picked and transferred
to 500-mL YPDE (2%) solutions in 2.8-L Fernbach flasks. Cultures were propagated at
30 °C with vigorous shaking (200 rpm) for 12 days. Aliquots (10 mL) were periodically
Table 3.1. Bacterial strains and plasmids used in this study
Descriptiona

Source

A. aceti 1023

Acetic-acid-tolerant factory strain

K. Kondob

A. aceti 10-8

Derivative of strain 1023, pro

K. Kondoc

A. aceti 2002

A. aceti type strain, DSM 2002

DSMZ

A. aceti AS10

Derivative of strain 10-8, pro, acetic acid sensitive

K. Kondoc

E. coli C41(DE3)

F′ ompT hsdSB(rB− mB−) gal dcm (DE3)

Avidisd

E. coli DH5α

F′ ϕ80lacZΔM15 Δ(lacZYA-argF)U169 deoR recA1 endA1
hsdR17(rK− mK+) phoA supE44 thi-1 gyrA96 relA1

Invitrogene

pET23a

T7 promoter expression vector, Apr

Novagen

pJK385

T7 promoter expression construct, encodes AarCH6, Apr

Chapter 2

pJK502

Derivative of pET23a, encodes SixAH6f

This study

pJK504

Derivative of pJK385, encodes AarCH6-C357Yg

This study

Strain or plasmid
Strains

Plasmids

a

Ampicillin resistant (Apr). b Described in reference (23). c Described in reference (5). d Described in
reference (24). e Described in reference (25). f PCR was performed to introduce a Ter175→Ser
mutation, adding SLEHHHHH to the C-terminus of SixA. g QuickChange mutagenesis was
performed to introduce a Cys357→Tyr mutation.
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Table 3.2. ODN primers used in this study
ODN

Sequence (5′ → 3′)a

Product

413

GAG CTC GAA TTC TTA GCG TTT GGC AAG CGG CAC ATA GTC AC

aarA

416

GAT ATA CAT ATG AGC GCG TCG CAG AAA GAA GGT AAG CTA TC

aarA

1221

CAG GAA GCC CTC ATA TGA CAG AGC G

aarC

1280

GCA ATA CTC GAG TTA TGA TGG GAG C

aarC

2004

GCC GCC ATA TGC GCC GCC TTG TTC TG

sixA

2005

GGC ATC TCG AGT GAG GGT CGC GCG AAT GT

sixA

2023

GCC GAT ACA ACC ACC AAT AAA AGC T

aarb

2028

GTT TAG GCT ACA TTG CCA TGA ACG GCA TGA

pJK504

2029

TCA TGC CGT TCA TGG CAA TGT AGC CTA AAC

pJK504

2037

GCC GGC ATA TGA CCG TGA CAG ACG ACC A

tyrA

2038

GCC GGC ATA TGC GAA ACG GAC TCC GCA

orf1

2053

GG TAG CGT TTA TTC GCT CTG CCG

aarb

a

Changes in the coding region relative to the genomic sequence are underlined. b The PCR amplicon
extends ~100 bp beyond both ends of the aar gene cluster.

removed and cells were harvested by centrifugation. Cell-free medium aliquots and cell
pellets were stored at –80 °C for subsequent analyses. Additional aliquots (3 mL) were
removed for RNA purification, mixed with 2 volumes of RNAprotect Bacteria reagent
(Qiagen), and incubated at room temperature for 5 minutes. Cells were then harvested by
centrifugation and cell pellets were stored at –80 °C. [Note: ethanol was added after the
YPD medium was autoclaved.]
Titration of acetate in A. aceti cultures. Percent acidity in A. aceti cultures was
determined by titration with 0.1 M sodium hydroxide (standardized with potassium
hydrogen phthalate) as described previously (2, 11). Uninoculated broth was also titrated
to determine the minimal background percent acidity present in YPD medium.
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Enzyme activity assays. Frozen cell pellets were resuspended in 10 mL ice-cold water,
repelleted by centrifugation, and then resuspended in 1 mL 50 mM potassium phosphate,
pH 8.0, and 100 mM potassium chloride. Cells were lysed by three cycles of sonication,
and debris was removed by centrifugation (16,100g and 4 °C for 15 min). SCACT and
CS activities in soluble lysates were determined using DTNB-dependent VisR and CS
assays as described previously (Chapter 2).
Isolation of RNA from A. aceti strain 1023. RNA was isolated using the RNeasy Mini
kit (Qiagen) according to the instructions of the manufacturer (protocol 4: enzymatic lysis
and proteinase K digestion of bacteria). Contaminating gDNA was removed by double
on-column DNase treatment using the RNase-Free DNase set (Qiagen). RNA used for
transcriptional mapping was also subjected to in-solution DNase treatment and then
repurified using the RNeasy Mini kit.
Reverse transcription-PCR (RT-PCR) amplification of aarA, sixA, and aarC. Onestep RT-PCR mixtures contained 1x Green GoTaq Flexi buffer, 4 mM dithioreitol (DTT),
1.25 mM magnesium chloride, 0.2 mM dNTPs, 1 µg DNase-treated total RNA, 0.3 µM
ODN primers (Table 3.2), 200 U Superscript II RNase H− reverse transcriptase
(Invitrogen), and 2.5 U GoTaq DNA polymerase (Promega). Reverse transcriptase was
omitted from PCR-control reactions. Amplification was performed in three stages: stage 1
(1 cycle), 30 min at 50 °C, 5 min at 94 °C; stage 2 (20 cycles, aarA; 25 cycles, sixA and
aarC), 0.5 min at 94 °C, 1 min at 62.5 °C, 1.5 min at 72 °C; and stage 3 (1 cycle), 5 min
at 72 °C.
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Approximate mapping of aar transcripts by RT-PCR. One-step RT-PCR was
performed as described above except that the annealing temperature (stage 2) was
reduced to 57.5 °C and the number of cycles in stage 2 was increased to 30. Reverse
transcriptase or reverse transcriptase and RNA were omitted from PCR-control reactions.
Reactions lacking RNA were supplemented with 10 ng gDNA and performed by K. E.
Nyffeler.
PCR amplification of the aar gene cluster. PCR mixtures contained 1x Phusion HF
buffer, 0.2 mM dNTPs, 125 ng A. aceti gDNA isolated with 20/G genomic tips (Qiagen),
0.2 µM ODN primers (Table 3.2), and 1 U Phusion DNA polymerase (New England
Biolabs). Amplification was performed in three stages: stage 1 (1 cycle), 2 min at 98 °C;
stage 2 (30 cycles), 10 s at 98 °C, 0.5 min at 65 °C, 2.5 min at 72 °C; and stage 3 (1
cycle), 5 min at 72 °C.
Purification of SixAH6. E. coli C41(DE3) cells freshly transformed with pJK502 were
propagated on Luria-Bertani (LB) medium containing 0.1 g/L ampicillin and 0.2% (w/v)
glucose (LB/Amp/Glc). [Cultures inoculated from frozen glycerol stocks failed to
overproduce SixAH6.] Production cultures (1 L LB/Amp/Glc) were inoculated with
overnight cultures at a 1:100 dilution and grown at 37 °C to an OD600 = 0.6. Cells were
then harvested by centrifugation and resuspended in 1 L LB/Amp containing 0.4 mM
isopropylthio-β-D-1-galactopyranoside (IPTG). Cultures were grown at 37 °C an
additional 3 h. Cells were then pelleted by centrifugation and stored at –80 °C. All
subsequent steps were performed at 4 °C. Cells (typically 5 g/L culture) were
resuspended in 5 mL/g 50 mM potassium phosphate, pH 6.0, and 100 mM potassium

54

chloride and disrupted by three cycles of sonication. Lysate was cleared by centrifugation
at 30,000g for 30 min, addition of streptomycin to 1% (w/v) from a 10% (w/v) stock,
incubation for 15 min, and additional centrifugation at 30,000g for 30 min. Solid
ammonium sulfate was then added to the cleared lysate to 25% saturation (144 g/L) over
30 min. After equilibrating an additional 30 min, solids were removed by centrifugation
at 30,000g for 10 min. Solid ammonium sulfate was then added to the supernatant to 45%
saturation (123 g/L) over 30 min. After equilibrating an additional 30 min, solids were
collected by centrifugation at 30,000g for 10 min, dissolved in a minimal volume of TK
buffer (50 mM Tris•HCl, pH 8.0, and 100 mM potassium chloride), and applied to a Ni2+charged nitrilotriacetic acid (Ni-NTA) agarose column (1.5 cm × 4.5 cm, 8.0 mL). The
column was washed with 5 column volumes of TK buffer containing 20 mM imidazole
and then developed in a linear gradient of imidazole (20 → 500 mM, 80 mL × 80 mL).
Fractions containing SixAH6 were identified by sodium dodecyl sulfate polyacrylamide
gel electrophoresis (SDS-PAGE), pooled, and concentrated to > 5 mg/mL by
ultrafiltration (Amicon Ultra-15; 3,000 MWCO). The concentration of imidazole was
reduced by several cycles of dilution and reconcentration. Single-use aliquots were flashfrozen and stored at –80 °C.
Preliminary analysis of SixA levels by Western blotting. Soluble proteins in A. aceti
strain 1023 lysate (previously prepared for enzyme activity assays) were separated by
SDS-PAGE (12%) and subsequently transferred to a PVDF membrane (0.2 µm, BioRad).
Transfer was performed for 1h at 100 V in Towbin buffer [25 mM Tris, 192 mM glycine,
and 20% (v/v) methanol]. The membrane was then blocked for 1 h with TTBS solution
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[100 mM Tris•HCl, pH 7.5, 150 mM sodium chloride, and 0.1% (v/v) Tween 20] and
probed for 1 h with custom polyclonal rabbit α-SixAH6 primary antibody (diluted
1:50,000 in TTBS solution; Cocalico Biologicals). Excess antibody was removed by
rinsing four times for 15 min with TTBS solution. The membrane was then probed for 1 h
with goat α-rabbit IgG (H+L) HRP conjugate secondary antibody (diluted 1:250,000 in
TTBS solution, Jackson ImmunoResearch). Excess antibody was again removed by
rinsing four times for 15 min with TTBS solution. The membrane was then soaked for 5
min in a 1:1 mixture of stable peroxide and luminol/enhancer solutions (Thermo
Scientific). Chemiluminescence was promptly measured using a ChemiImager 5500
imaging system (Alpha Innotech). The charge-coupled device (CCD) detector was
exposed to the blots for 1 − 5 min.
Preliminary analysis of AarC levels by Western blotting. AarC levels were
determined as described above for SixA except that the primary antibody was custom
polyclonal rabbit α-AarCH6 (diluted 1:50,000; Cocalico Biologicals) and the Towbin
buffer used for protein transfer was supplemented with 0.1% (w/v) sodium dodecyl
sulfate (SDS) to prevent protein from remaining trapped in the polyacrylamide gel.
Preliminary analysis of AarA levels by Western blotting. AarA levels were
determined as described above for AarC except that the primary antibody was custom
polyclonal chicken α-AarA (diluted 1:50,000; Cocalico Biologicals) and the secondary
antibody was rabbit α-chicken IgY (H+L) HRP conjugate (diluted 1:500,000; Thermo
Scientific).

56

Heterologous production of AarCH6-C357Y. E. coli C41(DE3) cells transformed
with pJK504 were propagated on LB medium containing 0.1 g/L ampicillin (LB/Amp).
Production cultures (1 L LB/Amp) were inoculated with overnight cultures at a 1:500
dilution and grown at 37 °C to an OD600 = 0.6. Production of recombinant AarCH6C357Y was then induced by addition of IPTG to 0.4 mM. Cells were grown at 15 °C an
additional 16 h, harvested by centrifugation, and stored at –80 °C. All subsequent steps
were performed at 4 °C. Cells (typically 5 g/L culture) were resuspended in 5 mL/g TK
buffer and disrupted by three cycles of sonication. Lysate was cleared by centrifugation at
30,000g for 30 min, addition of streptomycin to 1% (w/v) from a 10% (w/v) stock,
incubation for 15 min, and additional centrifugation at 30,000g for 30 min.
Analytical gel-filtration. Analytical gel-filtration was performed by K. L. Sullivan
using an ÄKTA fast protein liquid chromatography (FPLC) system (Amersham
Biosciences). SixAH6 (5 mg/mL in TK buffer but adjusted to 5% glycerol) was filtered
through a low-retention nylon membrane (0.22 µm, Fisher) and then centrifuged at
16,000g and 4 °C for 10 min prior to injection (0.1 mL) onto a Superdex 200 column (1.6
cm × 60 cm, 120 mL). The column was developed at 4 °C and 1 mL/min in TK buffer.
Solution sizes were determined by reference to size standards (Sigma MW-GF-1000,
Blue Dextran, and acetone) using Equation 1, where Ve is the peak elution volume, V0 is
the void volume, Vt is the included volume of the gel bed, and Kav is the partition
coefficient (proportional to the logarithm of the solution molecular weight).
K av =

Ve
Vt
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V0
V0

(1)

RESULTS
Diauxic growth of A. aceti. Three A. aceti strains were propagated in YPD medium
supplemented with 2% (v/v) ethanol. Both A. aceti strains 1023 and 10-8 [proline
auxotroph derived from A. aceti strain 1023 by treatment with N-methyl-N′-nitro-Nnitrosoguanidine (MNNG)] exhibited biphasic growth (Figure 3.1). The first log phase
for each of the strains coincided with ethanol oxidation and acetate accumulation (Figure

A

B
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D

Figure 3.1. Propagation of A. aceti strains 1023, 10-8, and AS10. (A) A. aceti strain 1023. (B) A. aceti
strain 1023 (biological replicate). (C) A. aceti strain 10-8. (D) A. aceti strain AS10. All strains were
grown in YPDE medium at 30 °C. Cell density (colored circles) and culture acidity (black squares)
were monitored throughout the 12-day growth period. The first and second log phases coincided with
acetate accumulation and depletion, respectively, while acetate levels remained relatively constant in
both stationary phases. A. aceti strain AS10 did not exhibit biphasic growth. Complete conversion of
ethanol [2% (v/v), 0.34 M] to acetic acid [0.34 M] would correspond to 2.1% acidity.
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3.1). A. aceti strains 1023 and 10-8 maintained relatively constant levels of acetate
throughout the first stationary phase but rapidly depleted levels of acetate as the second
log phase began. A. aceti strain AS10 (acetic-acid-sensitive derivative of A. aceti strain
10-8 produced by treatment with MNNG) did not undergo a diauxic shift, remaining in
the first stationary phase and maintaining the concentration of acetate in the medium until
the end of the growth period.
Enzyme activity assays. Cells were harvested from A. aceti cultures during the 12-day
growth period, and SCACT and CS activities were assayed in soluble lysates (Figure
3.2). A. aceti strain 1023 exhibited moderate SCACT and CS activities in the first log
phase and early first stationary phase as ethanol was being converted to acetate and
glucose was presumably being used as the primary carbon source. SCACT and CS
activities dropped dramatically (~100-fold decrease) during the first stationary phase and
then spiked (> 200-fold increase) during the second log phase as acetate was depleted.
Surprisingly, A. aceti strain 10-8 displayed very low SCACT and CS activities during
both the first log and first stationary phases. Only upon onset of the second log phase did
SCACT and CS activities rise to approximately those of A. aceti strain 1023. A. aceti
strain AS10 exhibited SCACT and CS activities near the threshold of detection
throughout the growth period, rising slightly at the last time point. The combination of
greatly reduced SCACT and CS activities may account for the previously observed acetic
acid sensitivity of A. aceti strain AS10.
Sequencing of the aar gene cluster. The aar gene cluster was amplified as a single
amplicon from A. aceti strain 1023, 10-8, or AS10. Multiple-coverage sequencing
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Figure 3.2. SCACT and CS activities in A. aceti lysates. (A) A. aceti strain 1023. (B) A. aceti strain
1023 (biological replicate). (C) A. aceti strain 10-8. (D) A. aceti strain AS10. (D/inset) Baseline
zoom, ~50x. Cells were harvested from A. aceti cultures throughout the 12-day growth period, and
SCACT (red circles) and CS (blue squares) specific activities were measured in soluble lysates. Vastly
differing patterns of activity were observed among the strains: strain 1023 showed high levels of
SCACT and CS activities in both log phases, strain 10-8 displayed high levels of SCACT and CS
activities in only the second log phase, while strain AS10 exhibited SCACT and CS activities just
above the limit of detection throughout the growth period.

identified three mutations relative to the deposited aar sequence from A. aceti strain 1023
(Table 3.3), encoding three mutants: AarA-A265V (A. aceti strain 10-8), AarA-E92K (A.
aceti strain AS10), and AarC-C357Y (A. aceti strain AS10).
The A. aceti strain 1023 biological replicate was originally believed to be A. aceti strain
2002. However, sequencing revealed a nucleotide-perfect match to the A. aceti strain
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Table 3.3. Mutations in the aar gene clustera
Strain

Mutation

Mutant

A. aceti 10-8

619G→A

AarA-A265V

A. aceti AS10

1139C→T

AarA-E92K

A. aceti AS10

4602G→A

AarC-C357Y

Mutations are relative to the deposited aar sequence from A. aceti strain 1023 (GenBank entry
DQ631551).

a

1023 sequence in the aar gene cluster. A. aceti strain 2002 is the most phylogenetically
distinct of the four strains discussed herein and should exhibit the most genotypic
variance. All attempts to amplify aarA, aarC, or the complete aar gene cluster from
authentic A. aceti strain 2002 gDNA failed. While undesirable, this failure is congruent
with the expected sequence divergence of the industrial vinegar-production strain 1023
and the type strain 2002.
Characterization of AarA and AarC mutants. AarCH6-C357Y was heterologously
overproduced in E. coli C41(DE3). While AarCH6-C357Y was abundant in the total
lysate, no soluble enzyme remained after insoluble protein was removed by
centrifugation (Figure 3.3). Furthermore, no SCACT activity was detected in the
kDa

T S

97
84
66
55
45
36

Figure 3.3. Overproduction of AarCH6-C357Y. The solubility of AarCH6-C357Y was assessed by
SDS-PAGE and specific activity. Lane T: total lysate and lane S: soluble lysate. While AarCH6C357Y was abundantly produced in recombinant E. coli C41(DE3), no enzyme remained after
insoluble protein was removed by centrifugation. SCACT activity (VisR assay) was not detected in
the soluble lysate. Lane S contains 5 µg protein. Size standard positions are indicated.
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recombinant E. coli C41(DE3) lysate. Insolubility explains the lack of SCACT activity in
the lysates of both recombinant E. coli C41(DE3) and A. aceti strain AS10.
[Crystallographic analysis of AarC (Chapter 4) revealed that Cys357 is buried within a
cluster of highly ordered hydrophobic residues. Introduction of a Cys357→Tyr mutation
would disrupt hydrophobic packing interactions and likely hinder formation of the core βsheet in the C-terminal domain.]
The effects of the mutations in AarA are unclear. Inspection of the hexameric structure
of AarA (PDB entry 2h12) revealed that both Ala265 and Glu92 are located at the
monomer-monomer interface, and neither residue has an obvious role in catalysis.
Nonetheless, perturbation of the oligomeric structure could have profound implications
for protein stability and catalytic activity. CS assays using lysate from A. aceti strain 10-8
or AS10 indicated that AarA-A265V retains most, if not all, activity, while AarA-E92K
has greatly reduced activity. Activity assays using lysate from A. aceti strains, however,
are likely influenced by overproduction of AarA, which would mask impaired catalytic
activity. The effects of the mutations could be better assessed using pure enzyme.
Unfortunately, efforts to duplicate the A265V or E92K mutation in plasmids encoding
AarA were unsuccessful.
Purification and characterization of SixAH6. Despite the apparent toxicity of the
gene product, SixAH6 was overproduced in E. coli C41(DE3) and purified by ammonium
sulfate fractionation and immobilized metal affinity chromatography (Figure 3.4).
Analytical gel-filtration and MALDI-TOF-MS indicated that SixAH6 is a predominantly
monomeric (Figure 3.5), 183-residue protein retaining Met1 (Figure A.3; 19,821 ± 2 Da
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Figure 3.4. Purification of SixAH6. Purity was assessed throughout the purification by SDS-PAGE.
Lane 1: clarified lysate, lane 2: 25 − 45% ammonium sulfate, and lane 3: Ni-NTA. SixAH6 migrates
more slowly than expected (19.8 kDa) and smears. Both abnormalities could be caused by incomplete
denaturation. MS analysis (Figure A.3) did not reveal peaks consistent with proteolysis products or
contaminating proteins. Each lane contains 5 µg protein. Size standard positions are indicated.

observed; 19,822 Da expected). No peak corresponding to N-terminally processed
SixAH6 lacking Met1 (19,690 Da expected) was observed by MALDI-TOF-MS analysis.
Without the N-terminal methionine, SixA(H6) is predicted to have a fleeting in vivo halflife (2 min, ExPASy, http://web.expasy.org/protparam/) resulting from an N-terminal
arginine (Arg2). Arginine is a secondary destabilizing residue in bacteria that marks
proteins for ClpAP-dependent proteolysis (12).

Figure 3.5. Analytical gel-filtration of SixAH6. The major peak at 91.6 mL corresponds to a
monomeric solution state (21 kDa observed, 19.8 kDa expected), while the minor peak at 82.1 mL
corresponds to a dimeric solution state (43 kDa observed, 39.6 kDa expected). A faulty mixer
increased oscillation in the baseline but did not affect elution. Gel-filtration was performed by K. L.
Sullivan.
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Preliminary analyses of AarA, SixA, and AarC levels by Western blotting.
Immunoblotting was performed to assess AarA, SixA, and AarC levels in A. aceti strain
1023 throughout the 12-day growth period (Figure 3.6). AarA and AarC levels were
moderate in the first log phase, low in the mid first stationary phase, and highest in the
second log phase when acetate was depleted from the medium. These protein levels
correlate with SCACT and CS activities. SixA was not detected in lysate from A. aceti
strain 1023 at any stage of the biphasic growth period. Pure SixAH6, however, strongly
cross-reacted with the custom antibody under the same conditions. A limit-of-detection
study indicated that SixA levels in the lysates were less than ~400 pg. [The limit-ofdetection study was performed with lysate that had been transferred to the membrane in
time (h) 48 112 232 C
AarA

50 ng
50 pg

SixA

SixAH6

AarC

Figure 3.6. Western blot analysis of AarA, SixA, and AarC levels in A. aceti strain 1023. (Left) AarA,
SixA, and AarC levels were measured in soluble lysates from A. aceti strain 1023 cells harvested
throughout the 12-day growth period. Lanes 48, 112, and 232 each contain 5 µg total protein. Lane C
contains 50 ng pure AarA, SixAH6, or AarCH6. AarA and AarC levels were highest during the first
and second log phases (48 and 232 h), while both levels were considerably lower during the first
stationary phase (112 h). SixA was not detected during any growth phase. (Right) Pure SixAH6 was
two-fold serially diluted in A. aceti strain 1023 lysate (112 h, 1 mg/mL, 5 µg total protein per lane).
The limit of detection was ~400 pg SixAH6. Transfer efficiency was improved relative to that of the
SixA detection experiment, which may have slightly altered the limit of detection.
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the presence of SDS, minimizing the amount of protein remaining embedded in the gel
and likely slightly lowering the limit of detection beyond that of the original SixA
immunoblot.] The lack of detectable levels of SixA is likely a consequence of the brief in
vivo half-life resulting from an N-terminal arginine (Arg2). Rapid degradation is a
common feature of regulatory proteins (13) like SixA. A short in vivo half-life allows for
more responsive attenuation of regulator function as the rate of regulator synthesis is
reduced.
Preliminary analyses of aarA, sixA, and aarC levels by RT-PCR. RT-PCR was
performed to monitor expression of aarA, sixA, and aarC in A. aceti strain 1023 during
growth in YPDE medium (Figure 3.7). Transcription of aarA and aarC increased as
acetate was produced in the first log and early first stationary phases. Transcription of
aarC further increased in the second log phase as acetate was consumed. The observed
levels of expression correlate with AarA and AarC levels and CS and SCACT activities.
Transcription of sixA peaked earlier in both log phases relative to levels of aarA and aarC
and decreased earlier in both stationary phases. All three genes were weakly expressed in
the second stationary phase. [RNA samples were not collected during the mid first
stationary phase when protein levels and enzyme activities were lowest.] Transcription of
the three aar genes appears to be differentially regulated.
Approximate mapping of aar transcripts by RT-PCR. RT-PCR primers were
selected such that amplicons would span the intergenic regions in the aar gene cluster
(Figure 3.8). RT-PCR products were observed for sixA − tyrA and sixA − orf1 but not for
aarA − sixA. Since aarC is divergently transcribed, the aar gene cluster appears to
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Figure 3.7. RT-PCR analysis of aarA, sixA, and aarC levels in A. aceti strain 1023. Levels of aarA,
sixA, and aarC mRNA were measured in total RNA isolated from A. aceti strain 1023 cells harvested
throughout the 12-day growth period. PCR controls lacking reverse transcriptase (RT) were
performed to assess the effects of contaminating gDNA. While all three products were amplified from
the same batches of total RNA, weak bands were only observed in sixA control reactions, suggesting a
need for higher stringency in these reactions. Levels of aarA and aarC increased as acetate
concentrations rose in the first log phase (24 h) and early first stationary phase (72 h). Levels of aarC
further increased as acetate was depleted during the second log phase. Levels of sixA peaked earlier in
both log phases relative to those of aarA and aarC and decreased earlier in both stationary phases. All
three genes appear to be differentially expressed. Size standard positions are indicated.

produce three transcripts: a single polycistronic transcript encodes sixA, tyrA, and orf1
and two monocistronic transcripts encode aarA and aarC (Figure 3.8). Each aar gene is
transcribed separately from the two others, allowing for independent and potentially
differential regulation.
Putative rho-independent terminator sequences are located downstream of aarA (TAA
AAC AGA CTA ACC CAA AAA GCC GAC TTC CCG TAA GGA AAG TCG GCT
TTT TGT TTG CAC) and aarC (TAA AAA AGG GGT GGA TTT CCA CCT CTT
TTT TTC GGC TTC), defining the aar gene cluster. [Sequences begin with the stop
codon and end with the expected T-rich region. Nucleotides shown in bold are predicted
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Figure 3.8. Transcriptional mapping of the aar gene cluster of A. aceti strain 1023. (Top) RT-PCRs
were performed with ODN primers that produced amplicons spanning intergenic regions: sixA − tyrA,
833 bp expected; sixA − orf1, 1639 bp expected; and aarA − sixA, 2049 bp expected. The faint bands
present in the aarA − sixA lane correspond to significantly shorter products than that expected for
aarA − sixA and likely result from mispriming. No products were observed in PCR-control reactions
lacking reverse transcriptase (RT). Conversely, all PCR-control reactions lacking RNA but containing
gDNA produced the expected amplicons (not shown). [K. E. Nyffeler performed the latter control
experiment.] Size standard positions are indicated. (Bottom) The aar gene cluster produces three
transcripts (blue arrows), one of which is polycistronic. Red arrows indicate the expected annealing
positions of ODN primers. The gene cluster is bookended by putative rho-independent terminator
sequences (vertical dotted lines) downstream of aarA and aarC.

to constitute the stem (black) and loop (gray) structures that compose the characteristic
hairpin motif. Terminator sequences were identified using the ARNold web server (http://
rna.igmors.u-psud.fr/toolbox/arnold/).] A putative rho-independent terminator sequence is
not present downstream of sixA, tyrA, or orf1, congruent with the proposed polycistronic
nature of these genes. Termination of transcription after sixA is presumably rho
dependent.
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DISCUSSION
Over centuries, the repeated passaging of vinegar-producing cultures has selected for
strains with the ability to rapidly accumulate and then prolongedly tolerate high
concentrations of vinegar, while further overoxidizing little of the product to carbon
dioxide (4). In the experiments performed in this study, the industrial vinegar strain A.
aceti 1023 quickly produced acetate in the first two days of growth as cell density
increased and then maintained and tolerated a high concentration of acetate (~280 mM
from 340 mM ethanol) for five days as cell density remained constant. The lack of
substantial acetate overoxidation during these periods could reasonably be attributed to
modulation of CAC enzyme levels. However, the findings discussed below suggest that
A. aceti strain 1023 employs an additional method, or methods, of regulating acetate
overoxidation.
Modulation of CAC enzyme synthesis by SixA. Synthesis of CAC enzymes is
regulated by the Arc two-component anoxic-redox-control system (7). The
transmembrane sensor kinase ArcB autophosphorylates under anoxic and low redox
conditions and then transphosphorylates ArcA (14), which in turn inhibits synthesis of
CAC enzymes (15). The presence of extracellular acetate enhances autophosphorylation
(16) and presumably further reduces CAC enzyme synthesis. However, by
dephosphorylating ArcB (7), SixA may prevent inhibition of CAC enzyme synthesis.
During vinegar production, when acetate levels in the medium can approach molar
concentrations, SixA may be essential. [A. aceti strain 1023 derivatives with interrupted
sixA sequences are sensitive to acetic acid (5).]
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While the expectedly short in vivo half-life of SixA prevented detection of the enzyme
by immunoblotting, RT-PCR revealed sixA expression was greatest in the early first and
early second log phases. This finding reconciles the apparent need of logarithmically
growing cells for high flux through the CAC and the high concentration of acetate in the
medium during these periods.
Regulation of acetate overoxidation in A. aceti strain 1023. Enzyme activity assays
and immunoblotting revealed that AarA and AarC were abundant during not only the
depletion of acetate but also during the initial accumulation of acetate and much of the
intervening conservation of acetate. The lack of substantial acetate overoxidation before
the eighth day but the moderate levels of AarA and AarC present for most of the growth
period imply that acetate catabolism during the initial stages of vinegar production was
not minimized solely by reduction of the abundance of CAC enzymes.
Further diminution of acetate overoxidation during the acetic acid accumulation and
conservation phases may result from the maintenance of a low cytoplasmic acetate
concentration (Figure 3.9). Acetic acid efflux from the A. aceti cytoplasm is performed by
an ABC transporter (17) and a proton-motive-force-dependent antiporter (18). Both
systems require energy input that could be provided by ethanol oxidation. Periplasmic
and cytoplasmic alcohol and aldehyde dehydrogenases are linked to a terminal oxidase
and the oxidative phosphorylation pathway (11), respectively, providing the protonmotive-force required for active efflux of acetic acid and other cellular processes. While
most ethanol was oxidized in the first log phase as acetic acid was being rapidly
produced, the subsequent, slower accumulation of acetic acid (Figure 3.1) suggests that a
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Figure 3.9. Regulation of acetate catabolism. Acetate overoxidation by the variant A. aceti CAC may
in part be modulated by the cytoplasmic acetate concentration. Both a proton-motive-force-dependent
antiporter and an ABC transporter counter the passive influx of acetic acid. Active efflux may be
powered by periplasmic alcohol (ADH) and aldehyde (ALDH) dehydrogenases during acetic acid
production. ADH and ALDH supply electrons for a terminal oxidase which provides the protonmotive-force required for synthesis of ATP and other cellular processes. Cytoplasmic NADHdependent ADH and ALDH (not shown) may also support efflux of acetic acid.

small but significant amount of ethanol remained, providing a source of energy to support
continued, active acetic acid efflux during the first stationary phase. The onset of the
acetate depletion phase has been observed to occur only when all ethanol has been
depleted (2, 4, 19) and ethanol oxidation can no longer provide the necessary protonmotive-force to support active acetic acid efflux. This metabolic shift may be delayed by
the variable but low cytoplasmic pH of A. aceti (20), which should reduce diffusively
trapped acetate (21). Additionally, the high acetate Km in the AarC-catalyzed SCACT
reaction (Chapters 2 and 4) may minimize background acetate overoxidation during the
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acetate accumulation and acetate conservation phases (while a low cytoplasmic acetate
concentration is maintained).
Acetic acid sensitivity in A. aceti strain AS10. A. aceti strain AS10 was previously
found to be sensitive to acetic acid (5). This phenotype was attributed to an undefined
mutation in aarC. This study shows that A. aceti strain AS10 encodes AarC-C357Y, a
mutant with dramatically lower solubility than the wild-type enzyme. A previously
unknown mutation in aarA was also identified. A. aceti strain AS10 encodes AarA-E92K.
Both mutants supported greatly diminished enzymatic activities in lysates that would
substantially slow, if not halt, acetate overoxidation. An inability to remove excess
acetate from the cytoplasm by overoxidation would be consistent with the observed
acetic-acid-sensitive phenotype. Furthermore, the lack of a second log phase suggests that
acetate overoxidation and biphasic growth are linked in A. aceti.
Acetate metabolism in type and vinegar-production strains. A. aceti strain 1023 has
a highly specialized CAC. While AarC facilitates acetate overoxidation by bypassing
substrate-level phosphorylation and adenylation (Chapter 2), the lack of succinyl-CoA
synthetase (SCS) makes flux through the CAC dependent upon the cytoplasmic acetate
concentration. Recent sequencing of the genome of A. aceti strain NBRC 14818
(regarded as the "other" type strain) revealed far more versatile pathways of acetate
metabolism (3) that avoid this limitation (Figure 3.10). SCS permits acetate-independent
flux through the CAC, while isocitrate lyase and malate synthase provide an assimilatory
pathway for acetate utilization. In this varied metabolic scheme, AarC may be relegated
solely to acetic acid resistance.

71

CoA

citrate

AarA

oxaloacetate

Pta

acetyl-CoA

CoA
Mqo

Mdh

Acs

AcnA
CoA

isocitrate

acetyl~P

IcdA

AckA

acetate

malate

CO2

α-ketoglutarate
CoA
SucAB

FumA

A. aceti
strain 1023

CO2
AarC

fumarate

succinyl-CoA
SucCD

SdhABCD
succinate
CoA

citrate

AarA

oxaloacetate

Pta

acetyl-CoA

CoA
Mqo

malate

Mdh

CoA

Acs

AcnA
CoA

acetyl~P

glyoxylate

AceA

CO2

α-ketoglutarate
CoA
SucAB

FumA

A. aceti
strain NBRC 14818

IcdA

AckA

acetate

GlcB
CoA

isocitrate

CO2
succinyl-CoA

fumarate
SucCD

SdhABCD
succinate

CoA
AarC

acetate

acetyl-CoA

Figure 3.10. Acetate metabolism pathways in A. aceti. Gray arrows indicate enzymes that are not
encoded in the genome sequences. (Top) A. aceti strain 1023 has a highly specialized CAC,
conferring acetic acid resistance through efficient cytoplasmic acetate overoxidation. AarC preserves
the cyclic nature of the CAC in the absence of SCS, isocitrate lyase, and malate synthase. (Bottom) A.
aceti strain NBRC 14818 has a far more versatile CAC, maintaining the canonical route for acetateindependent flux while providing both dissimilatory and assimilatory pathways for acetate
metabolism. SCS, both glyoxylate shunt enzymes, and AarC support recycling of oxaloacetate. Mdh
is functionally replaced by Mqo in both strains. The A. aceti strain NBRC 14818 CAC was
reproduced from (3).

Diverse pathways of acetate metabolism provide clear adaptive advantages in the
complex, nutritionally variable fruit-associated niches in which A. aceti is commonly
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found (1). In a defined industrial setting, however, a glyoxylate shunt may not be
beneficial and may increase acetate consumption during ethanol oxidation. Selection for
strains that produce the highest yield of vinegar may have eliminated those capable of
acetate assimilation.
Conclusion. Biphasic growth in YPDE medium is accompanied by distinct stages of
acetate accumulation, conservation, and depletion. While AarC is most abundant during
the acetate overoxidation phase, the moderate levels of AarC present during the acetate
accumulation and early acetate conservation phases seem to preclude direct modulation
of enzyme levels from being the sole method by which acetate catabolism is regulated.
Further reduction of acetate overoxidation prior to the acetate depletion phase may result
from the active maintenance of a low cytoplasmic acetate concentration.

FUTURE DIRECTIONS
The work described herein was of a preliminary nature but established the methods
necessary for a thorough study and made apparent the deficiencies in the current
experimental design. [1] A more complete analysis of metabolite levels is needed.
Ethanol and glucose concentrations should be measured enzymatically or
chromatographically as described previously (2) to supplement the analysis of acetate
levels. [2] Regulation of acetic acid influx and efflux is likely critical for acetate
overoxidation and resistance. Cytoplasmic acetate concentrations should be determined
throughout the biphasic growth period using a radiation-independent method described
previously (22). [3] The MNNG-derived strains are largely genotypically uncharacterized
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and potentially misleading. The presence of previously unidentified mutations in aarA (A.
aceti strains 10-8 and AS10) and the lack of induction of AarA and AarC in the first log
phase (A. aceti strains 10-8 and possibly AS10) suggest that a number of additional
unidentified mutations may be present. Precise mutations, while challenging to generate
in A. aceti, are needed if definitive conclusions are to be drawn. Alternatively, the A. aceti
type strain NBRC 14818, which now has an available genome sequence, could be
compared with A. aceti strain 1023 to examine the effects of directed evolution on acetic
acid production, conservation, and resistance.
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Chapter 4.
Crystallographic, mechanistic, and further biophysical characterization of
succinyl-CoA:acetate CoA-transferase (AarC)

77

INTRODUCTION
Coenzyme A (CoA)-transferases catalyze the reversible transfer of CoA from acylCoA thioesters to free acids and play diverse metabolic roles in organisms from all lines
of descent. All three classes of CoA-transferase share mechanistic features, but only class
I and II enzymes appear to have a common ancestor (1).
Class I CoA-transferases exhibit ping-pong kinetics and employ a substituted-enzyme
mechanism (Scheme 4.1) (2, 3). Upon formation of the enzyme•acyl-CoA Michaelis
complex, the protein undergoes a conformational shift that accelerates catalysis (4).
Attack by the nucleophilic glutamate transiently produces the covalent acylglutamyl
anhydride intermediate and the CoA thiolate (4-6), while subsequent attack by the
nucleophilic CoA thiolate produces the glutamyl-CoA thioester intermediate and the

+

+

Scheme 4.1. Abbreviated class I CoA-transferase mechanism. The class I reaction proceeds through a
series of anhydride, tetrahedral oxyanion (not shown), and thioester intermediates. Only the covalent
thioester intermediate has been previously crystallographically observed. All individual steps and the
overall reaction are fully reversible.
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carboxylate product (7). The carboxylate product characteristically dissociates before the
carboxylate substrate binds.
Kinetic experiments indicated that the acyl moiety of the acyl-CoA substrate, the first
acylglutamyl anhydride intermediate, and the carboxylate product share a common
binding pocket (5). Only the glutamyl-CoA thioester has been previously
crystallographically observed for a class I enzyme (8). Both Michaelis complexes, both
acylglutamyl anhydride intermediates, and both product complexes have remained
elusive.
Class I CoA-transferases are frequently involved in fatty acid metabolism and often use
acetyl-CoA or succinyl-CoA as a CoA donor (8, 9). In the acidophilic acetic acid
bacterium Acetobacter aceti, the class I CoA-transferase and acetic-acid-resistance
protein succinyl-CoA:acetate CoA-transferase (AarC, SCACT) facilitates metabolic
"overoxidation" of acetic acid to carbon dioxide in a specialized citric acid cycle
(Chapters 2 and 3).
This study shows that AarC is unusually stringent and catalytically rapid and
appropriately acid tolerant. All catalytic residues and determinants of substrate specificity
were identified in both the primary binding site and a previously unidentified secondary
(carboxylate) binding site. A novel oxyanion hole configuration is utilized to stabilize
tetrahedral oxyanion intermediates in what appears to be the archetypal mechanism for
class I enzymes. Molecular modeling and molecular mechanics calculations were
employed to augment crystallographic results, providing the first complete structural
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description of the ground-state complexes and intermediates in a class I CoA-transferase
reaction.

MATERIALS AND METHODS
Reagents and general analytical methods. Chemicals were purchased from SigmaAldrich or Fisher in the highest purity available unless otherwise noted. DethiaacetylCoA was synthesized by H. Jiang as described previously (10). Oligodeoxynucleotide
(ODN) primers were obtained from Integrated DNA Technologies and used without
further purification. A. aceti citrate synthase with a C-terminal hexahistidine affinity tag
(AaCSH6) was isolated by C. Z. Constantine as described previously (10). Protein
quantitation by the method of Bradford was performed as described previously (11).
Absorbance measurements were recorded on an 8453 UV-visible spectrophotometer
(Agilent Technologies). Plasmids were sequenced by the Purdue University Genomics
Core Facility. Protein mass was determined using electrospray-ionization time-of-flight
mass spectrometry (ESI-TOF-MS) by the Washington University Mass Spectrometry
Resource.
Mutagenesis. Mutagenesis reactions were performed by T. J. Kappock using the
QuikChange II Site-Directed Mutagenesis kit (Stratagene), pJK385 (Table 4.1), and
appropriate ODN primers (Table 4.2).
Purification of wild-type and mutant AarCH6. E. coli C41(DE3) cells transformed
with pJK385 and pREP4-groELS (Table 4.1) were propagated on Luria-Bertani (LB)
medium containing 0.1 g/L ampicillin and 0.07 g/L kanamycin (LB/Amp/Kan).
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Table 4.1. Bacterial strains and plasmids used in this study
Descriptiona

Source

E. coli C41(DE3)

F′ ompT hsdSB(rB− mB−) gal dcm (DE3)

Avidisb

E. coli DH5α

F′ ϕ80lacZΔM15 Δ(lacZYA-argF)U169 deoR recA1 endA1
hsdR17(rK− mK+) phoA supE44 thi-1 gyrA96 relA1

Invitrogenc

pJK357

T7 promoter expression construct, encodes AarC, Apr

Chapter 2

pJK385

T7 promoter expression construct, encodes AarCH6, Apr

Chapter 2

pJK512

Derivative of pJK385, encodes AarCH6-R228E, Apr

This study

pJK513

Derivative of pJK385, encodes AarCH6-E294A, Apr

This study

pJK514

Derivative of pJK385, encodes AarCH6-E435A, Apr

This study

pJK516

Derivative of pJK385, encodes AarCH6-E435Q, Apr

This study

pJK517

Derivative of pJK385, encodes AarCH6-E435D, Apr

This study

pJK524

Derivative of pJK385, encodes AarCH6-N347A, Apr

This study

pJK564

Derivative of pJK385, encodes AarCH6-S71A, Apr

This study

pREP4-groELS

T7 promoter expression construct, encodes GroEL/ES, Kmr

P. Coled

Strain or plasmid
Strains

Plasmids

a Ampicillin

resistant (Apr) and kanamycin resistant (Kmr). b Described in reference (35). c Described
in reference (36). d Described in reference (37).

Production cultures (1 L LB/Amp/Kan) were inoculated with overnight cultures at a
1:500 dilution and grown at 37 °C to mid-log phase (OD600 = 0.6). Production of
recombinant AarCH6 was then induced by addition of isopropyl-β-D-1thiogalactopyranoside (IPTG) to 0.4 mM. Cells were grown at 15 °C an additional 16 h,
harvested by centrifugation, and either used immediately or stored at –80 °C. All
subsequent steps were performed at 4 °C. Cells (typically 5 g/L culture) were
resuspended in 5 volumes of TK buffer (50 mM Tris•HCl, pH 8.0, and 100 mM
potassium chloride) and disrupted by sonication. Lysate was cleared by centrifugation at
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Table 4.2. ODN primers used in this study
ODN

Sequence (5′ → 3′)a

Product

2079

GCA CGA ATG ACC GGG ACG AGA ATG CCC CGT TTG CCG C

pJK512

2080

GCG GCA AAC GGG GCA TTC TCG TCC CGG TCA TTC GTG C

pJK512

2081

CTG GTG GGC TAT AGT GCG GTG ATT CAG GAT GGC

pJK513

2082

GCC ATC CTG AAT CAC CGC ACT ATA GCC CAC CAG

pJK513

2083

GAT TTT TGT AAC CGC GCA GGG GCT GGC GG

pJK514

2084

CCG CCA GCC CCT GCG CGG TTA CAA AAA TC

pJK514

2093

CAG ATT TTT GTA ACC CAG CAG GGG CTG GCG

pJK516

2094

CGC CAG CCC CTG CTG GGT TAC AAA AAT CTG

pJK516

2095

CAG ATT TTT GTA ACC GAT CAG GGG CTG GCG GAT C

pJK517

2096

GAT CCG CCA GCC CCT GAT CGG TTA CAA AAA TCT G

pJK517

2101

AGC AGG ATG TCA GCG CCA GCC CCG GCA TTA

pJK524

2102

TAA TGC CGG GGC TGG CGC TGA CAT CCT GCT

pJK524

2176

CAG CTG AGG GCC TGT GGC TGC GCC CGT AAT CAG

pJK564

2177

CTG ATT ACG GGC GCA GCC ACA GGC CCT CAG CTG

pJK564

a

Changes in the coding region relative to the genomic sequence are underlined.

30,000g for 30 min, addition of streptomycin to 1% (w/v) from a 10% (w/v) stock,
incubation for 15 min, and additional centrifugation at 30,000g for 30 min. Solid
ammonium sulfate was then added to the cleared lysate to 35% saturation (208 g/L) over
30 min. After equilibrating an additional 30 min, solids were removed by centrifugation
at 30,000g for 10 min. Solid ammonium sulfate was then added to the supernatant to 75%
saturation (275 g/L) over 30 min. After equilibrating an additional 30 min, solids were
collected by centrifugation at 30,000g for 10 min, dissolved in TK buffer, and applied to
a Ni2+-charged nitrilotriacetic acid (Ni-NTA) agarose column (1.5 cm × 2.5 cm, 4.4 mL)
equilibrated in buffer A (50 mM Tris•HCl, pH 8.0, and 300 mM sodium chloride). The
column was rinsed with 10 column volumes (CV) of buffer A containing 10 mM
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imidazole and then developed in a linear gradient of imidazole (10 → 500 mM, 40 mL ×
40 mL). Fractions containing AarCH6 were identified by sodium dodecyl sulfate
polyacrylamide gel electrophoresis (SDS-PAGE), pooled, and concentrated to > 5 mg/
mL by ultrafiltration (Amicon Ultra-15, 30,000 MWCO). A portion of the pure AarCH6
solution (10 mg) was applied to a Sephadex G200 column (2.5 cm × 28.0 cm, 140 mL)
equilibrated in TK buffer. Protein was then eluted with additional TK buffer, and
fractions containing AarCH6 were identified by SDS-PAGE, pooled, and concentrated by
ultrafiltration as described above. The portion of the pure AarCH6 solution that was not
applied to the gel-filtration column was exchanged into TK buffer by several cycles of
dilution and reconcentration. Single-use aliquots were flash-frozen and stored at –80 °C.
AarCH6-S71A, AarCH6-R228E, AarCH6-N347A, AarCH6-E435A, AarCH6-E435D,
and AarCH6-E435Q were purified as described above for wild-type AarCH6 except that
E. coli C41(DE3) cells were transformed with pJK564/pREP4-groELS, pJK512/pREP4groELS, pJK524/pREP4-groELS, pJK514/pREP4-groELS, pJK516/pREP4-groELS, or
pJK517/pREP4-groELS (Table 4.1). [AarCH6-S71A was isolated by K. E. Nyffeler.]
AarCH6-E294A was purified similarly except that E. coli C41(DE3) cells were
transformed with only pJK513; pREP4-groELS was not coexpressed. None of the
AarCH6 mutants were gel-filtered.
Purification of AarC. E. coli C41(DE3) cells transformed with pJK357 (Table 4.1)
were propagated on LB medium containing 0.1 g/L ampicillin (LB/Amp). Production
cultures (1 L LB/Amp) were inoculated with overnight cultures at a 1:500 dilution and
grown at 37 °C to mid-log phase (OD600 = 0.6). Production of recombinant AarC was
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then induced by addition of IPTG to 0.4 mM. Cultures were grown at 15 °C an additional
16 h, harvested by centrifugation, and either used immediately or stored at –80 °C. All
subsequent steps were performed at 4 °C. Cells (typically 5 g/L culture) were
resuspended in 5 volumes of buffer B (50 mM potassium phosphate, pH 6.0, and 100 mM
potassium chloride) and disrupted by sonication. Lysate was cleared by centrifugation at
30,000g for 30 min, addition of streptomycin to 1% (w/v) from a 10% (w/v) stock,
incubation for 15 min, and additional centrifugation at 30,000g for 30 min. Solid
ammonium sulfate was then added to the cleared lysate to 43% saturation (263 g/L) over
30 min. After equilibrating an additional 30 min, solids were removed by centrifugation
at 30,000g for 10 min. Solid ammonium sulfate was then added to the supernatant to 68%
saturation (167 g/L) over 30 min. After equilibrating an additional 30 min, solids were
collected by centrifugation at 30,000g for 10 min, dissolved in buffer C (20 mM
potassium phosphate, pH 7.0), and applied to a Sephadex G25 column (2.5 cm × 40.0 cm,
200 mL) equilibrated in buffer C. Protein was eluted with additional buffer C, and
fractions containing protein or salt were identified by absorbance (280 nm) and
conductivity measurements, respectively. Fractions containing protein were pooled,
concentrated by ultrafiltration as described above, and applied to a diethylaminoethyl
(DEAE) Sepharose CL-6B column (2.5 cm × 8.0 cm, 39 mL) equilibrated in buffer C.
The column was rinsed with ~1 CV of buffer C and then developed in a linear gradient of
salt (0 → 1.2 M potassium chloride, 400 mL × 400 mL). Fractions containing AarC were
identified by SDS-PAGE, pooled, concentrated by ultrafiltration as described above,
exchanged into buffer D (50 mM MES, pH 6.2, 5 mM magnesium chloride, and 20 mM
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potassium chloride) by several cycles of dilution and reconcentration, and applied to a
Cibacron Blue 3GA agarose column (2.5 cm × 12.5 cm, 61 mL) equilibrated in buffer D.
The column was rinsed with ~1 CV of buffer D and then developed in a linear gradient of
salt (0.02 → 1.2 M potassium chloride, 350 mL × 350 mL). Fractions containing AarC
were identified by SDS-PAGE, pooled, concentrated by ultrafiltration as described above,
and exchanged into 50 mM potassium phosphate, pH 8.0, and 100 mM potassium
chloride by several cycles of dilution and reconcentration. Single-use aliquots were flashfrozen and stored at –80 °C.
SCACT assays. Citrate synthase-dependent VisF/VisR assays and high performance
liquid chromatography (HPLC)-coupled LCF/LCR assays were performed as described
previously (Chapter 2) except that the concentrations of the enzymes and substrates and
the durations of the reactions were adjusted as required for the AarCH6 mutants. A unit is
defined as the amount of enzyme that forms 1 µmole of product per minute.
Alternate substrate screen. Alternate CoA-acceptors were screened in modified LCR
assays containing 50 mM potassium phosphate, pH 8.0, 100 mM potassium chloride, 20
mM carboxylate, pH 8.0, 1.0 mM acetyl-CoA, and 5,000 ng AarCH6. Aliquots (0.1 ml)
were withdrawn prior to the addition of enzyme and 5 and 30 min after the addition of
enzyme, quenched with 6.25% trichloroacetic acid (0.4 ml), vortexed briefly, and
centrifuged at 16,100g for 3 min. The soluble portion was transferred to an autosampler
vial and analyzed by reverse-phase ion-pair HPLC. Compounds identified as alternate
substrates were examined in saturation experiments employing modified LCR assays in
which succinate was replaced by the new CoA-acceptor.
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HPLC analysis. CoA and CoA thioesters were resolved on a Breeze HPLC system
(Waters) equipped with a Symmetry C18 column (4.6 mm × 75 mm, 3.5 µm; Waters).
Elution was performed at 30 °C and a flow rate of 0.8 mL/min with detection at 260 nm.
A mixture of 200 mM sodium phosphate and 150 mM sodium acetate, pH 4.6, was used
in a water/methanol solvent system. The gradient program was 0 – 5 min, 4.5% methanol
(isocratic); 5 – 15 min, 4.5 → 15% methanol (linear gradient); 15 – 17 min, 15%
methanol (isocratic); 17 – 22 min, 15 → 4.5% methanol (linear gradient); and 22 – 27
min, 4.5% methanol (isocratic). The intermediate isocratic phase was extended by 5 min
for elution of samples containing butyrate, while the initial and final isocratic phases
were stripped of methanol for elution of samples containing formate, glycolate,
glyoxylate, oxalate, or tartrate. Injections (25 – 100 µL) were performed by a 717plus
autosampler (Waters). Acyl-CoA peak areas were compared to an acetyl-CoA calibration
curve as described previously (Chapter 2).
Thermal denaturation. Temperature-induced changes in the structures of AarC and
AarCH6 were monitored using a Chirascan circular dichroism (CD) spectropolarimeter
(Applied Photophysics). AarC or AarCH6 (19 µg/mL, 0.34 µM) was equilibrated at 20 °C
for 30 min in a 10-mm pathlength quartz cuvette containing 50 mM potassium phosphate,
pH 3.5 – 8.5, and 100 mM potassium chloride before a far-UV spectrum (3 scans, 200 –
260 nm, 1 nm bandwidth, 1 nm step, 1 s/point) was recorded. [Each spectrum was
corrected by subtracting a buffer-only background spectrum.] The sample was then
heated from 20 – 90 °C at a continuous rate of 0.5 °C/min. Ellipticity was monitored at
222 nm (1 nm bandwidth, 0.5 °C step, 12 s/point), and solution temperature was directly
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measured using a probe inserted through the cuvette stopper. Melting profiles were fit to
a double-sigmoid equation using Pro-Data Viewer (Applied Photophysics) and the
steepest point of each profile was taken as the melting temperature (Tm).
Crystallization and cryoprotection. A sparse-matrix screen of AarCH6 crystallization
conditions was performed using Wizard I and II kits (Emerald BioSystems) in hangingdrop vapor-diffusion experiments. Reservoirs contained 0.5 mL Wizard solution
supplemented with 25 mM 2-mercaptoethanol. Drops contained 2 µL AarCH6 (6.0 mg/
mL protein, 45 mM Tris•HCl, pH 8.0, 90 mM potassium chloride, and 2.0 mM CoA) and
2 µL reservoir solution. Trays were incubated at room temperature (~22 °C). Two
promising conditions (I-36 and II-4) identified in the sparse-matrix screen were used to
grow large numbers of AarCH6 crystals. Reservoirs contained either 1.7 – 2.0 M
ammonium sulfate, 0.2 M sodium chloride, 0.1 M sodium cacodylate, pH 6.5, and 25
mM 2-mercaptoethanol or 0.8 – 1.0 M sodium citrate, 0.1 M imidazole, pH 8.2, and 25
mM 2-mercaptoethanol. Drops were prepared as described above. AarC (5.6 mg/mL
protein, 45 mM potassium phosphate, pH 8.0, 90 mM potassium chloride, and 2.0 mM
CoA) was crystallized in the same manner. Additional crystallization experiments were
performed in which sodium citrate was replaced by 0.5 – 1.4 M sodium succinate,
sodium L-malate, or sodium acetate.
Crystals were soaked for 24 h at room temperature in either 15% (w/v) sorbitol, 2.2 M
ammonium sulfate, 0.1 M sodium cacodylate, pH 6.5, 0.25 M sodium chloride, 25 mM 2mercaptoethanol, and 2.0 mM CoA or 15% (w/v) sorbitol, 1.1 M sodium citrate, 0.1 M
imidazole, pH 8.2, 25 mM 2-mercaptoethanol, and 2.0 mM CoA and then flash-cooled by
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immersion in liquid nitrogen. Acetyl-CoA (2.0 mM), succinyl-CoA (2.0 mM),
dethiaacetyl-CoA (10 mM), or water was substituted for CoA in drops and
cryoprotectants in an effort to obtain alternate ligand-bound or unliganded structures.
Alternatively, crystals grown without substrate or inhibitor present were soaked in
cryoprotectant lacking ligand for 22 h and then transferred to cryoprotectant containing
acetyl-CoA for 2 h before being flash-cooled as described above.
Crystallographic data collection and refinement. X-ray diffraction data were
collected at the Advanced Photon Source, Argonne National Laboratory. Diffraction data
were indexed, integrated, and scaled in HKL2000 (12). The structure of
AarCH6•CoA•citrate was solved by molecular replacement using a threaded AarC model
(monomer, residues 3 – 505) generated with SWISS-MODEL (13). The homology model
was an uncharacterized CoA-transferase (PDB entry 2g39, 48% identity) from
Pseudomonas aeruginosa. For all subsequent AarC(H6) models, AarCH6•CoA•citrate
(subunit A, residues 2 – 514) was used as the search model for molecular replacement.
All refinement was performed with PHENIX (14). Automated building (PHENIX
AutoBuild) was used to improve the starting structures of AarCH6•CoA•citrate and
AarCH6-S71A•CoA. Subsequent early rounds of refinement for each model consisted of
rigid-body refinement, simulated annealing, coordinate optimization, isotropic
temperature-factor refinement, and automated water picking. Later rounds of refinement
for each model included only coordinate optimization, isotropic temperature-factor
refinement, and occupancy refinement. Noncrystallographic symmetry (NCS) restraints
were applied for automated building of the AarCH6•CoA•citrate model and for all stages
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of refinement of the medium-resolution AarCH6•CoA, AarCH6-R228E•CoA
[anomalous], and AarCH6-E294A•dethiaacetyl-CoA models. Manual building and water
picking were conducted in Coot (15) following each round of automated refinement.
Ligand coordinates and restraints were obtained from HIC-Up (16) and manually
modified using PHENIX. All structural images were generated with PyMOL (17).
Molecular mechanics calculations. Michaelis complexes and the glutamylsuccinyl
anhydride intermediate were manually constructed in active sites containing the
crystallographically observed acetylglutamyl anhydride and glutamyl-CoA thioester
intermediates (AarCH6•CoA•acetate). A single water (HOH517) and all residues (Phe35,
Thr36, Ala70, Ser71, Phe92, Leu114, Gln267, Gly269, Val270, Glu294, Val295, Asn361,
Gly387, Gly388, and Ser389) directly contacting modeled atoms were included during
building and subsequent energy minimization. Hydrogen atoms were added in
appropriate riding positions before equilibrium conformer calculations incorporating a
Monte Carlo search method (5,000 K) and MMFF94 force field were performed. Only
the positions of hydrogen atoms and modeled nonhydrogen atoms were refined during
energy minimization. All nonhydrogen protein atoms and selected ligand atoms were
"frozen." Corrections for implicit solvent were not applied at any point during
refinement. All calculations were performed with Spartan '02 (Wavefunction).

RESULTS
Isolation of wild-type and mutant AarCH6. Earlier attempts to increase the solubility
of AarCH6 by employing E. coli C41(DE3) for protein production and/or lowering the
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induction temperature were only marginally successful as ~90% of total AarCH6
remained insoluble (Chapter 2). Co-overproducing AarCH6 with the chaperonins GroEL/
ES, however, increased soluble AarCH6 by ~10-fold (Figure 4.1). While total AarCH6
was lessened, presumably as a result of competitive synthesis of GroEL/ES, solubility
was greatly improved. Purification of AarCH6 was performed as described previously
(Chapter 2) except that gel-filtration chromatography was introduced to facilitate
crystallization.
AarCH6 mutants were purified as described previously for the wild-type enzyme
(Chapter 2, Figure 4.1). Co-overproduction of GroEL/ES improved the solubility of
AarCH6-S71A, AarCH6-R228E, AarCH6-N347A, and AarCH6-E435D, but failed to
relieve the complete insolubility of AarCH6-E435A and AarCH6-E435Q. AarCH6E294A was overproduced without co-overproduction of GroEL/ES and displayed
solubility similar to that of the wild-type enzyme. ESI-TOF-MS analysis of the AarCH6
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Figure 4.1. Overproduction and purification of wild-type (WT) and mutant AarCH6. (Left) AarCH6
was overproduced in E. coli C41(DE3). Limited solubility was dramatically improved by cooverproduction of GroEL/ES. Lane T: total lysate and lane S: soluble lysate. GroES (10 kDa)
presumably runs with the dye front. (Right) AarCH6 mutants were purified by ammonium sulfate
fractionation and immobilized metal affinity chromatography as described in the Materials and
Methods. [K. E. Nyffeler purified AarCH6-S71A.] Even when co-overproduced with GroEL/ES,
AarCH6-E435A and AarCH6-E435Q were insoluble (not shown). Each lane contains 5 µg protein.
Size standard positions are indicated.
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mutants was consistent with the expected alterations in 513-residue proteins lacking
Met1: AarCH6-S71A (55,831 Da observed; 55,831 Da expected; Figure A.4), AarCH6R228E (55,821 Da observed; 55,820 Da expected; Figure A.5), AarCH6-E294A (55,789
Da observed; 55,789 Da expected; Figure A.6), AarCH6-N347A (55,804 Da observed;
55,804 Da expected; Figure A.7), and AarCH6-E435D (55,833 Da observed; 55,833 Da
expected; Figure A.8).
Isolation and partial kinetic characterization of AarC. AarC was purified to near
homogeneity by ammonium sulfate fractionation, gel-filtration chromatography, ion
exchange chromatography, and dye affinity chromatography (Figure 4.2 and Table 4.3).
ESI-TOF-MS analysis of AarC was consistent with a 504-residue protein lacking Met1
(54,695 Da observed; 54,695 Da expected; Figure A.9).
Acetate saturation experiments using AarC produced kinetic constants [kcat = 290 ± 30
s−1, Km = 110 ± 20 mM, kcat/Km = (2.6 ± 0.5) × 103 M−1 s−1, and Ki = 1600 ± 500 mM] that
are similar to those of AarCH6 (Chapter 2), suggesting the C-terminal hexahistidine tag
does not significantly affect binding affinity or catalytic activity.
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Figure 4.2. Purification of AarC. Purity was assessed throughout the purification by SDS-PAGE and
specific activity (Table 4.3). Lane 1: clarified lysate, lane 2: 43 – 68% ammonium sulfate, lane 3:
G25, lane 4: DEAE, and lane 5: Cibacron Blue 3GA. Each lane contains 5 µg protein. Size standard
positions are indicated.
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Table 4.3. AarC purification charta
Protein (mg)

Activity (U)b

Sp. activity (U/mg)

Fold purification

Yield (%)

Clarified lystate

550

3200

5.9

1.0

100

43 − 68% (NH4)2SO4

260

2600

10

1.7

81

G25

200

2400

12

2.0

75

DEAE

33

2000

60

10

63

Cibacron Blue 3GA

5.7

400

71

12

13

Stage

a AarC

was purified from 4 1-L production cultures (~20 g cell paste). b SCACT activity was measured using the VisR assay.
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Substrate specificity. Twenty-four carboxylates (formate, trifluoroacetate, glycolate,
glyoxylate, oxalate, propionate, L-lactate, DL-lactate, pyruvate, malonate, butyrate,
acetoacetate, maleate, fumarate, D-malate, L-malate, oxaloacetate, D-tartrate, L-tartrate,
DL-methylsuccinate, glutarate, α-ketoglutarate, citrate, and DL-isocitrate; Figure A.10)
were screened as possible alternate CoA-acceptors in modified LCR assays. Only nine
supported specific activity above that of the limit of detection (~0.01 U/mg), and none
supported activity above 10% of that produced by acetate or succinate (Figure 4.3A).
Saturation experiments revealed a substantial gap between the catalytic efficiencies of the
physiological substrates and those of the alternate substrates (Figure 4.3B and Table A.1).
This gap largely resulted from consistently lower turnover numbers. Conversely,

A

B

Figure 4.3. Alternate substrate screen. (A) Twenty-four carboxylates were screened as possible
alternate CoA-acceptors in modified LCF/LCR assays. Only nine supported detectable CoAtransferase activity. The limit of detection was ~0.01 U/mg. (B) Kinetic constants [kcat (red circles),
Km (blue squares), and kcat/Km (green diamonds)] were determined for the alternate substrates using
modified LCF/LCR assays. The highest catalytic efficiencies were observed with the physiological
substrates acetate and succinate. L-malate produced two acyl-CoA/acyl-isoCoA product pairs that are
likely constitutional isomers. Kinetic parameters (Table A.1) are provided in Appendix A.
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Michaelis constants varied dramatically (but remained consistently higher than that of
succinate).
Crystallization, cryoprotection, and data collection. A sparse-matrix screen yielded
AarCH6 crystals with two distinct morphologies. Hexagonal crystals were produced in
ammonium sulfate, while orthorhombic crystals were generated in sodium citrate (Figure
4.4). Crystals routinely grew to full size in 2 – 14 days with growth occurring most
rapidly from AarCH6 that had been coproduced with GroEL/ES and subsequently gelfiltered. Crystals of both morphologies were soaked in cryoprotectant for 24 h without
noticeable deterioration. Soaking of the hexagonal crystals for shorter periods produced
diffraction patterns with dark ice rings. Shorter soaks were not attempted with the
orthorhombic crystals.
Despite the pleasing appearance of the hexagonal crystals, diffraction data never
extended beyond 2.8 Å and often failed to extend beyond 3.5 Å. The aesthetically less
attractive orthorhombic crystals regularly diffracted to 2.0 Å and often approached 1.5 Å.
The orthorhombic crystals, however, were plagued by microscopic heterogeneity and a

A

B

Figure 4.4. AarCH6 crystals. (A) Hexagonal crystals grown in ammonium sulfate. (B) Orthorhombic
crystals grown in sodium citrate. Black bars represent 0.1 mm.
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propensity to grow in clusters. Attempts to circumvent these shortcomings by employing
altered precipitant concentrations and/or pH conditions failed, while efforts to grow
AarCH6 crystals in sodium acetate, sodium L-malate, or sodium succinate produced only
microcrystals. Despite these failures, usable high-resolution datasets were obtained by
screening large numbers of orthorhombic crystals in carefully selected orientations.
Secondary, tertiary, and quaternary structures. In sodium citrate, AarCH6
crystallized in the space group P212121 with an asymmetric unit containing the expected
biological dimer. Each monomer is composed of distinct N-terminal (residues 2 – 170,
216 – 223) and C-terminal (residues 179 – 181, 236 – 505) domains displaying open α/βfolds (Figures 4.5A and 4.6). The N-terminal domain possesses a three layer architecture.
A core seven-strand parallel β-sheet (β9, β7, β5, β1, β2, β3, β4) with a single antiparallel
edge (β6) is sandwiched between four surface-exposed α-helices (α1 – α4) and two semiburied α-helices (α5 and α6) at the subunit interface. The C-terminal domain is similarly
arranged. A core eight-strand parallel β-sheet (β8, β13, β12, β11, β10, β14, β19, β22) with
a single antiparallel edge (β23) is sandwiched between five surface-exposed α-helices (α7
– α11) and three buried α-helices (α12 – α14) at the subunit interface. The C-terminal
domain is additionally composed of a two-strand antiparallel β-sheet (β16 and β17), a
four-strand mixed β-sheet (β15, β16, β20, and β21), and three flanking α-helices (α15 –
α17). The domains are joined by two rigid loops (residues 171 – 178 and 182 – 215) and
a single flexible domain linker (residues 224 – 235) spanning a deep, funnel-shaped cleft.
The extensive, highly hydrated monomer-monomer interface buries 3,500 Å2 per
subunit (17% of the total surface area). Four chloride ions are present at the interface,
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Figure 4.5. Crystallographic characterization of AarCH6•CoA•citrate (PDB entry 4eu7). (A) AarCH6
possesses a dimeric quaternary structure (green and blue subunits) with four chloride ions (yellow
spheres) associated with buried arginine residues at the monomer-monomer interface. CoA (black)
and citrate (gray) are bound in a deep, funnel-shaped active-site cleft between the N- and C-terminal
domains of each subunit. (B) Ligands were identified based upon strong and unambiguous electron
density. The subterminal methylene carbon and terminal thiol sulfur of CoA were modeled in two
alternate conformations. The σA-weighted 2mFo − DFc map, calculated with CoA, citrate, and Glu294
omitted, is contoured at 1.0 sigma and carved with a 2-Å radius. (C) CoA and citrate are bound near
the catalytic glutamate Glu294 (divergent stereodiagram). Citrate forms electrostatic and/or hydrogenbonding interactions (yellow dotted lines) with Ser71, Thr94, and Arg228. The much larger CoA
forms hydrogen-bonding interactions with only Ile364, Asn384, and Lys408. All other hydrogenbonding interactions are mediated by water (not shown).
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Figure 4.6. AarC(H6) topology diagram. Each subunit is composed of distinct N- and C-terminal
domains displaying open α/β folds. The domains are joined by two static loops and a single dynamic
domain linker that spans a deep active-site cleft. All 310-helices are omitted.

associated with buried and otherwise uncompensated arginine residues [Arg120 (A/B)
and Arg354 (A/B)]. When the chloride ions were modeled as water molecules,
corresponding B-factors were substantially lower than those of surrounding protein atoms
and residual density remained in the σA-weighted mFo − DFc difference map. The
presence of heavy atoms was further substantiated by anomalous density centered around
the chloride ions (AarCH6-R228E•CoA [anomalous], PDB entry 4eua, Tables 4.6 and
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4.7; Figure 4.7). Given the buried locations of Arg120 and Arg354 in the dimer and the
lack of nearby negatively charged residues, the four chloride ions are likely necessary for
oligomerization of AarC(H6).
In ammonium sulfate, AarCH6 (AarCH6•CoA, PDB entry 4eu4, Tables 4.4 and 4.5)
crystallized in the space group P6222 with the same asymmetric unit as crystals grown in
sodium citrate. Despite the vastly different solvent contents of the two crystal forms
(orthorhombic, ~40%; hexagonal, ~70%), corresponding AarCH6 structures were highly
similar (Rmsd = 0.54 Å for all Cα atoms, residues 2 – 505). Only the conformation of the
hexahistidine tag of subunit A from the orthorhombic crystals was distinct. Formation of
a 310-helix and favorable crystal packing interactions with an adjacent asymmetric unit
allowed the complete hexahistidine tag (residues 506 – 514) to be observed. Ordered
hexahistidine tags are rare and are often attributed to stabilizing packing contacts (18).
Such interactions were lacking for subunit B in the orthorhombic crystals and both

R354 (A)

N112 (A)
Cl516 (B)
R120 (A)
R354 (B)
Cl515 (A)

Cl516 (A)

HOH
N125 (A)
HOH

G443 (B)

V196 (A)
HOH

Figure 4.7. Chloride ions at the monomer-monomer interface. Four chloride ions (yellow spheres) are
associated with buried and otherwise uncompensated arginine residues at the subunit interface
(subunit A, green; subunit B, blue). The σA-weighted 2mFo − DFc map (gray, AarCH6-R228E•CoA,
PDB entry 4eu9) is contoured at 1.5 sigma. The NCS-averaged, σA-weighted anomalous map (purple,
AarCH6-R228E•CoA [anomalous], PDB entry 4eua) is contoured at 2.8 sigma. Neither map is carved
in the region shown. All indicated electrostatic interactions (cyan dotted lines) occur over 2.8 − 3.5 Å.
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subunits in the more sparsely packed hexagonal crystals. The similarity of the structures
observed in the two different crystal forms suggests that crystal-packing interactions do
not significantly perturb the solution-state conformation of AarCH6.
AarC crystals grown in sodium citrate closely resemble AarCH6 crystals grown in
sodium citrate. Moreover, the structure of AarC (AarC•CoA•citrate, PDB entry 4eud,
Tables 4.8 and 4.9) closely resembles the structure of AarCH6 (AarCH6•CoA•citrate,
PDB entry 4eu7, Rmsd = 0.17 Å for all Cα atoms, residues 2 – 505). A high degree of
structural similarity is congruent with the nearly identical kinetic constants obtained with
AarC and AarCH6.
Active site. Electron density consistent with CoA and citrate was observed in the
funnel-shaped cleft between the N- and C-terminal domains of AarCH6
(AarCH6•CoA•citrate, PDB entry 4eu7, Tables 4.4 and 4.5; Figure 4.5B). The adenine
moiety of CoA is located in a hydrophobic pocket (Ile364, Val377, Met383, Ala407, and
Ile412) near the entrance to the cleft, while the pantetheine arm extends into the active
site, terminating near Glu294 (Figure 4.5B/C). Only three direct hydrogen bonds are
present between CoA and the protein (Ile364, Asn384, and Lys408), while all other
hydrogen bonds are water mediated. Other than a single hydrophobic contact between the
panthetheine arm and Phe92, CoA exclusively contacts residues in the C-terminal
domain. Conversely, citrate contacts only residues in the N-terminal domain and the
domain linker, forming extensive electrostatic and/or hydrogen-bonding interactions with
the side chains of Ser71, Thr94, and Arg228.
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Proposed role of Glu294. Glu294 seems ideally positioned to form the covalent mixed
anhydride and thioester intermediates characteristic of class I (and III) CoA-transferase
reactions. Moreover, introduction of a Glu294→Ala mutation reduced specific activity to
a level that could not be detected at a threshold 10,000-fold below the activity of wildtype enzyme. AarCH6-E294A (AarCH6-E294A•CoA, PDB entry 4eub, Tables 4.8 and
4.9) did not undergo structural rearrangements that could account for the observed loss of
activity.
Proposed role of Glu435. A previously published multiple sequence alignment
predicted that Glu435 is the reactive active-site glutamate in AarC (19). Glu435,
however, is located outside the active-site cleft and constitutes part of a highly conserved
β-hairpin motif. Furthermore, AarCH6-E435D possesses catalytic properties similar to
those of AarCH6 (Table 4.10). Insolubility prevented kinetic characterization of AarCH6E435A and AarCH6-E435Q but supports relegation of Glu435 to a purely structural role.
Proposed role of Arg228. The structural similarity between citrate and succinate could
imply that Thr94 and Arg228 (and Ser71) participate in recognition of the physiological
carboxylate substrates. The significant gap between citrate and Glu294, however, seems
to preclude participation of either residue in Michaelis complexes. Alternatively, Thr94
and Arg228 (and Ser71) may comprise an auxiliary binding site.
AarCH6-R228E exhibited a pronounced defect in apparent binding of carboxylate
substrates. At concentrations in excess of 0.5 M, neither acetate nor succinate could
saturate AarCH6-R228E (Figure 4.8 and Table 4.10). Catalytic activity and apparent
binding of acyl-CoA substrates were relatively unimpaired. While the side chain of
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Table 4.4. Data-collection statistics for wild-type AarCH6a
AarCH6
(4eu3)

AarCH6•CoA
(4eu4)

{AarCH6}•CoA
(4eu5)

AarCH6•CoA•acetate
(4eu6)

AarCH6•CoA•citrate
(4eu7)

Beamline

21-ID-F

21-ID-G

23-ID-D

21-ID-F

21-ID-G

Wavelength (Å)

0.97872

0.97856

1.0331

0.97872

0.97856

Space group

P212121

P6222

P212121

P212121

P212121

a = 67.5, b = 110.3,
c = 119.8

a = b = 150.2,
c = 290.4

a = 67.6, b = 110.6,
c = 119.5

a = 67.2, b = 110.4,
c = 119.8

a = 67.4, b = 110.9,
c = 120.4

Solvent content (%)b

38.4

70.9

38.5

38.1

38.9

Matthews coefficient (Å3/Da)b

2.00

4.23

2.00

1.99

2.01

50 – 1.58
(1.61 – 1.58)

50 – 2.80
(2.85 – 2.80)

50 – 1.75
(1.81 – 1.75)

50 – 1.99
(2.02 – 1.99)

50 – 1.70
(1.73 – 1.70)

1,502,448

845,333

865,507

787,079

1,319,072

121,024 (5,211)

46,836 (2,173)

91,574 (9,057)

61,848 (3,022)

99,312 (4,801)

Redundancy

12.4 (4.9)

18.0 (12.5)

9.5 (7.3)

12.7 (12.1)

13.3 (8.4)

Completeness (%)

98.4 (86.0)

97.1 (92.2)

100.0 (100.0)

99.7 (99.1)

99.8 (97.6)

〈I/σ(I)〉

21.4 (2.1)

34.1 (3.9)

27.5 (3.6)

34.1 (7.2)

30.0 (2.9)

Rsymc (%)

10.3 (44.2)

11.4 (71.8)

12.4 (62.3)

11.0 (53.0)

10.5 (54.2)

Unit-cell dimensions (Å)

Resolution (Å)
Measured reflections
Unique reflections

a

Values in parentheses are for the outermost resolution shell. b Solvent contents and Matthews coefficients were calculated using a web applet (http://
www.ruppweb.org/Mattprob/) (38, 39). c Rsym = ∑hkl ∑i |Ii(hkl) − 〈Ii(hkl)〉| / ∑hkl ∑i Ii(hkl), where Ii(hkl) is the intensity of the ith observation of reflection hkl
and 〈Ii(hkl)〉 is the mean intensity of all observations i of reflection hkl.
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Table 4.5. Refinement statistics for wild-type AarCH6a
AarCH6d
(4eu3)

AarCH6•CoA
(4eu4)

{AarCH6}•CoA
(4eu5)

AarCH6•CoA•acetatee
(4eu6)

AarCH6•CoA•citrate
(4eu7)

40.2 – 1.58
(1.60 – 1.58)

41.5 – 2.80
(2.90 – 2.80)

42.8 – 1.74
(1.81 – 1.74)

34.8 – 1.99
(2.02 – 1.99)

28.8 – 1.70
(1.76 – 1.70)

109,938/5,768

42,623/2,273

83,914/4,400

58,685/3,092

91,142/4,802

Total atoms

9,106

8,179

8,870

8,488

9,207

Protein atoms

7,817

7,684

7,789

7,786

7,843

Water atoms

1,272

295

981

595

1,236

Ligand atoms

17

200

100

107

128

Rcrystb (%)

15.6 (25.8)

17.8 (28.7)

16.7 (21.8)

16.4 (16.5)

15.6 (22.3)

Rfreec (%)

18.9 (29.8)

22.3 (35.9)

20.9 (28.3)

20.9 (24.3)

19.4 (26.7)

Average B-factor (Å2)
Protein
Water
Ligand

12.6
24.8
18.5

49.7
45.0
58.7

17.0
25.9
18.9

22.4
27.9
26.3

17.0
29.4
24.1

Rmsd from ideal geometry
Bond lengths (Å)
Bond angles (°)

0.006
1.07

0.008
1.20

0.006
1.06

0.007
1.05

0.006
1.04

Ramachandran plot (%)
Favored regions
Additionally allowed regions
Outlying regions

97.0
2.9
0.1

92.5
6.9
0.6

97.0
2.7
0.3

96.8
2.8
0.4

96.6
3.2
0.2

Resolution (Å)
Reflections (working/test)

a

Values in parentheses are for the outermost resolution shell. b Rcryst = ∑hkl |Fo − Fc| / ∑hkl Fo, where Fo and Fc are the observed and calculated structure
factors, respectively. c Rfree was calculated in the same manner as Rcryst using the 5% of reflections excluded from refinement. With the exception of the
AarCH6-S71A•CoA, AarCH6-R228E•CoA [anomalous], and AarCH6-E294A•dethiaacetyl-CoA datasets, a consistent set of reflections was set aside for all
datasets of the space group P212121, including those datasets described in Tables 4.7 and 4.9. d Citrate was modeled in the active site of subunit B. e The
covalent acetylglutamyl anhydride and glutamyl-CoA thioester intermediates were modeled in subunits A and B, respectively.
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Table 4.6. Data-collection statistics for mutant AarCH6a
AarCH6-S71A•CoA
(4eu8)

AarCH6-R228E•CoA
(4eu9)

AarCH6-R228E•CoA [anomalous]
(4eua)

Beamline

21-ID-F

21-ID-F

21-ID-D

Wavelength (Å)

0.97872

0.97872

1.9075

Space group

P212121

P212121

P212121

a = 67.3, b = 109.7,
c = 120.1

a = 67.1, b = 110.1,
c = 119.8

a = 67.4, b = 110.5,
c = 119.2

Solvent content (%)b

38.0

37.9

38.1

Matthews coefficient (Å3/Da)b

1.99

1.98

1.99

50 – 1.81
(1.84 – 1.81)

50 – 1.48
(1.51 – 1.48)

50 – 2.40
(2.49 – 2.40)

968,154

2,010,407

201,712

81,672 (4,005)

148,137 (7,318)

34,893 (3,477)

11.9 (11.7)

13.6 (12.9)

5.8 (5.7)

100.0 (100.0)

99.9 (99.8)

98.2 (100.0)

〈I/σ(I)〉

40.3 (5.9)

38.4 (4.4)

54.6 (33.5)

Rsymc (%)

8.3 (48.2)

7.9 (57.4)

6.3 (10.9)

Unit-cell dimensions (Å)

Resolution (Å)
Measured reflections
Unique reflections
Redundancy
Completeness (%)

a

b

Values in parentheses are for the outermost resolution shell. Solvent contents and Matthews coefficients were calculated using a web applet (http://
www.ruppweb.org/Mattprob/). c Rsym = ∑hkl ∑i |Ii(hkl) − 〈Ii(hkl)〉| / ∑hkl ∑i Ii(hkl), where Ii(hkl) is the intensity of the ith observation of reflection hkl and
〈Ii(hkl)〉 is the mean intensity of all observations i of reflection hkl.
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Table 4.7. Refinement statistics for mutant AarCH6a
AarCH6-S71A•CoA
(4eu8)

AarCH6-R228E•CoAd
(4eu9)

AarCH6-R228E•CoA [anomalous]
(4eua)

Resolution (Å)

34.7 – 1.81
(1.83 – 1.81)

31.0 – 1.48
(1.50 – 1.48)

44.6 – 2.40
(2.43 – 2.40)

Reflections (working/test)

77,516/4,077

140,548/7,386

62,276/3,330

Total atoms

8,513

9,290

8,364

Protein atoms

7,724

7,862

7,764

Water atoms

689

1,326

500

Ligand atoms

100

102

100

Rcrystb (%)

18.0 (24.0)

15.7 (19.1)

15.2 (15.3)

Rfreec (%)

22.6 (29.6)

17.9 (22.1)

20.9 (23.6)

Average B-factor (Å2)
Protein
Water
Ligand

20.1
27.7
27.1

13.3
26.3
20.0

16.9
19.0
31.3

Rmsd from ideal geometry
Bond lengths (Å)
Bond angles (°)

0.007
1.11

0.006
1.14

0.007
1.02

Ramachandran plot (%)
Favored regions
Additionally allowed regions
Outlying regions

96.5
3.0
0.5

97.0
2.9
0.1

96.5
3.4
0.1

a

Values in parentheses are for the outermost resolution shell. b Rcryst = ∑hkl |Fo − Fc| / ∑hkl Fo, where Fo and Fc are the observed and calculated structure
factors, respectively. c Rfree was calculated in the same manner as Rcryst using the 5% of reflections excluded from refinement. With the exception of the
AarCH6-S71A•CoA, AarCH6-R228E•CoA [anomalous], and AarCH6-E294A•dethiaacetyl-CoA datasets, a consistent set of reflections was set aside for all
datasets of the space group P212121, including those datasets described in Tables 4.5 and 4.9. d Both the glutamyl-CoA thioester intermediate and glutamate/
CoA were modeled in the active site of subunit B.
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Table 4.8. Data-collection statistics for mutant AarCH6 and wild-type AarCa
AarCH6-E294A•CoA
(4eub)

AarCH6-E294A•dethiaacetyl-CoA
(4euc)

AarC•CoA•citrate
(4eud)

Beamline

21-ID-F

21-ID-G

23-ID-B

Wavelength (Å)

0.97872

0.97856

1.0332

Space group

P212121

P212121

P212121

a = 67.4, b = 110.3,
c = 120.2

a = 79.5, b = 104.1,
c = 120.1d

a = 67.7, b = 110.6,
c = 119.9

Solvent content (%)b

38.6

44.8

40.1

Matthews coefficient (Å3/Da)b

2.00

2.23

2.05

50 – 1.97
(2.00 – 1.97)

50 – 2.65
(2.70 – 2.65)

50 – 1.94
(2.01 – 1.94)

904,072

438,134

605,583

63,807 (3,167)

29,835 (1,441)

64,164 (6,136)

Redundancy

14.2 (13.4)

14.7 (14.9)

9.4 (6.5)

Completeness (%)

100.0 (99.9)

100.0 (100.0)

97.3 (94.8)

〈I/σ(I)〉

28.4 (6.3)

33.9 (6.2)

20.0 (3.9)

Rsymc (%)

12.0 (49.1)

14.0 (75.4)

21.4 (60.0)

Unit-cell dimensions (Å)

Resolution (Å)
Measured reflections
Unique reflections

a

Values in parentheses are for the outermost resolution shell. b Solvent contents and Matthews coefficients were calculated using a web applet (http://
www.ruppweb.org/Mattprob/). c Rsym = ∑hkl ∑i |Ii(hkl) − 〈Ii(hkl)〉| / ∑hkl ∑i Ii(hkl), where Ii(hkl) is the intensity of the ith observation of reflection hkl and
〈Ii(hkl)〉 is the mean intensity of all observations i of reflection hkl. d Altered unit-cell dimensions resulted from a unique crystal-packing arrangement.
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Table 4.9. Refinement statistics for mutant AarCH6 and wild-type AarCa
AarCH6-E294A•CoA
(4eub)

AarCH6-E294A•dethiaacetyl-CoA
(4euc)

AarC•CoA•citrated
(4eud)

Resolution (Å)

40.2 – 1.97
(2.00 – 1.97)

43.5 – 2.64
(2.73 – 2.64)

42.8 – 1.95
(2.02 – 1.95)

Reflections (working/test)

60,553/3,179

28,286/1,489

57,803/3,021

Total atoms

8,583

7,987

8,544

Protein atoms

7,686

7,676

7,686

Water atoms

795

205

745

Ligand atoms

102

106

113

Rcrystb (%)

15.4 (18.2)

16.8 (22.2)

15.9 (17.8)

Rfreec (%)

20.9 (26.4)

22.5 (29.7)

20.6 (26.0)

Average B-factor (Å2)
Protein
Water
Ligand

17.9
25.1
14.3

46.9
36.8
43.9

18.8
25.5
29.1

Rmsd from ideal geometry
Bond lengths (Å)
Bond angles (°)

0.007
1.07

0.009
1.07

0.007
1.03

Ramachandran plot (%)
Favored regions
Additionally allowed regions
Outlying regions

97.6
2.1
0.3

95.4
4.5
0.1

96.7
3.0
0.3

a

Values in parentheses are for the outermost resolution shell. b Rcryst = ∑hkl |Fo − Fc| / ∑hkl Fo, where Fo and Fc are the observed and calculated structure
factors, respectively. c Rfree was calculated in the same manner as Rcryst using the 5% of reflections excluded from refinement. With the exception of the
AarCH6-S71A•CoA, AarCH6-R228E•CoA [anomalous], and AarCH6-E294A•dethiaacetyl-CoA datasets, a consistent set of reflections was set aside for all
datasets of the space group P212121, including those datasets described in Tables 4.5 and 4.7. d Citrate was only modeled in the active site of subunit B.
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Table 4.10. Wild-type and mutant AarCH6 kinetic constantsa
Substrate
acetate

succinyl-CoA

succinate

acetyl-CoA

---

Parameter

WT

S71Ac

R228E

N347A

E435D

kcat (s−1)

280 ± 40

4.85 ± 0.07

3.4 ± 0.1e

12.2 ± 0.2

370 ± 50

Km (mM)

70 ± 20

167 ± 6

6±1

78 ± 5

110 ± 30

kcat/Km (M−1 s−1)

(4 ± 1) × 103

(2.9 ± 0.1) × 101

(6 ± 1) × 102

(1.6 ± 0.1) × 102

(3 ± 1) × 103

Ki (mM)

1,600 ± 800

NAd

NA

NA

2,000 ± 2,000

kcat (s−1)

201 ± 8

6.2 ± 0.6

16.0 ± 0.4f

12.1 ± 0.9

340 ± 10

Km (µM)

22 ± 4

90 ± 20

122 ± 9

38 ± 7

40 ± 5

kcat/Km (M−1 s−1)

(9 ± 2) × 106

(7 ± 2) × 104

(1.3 ± 0.1) × 105

(3.2 ± 0.6) × 105

(9 ± 1) × 106

Ki (µM)

NA

700 ± 200

NA

4000 ± 2000

NA

kcat (s−1)

71 ± 2

6.2 ± 0.1

800 ± 500

2.07 ± 0.02h

153 ± 2

Km (mM)

0.9 ± 0.1

21 ± 2

3000 ± 2000

0.76 ± 0.03

2.1 ± 0.1

kcat/Km (M−1 s−1)

(7.9 ± 0.9) × 104

(3.0 ± 0.3) × 102

(3 ± 3) × 102

(2.7 ± 0.1) × 103

(7.3 ± 0.4) × 104

kcat (s−1)

75 ± 2

40 ± 20

105 ± 3g

1.97 ± 0.07

129 ± 3

Km (µM)

22 ± 2

500 ± 300

45 ± 5

3.0 ± 0.4

25 ± 3

kcat/Km (M−1 s−1)

(3.4 ± 0.3) × 106

(8 ± 6) × 104

(2.3 ± 0.3) × 106

(6.6 ± 0.9 ) × 105

(5.2 ± 0.6) × 106

Ki (µM)

NA

70 ± 40

NA

5000 ± 2000

NA

Keqb

0.14 ± 0.05

0.08 ± 0.06

0.1 ± 0.1

0.03 ± 0.01

0.07 ± 0.03

a

SCACT activities were measured using LCF/LCR assays. Saturation experiments were performed in duplicate for the mutant enzymes. No activity was
detected with AarCH6-E294A. Kinetic constants for the wild-type (WT) enzyme were taken from Chapter 2. b Haldanes were calculated as described in
Chapter 2. c Assays were shortened to 17 − 35 s. d Substrate inhibition was not observed (not applicable). e The concentration of succinyl-CoA was 500 µM.
The data were fit to a modified Michaelis-Menten equation (Figure 4.8). f The concentration of acetate was 750 mM. g The concentration of succinate was
550 mM. h The concentration of acetyl-CoA was 100 µM.
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A

B

Figure 4.8. Kinetic characterization of AarCH6-R228E. Both physiological carboxylate substrates
failed to saturate AarCH6-R228E. (A) Acetate "saturation" plot. Kinetic data were only satisfactorily
fit when an additional linear-slope term was added to the Michaelis-Menten equation (v = Vmax ×
[acetate]/(Km + [acetate]) + slope × [acetate]). (B) Succinate "saturation" plot. Kinetic data were
equally well fit by the Michaelis-Menten equation (red solid line) and a linear equation (blue dashed
line). Potassium succinate is insoluble above ~650 mM at pH 8. Kinetic constants are given in Table
4.10.

Glu228 is well-removed from the proposed auxiliary binding site (AarCH6-R228E•CoA,
PDB entry 4eu9, Tables 4.6 and 4.7), the charge reversal appears to have partially
neutralized much of the positively charged active-site cleft (Figure 4.9). Altered
electrostatic interactions could be responsible for much, if not all, of the loss of apparent
binding affinity.
Substrate specificity (AarCH6-R228E). Four zwitterionic carboxylates (3aminopropionate, 4-aminobutyrate, glycylglycine, and 4-guanidinobutyrate; Figure A.11)
were screened as possible alternate CoA-acceptors in modified VisR and LCR assays
containing AarCH6-R228E. None of the substrates produced detectable CoA-transferase
activity, suggesting charge complementation alone is not sufficient to alter specificity.
Citrate inhibition. While citrate was unable to support CoA-transferase activity,
SCACT activity was competitively inhibited by citrate in modified LCR assays
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A
R228
citrate
CoA

B
E228

CoA

Figure 4.9. Electrostatic surfaces surrounding the auxiliary binding sites of AarCH6 and AarCH6R228E. (A) AarCH6 (PDB entry 4eu6). (B) AarCH6-R228E (PDB entry 4eu9). The protein surfaces
are colored red for negatively charged areas and blue for positively charged areas. The saturation of
the colors is proportional to the degree of electrostatic charge from −7 kT/e to +7 kT/e. The charge
surfaces were computed at pH 7 using the PDB2PQR (40) web server and the APBS (41) plugin for
PyMOL. CoA and citrate are depicted in ball-and-stick representation.

containing a varied concentration of succinate and a fixed concentration of acetyl-CoA
(Figure 4.10). Inhibition was too weak to be physiologically relevant (Ki = 150 ± 30 mM)
but supports the proposed role of Thr94 and Arg228 in auxiliary binding of carboxylate
substrates.
Conformational dynamics. Wild-type and mutant AarCH6 adopted several distinct
conformations ranging from fully open to fully closed (Figure 4.11). The most open
conformation was assumed by unliganded AarCH6 (AarCH6, PDB entry 4eu3, Tables 4.4
and 4.5), making the active site readily accessible to acyl-CoA substrates. Upon binding
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Figure 4.10. Citrate-dependent inhibition of SCACT activity. Citrate was a competitive inhibitor in
modified LCR assays containing a variable concentration of succinate (0.4 – 20 mM) and fixed
concentrations of acetyl-CoA (0.5 mM) and citrate [0 (red circles), 25 (blue squares), 75 (green
diamonds), or 125 mM (orange triangles)]. Kinetic constants and error estimates were determined by
global nonlinear fitting using gnuplot 4.4.

CoA, AarCH6 proceeded through three stages of constriction. The first stage left the
active site largely open but through small, local structural shifts improved hydrogenbonding, electrostatic, and hydrophobic interactions with the adenine and ribose rings, the
3′-phosphate, and the proximal carbonyl oxygen of the pantetheine arm. The second stage
greatly narrowed the active site. Helices α8 – α11 and the loop connecting β10 and α8
translated toward CoA to maximize hydrogen-bonding and electrostatic interactions with
the diphosphate moiety and the proximal amide nitrogen and adjacent hydroxyl of the
pantetheine arm ({AarCH6}•CoA, PDB entry 4eu5, Tables 4.4 and 4.5; Figure 4.12B/C).
The concomitant relocation of Val270 created a closed reaction pocket defined by the
hydrophobic residues Phe35, Thr36, Ala70, Phe92, Leu114, and Val295, isolating the
catalytic glutamate and CoA thiol from bulk solvent (Figure 4.12A). An accompanying
rotation of the domain linker placed the side chain of Phe232 between α9 and the mobile
loop connecting β10 and α8. The third and final stage appears to be an incremental
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linker

CoA

Figure 4.11. Stepwise constriction of AarCH6 (and AarCH6-E294A). The active-site cleft of AarCH6
narrows upon binding CoA. Helices α8 − α11 translate toward CoA, maximizing hydrogen-bonding
and electrostatic interactions with the diphosphate moiety and the pantetheine arm. Concomitantly, the
side chain of Val270 forms an isolated hydrophobic pocket around the catalytic residues and CoA
thiol, while the domain linker rotates, pushing Asn229 and Phe232 into the active-site cleft and
pulling Arg228 onto the protein surface. Residues in the fully open conformation are colored green
(PDB entry 4eu3), residues in the mostly open conformation are colored cyan (PDB entry 4eu7),
residues in the predominantly closed conformation are colored purple (PDB entry 4eu5), and residues
in the fully closed conformation are colored yellow (PDB entry 4eub). CoA and citrate from all
models are depicted in ball-and-stick representation.

continuation of the second stage (AarCH6-E294A•CoA, PDB entry 4eub, Tables 4.8 and
4.9). Rotation of the domain linker continued toward the N-terminal domain, pushing the
side chain of Asn229 into the active site while pulling the side chain of Arg228 onto the
protein surface, effectively removing the auxiliary binding site.
Relatively high B-factors in the dynamic portions of all structures, including the
unliganded structure, suggest an equilibrium between the open and closed conformations.
CoA seems to shift the equilibrium toward the closed conformation by forming favorable
hydrogen-bonding and electrostatic interactions with the loop connecting β10 and α8 and
the N-terminus of α8 that constrict the active site. Conversely, citrate seems to shift the
equilibrium toward the open conformation by forming favorable hydrogen-bonding and
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V377

V377

V273
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Figure 4.12. Conformational motions in AarCH6. (A) The active-site cleft of AarCH6 constricts upon
binding CoA, isolating the catalytic glutamate and CoA thiol from bulk solvent. For reference, CoA
from the closed structure was superposed onto the open, unliganded structure. (B) Changes in the
active site are accompanied by significant shifts in surrounding loops and helices. Dynamic regions
(Rmsd ≥ 0.5 Å for Cα atoms) are differentially colored. (C) Constriction of the active-site cleft
maximizes electrostatic and hydrogen-bonding interactions (yellow dotted lines) with CoA (divergent
stereodiagram). In all panels, residues in the open conformation are colored green (PDB entry 4eu3),
residues in the closed conformation are colored purple (PDB entry 4eu5), and CoA is colored black.

electrostatic interactions with the side chain of Arg228 that inhibit rotation of the domain
linker.
Characterization of a pseudo Michaelis complex. AarCH6-E294A was
cocrystallized with dethiaacetyl-CoA (AarCH6-E294A•dethiaacetyl-CoA, PDB entry
4euc, Tables 4.8 and 4.9), and clear electron density was observed in the closed activesite cleft consistent with the complete and ordered ligand (Figure 4.13). [DethiaacetylCoA is an unreactive analogue of acetyl-CoA in which the thioester sulfur is replaced by
a methylene group.] The CoA moiety of dethiaacetyl-CoA is bound in the same extended
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Ala294

dethiaacetyl-CoA

Figure 4.13. Pseudo Michaelis complex between AarCH6-E294A and dethiaacetyl-CoA (PDB entry
4euc). Electron density consistent with dethiaacetyl-CoA was observed in the active site of AarCH6E294A. The NCS-averaged, σA-weighted 2mFo − DFc map, calculated with dethiaacetyl-CoA and
Ala294 omitted, is contoured at 1.0 sigma and carved with a 2.6-Å radius.

conformation as described above for CoA. The "acetyl" group, however, does not
continue toward Ala294 but wraps back toward the pantetheine arm, forming hydrogenbonding interactions with the backbone nitrogen of Gly388 and the distal amide nitrogen
of the CoA moiety (Figure 4.14). [This conformation would seemingly prepare acetylCoA for nucleophilic attack by Glu294 and stabilize the resulting tetrahedral oxyanion
intermediate.] The terminal methyl group forms hydrophobic contacts with the side
chains of Phe35, Thr36, Ala70, Phe92, Leu114, Val270, Ala294, and Val295.
Freeze-trapping of covalent intermediates. Multiple experimental conditions were
screened in an effort to obtain covalent anhydride and thioester intermediates. While
cocrystallization and prolonged soaking in drops and cryoprotectants supplemented with
acetyl-CoA (or succinyl-CoA) failed, a 22-h soak in cryoprotectant without ligand
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Figure 4.14. Pseudo Michaelis complex between AarCH6-E294A and dethiaacetyl-CoA (PDB entry
4euc) [2]. Dethiaacetyl-CoA (black) binds in a curled conformation. The ketone carbonyl oxygen
forms hydrogen-bonding interactions (yellow dotted lines) with the backbone nitrogen of Gly388 and
the distal amide nitrogen of the CoA moiety, while the terminal methyl group forms hydrophobic
contacts with the side chains of Phe35, Thr36, Ala70, Phe92, Leu114, Val270, Ala294, and Val295. In
the fully closed conformation, Arg228 (not shown) is pulled from the active site and the side chain of
Gln297 reorients to form hydrogen-bonding interactions with the backbone carbonyl oxygen of
Gly269 and the backbone nitrogen of Gly271.

followed by a short 2-h soak in cryoprotectant supplemented with acetyl-CoA was
successful. [Under conditions similar to those employed for crystallization and
cryoprotection the acyl-CoA substrates have ~10 h half-lives (Chapter 2).]
Electron density consistent with the acetylglutamyl anhydride/CoA thiolate and
glutamyl-CoA thioester was observed in both active sites of the dimeric asymmetric unit
(AarCH6•CoA•acetate, PDB entry 4eu6, Tables 4.4 and 4.5; Figure 4.15). The
predominant intermediate was modeled and refined in each. Electron density consistent
with acetate was also observed in the proposed auxiliary binding site of the subunit with
the greatest density congruent with the glutamyl-CoA thioester (Figure 4.15). Dynamic
regions of the active sites and surrounding mobile secondary structural elements
possessed relatively weak density consistent with the proposed equilibrium between open
and closed conformations.
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The proximal and distal carbonyl oxygens of the acetylglutamyl anhydride form
hydrogen-bonding interactions with the side chain of Asn347 and the backbone nitrogen
of Gly388/distal amide nitrogen of CoA, respectively. This arrangement prepares the
mixed anhydride for nucleophilic attack at either carbonyl, forming the glutamyl-CoA
thioester (proximal carbonyl) or reforming acetyl-CoA (distal carbonyl). Intervening
tetrahedral oxyanion intermediates would be stabilized by the side chain of Asn347
(position 2) or the backbone nitrogen of Gly388/distal amide nitrogen of CoA (position
1), respectively (Scheme 4.2). The leaving-group potentials of acetate and Glu294 are
likely increased by these same hydrogen-bonding interactions. The terminal methyl group

Glu294

Glu294

acetate

CoA

CoA

Figure 4.15. Covalent anhydride and thioester intermediates (PDB entry 4eu6). Electron density
consistent with the acetylglutamyl anhydride and glutamyl-CoA thioester intermediates was observed
in both active sites of the dimeric asymmetric unit following a short 2-h soak in cryoprotectant
supplemented with acetyl-CoA. Only the predominant intermediate was modeled in each. (Left)
Anhydride intermediate. (Right) Thioester intermediate. The points of covalent attachment are
indicated (black arrows). The σA-weighted 2mFo − DFc map, calculated with CoA, acetate, and
Glu294 omitted, is contoured at 0.9 (anhydride) and 0.6 (thioester) sigma and carved with a 2-Å
radius.
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Asn347

Gly388
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CoA

CoA

Scheme 4.2. Tetrahedral oxyanion intermediates. Four tetrahedral oxyanion intermediates [R = -CH3
(acetyl) or -CH2CH2COO− (succinyl)] are formed at two unique positions during the SCACT reaction.
None are formed within a traditional oxyanion hole, but all are stabilized by one or more hydrogenbonding interactions.

of the mixed anhydride forms hydrophobic contacts with the side chains of Phe35, Thr36,
Ala70, Phe92, Leu114, Val270, and Val295. The accompanying CoA thiolate is bound in
the same extended conformation described above for CoA with the terminal sulfur
forming hydrogen-bonding interactions with HOH517 and the backbone nitrogen of
Val270.
The carbonyl oxygen of the glutamyl-CoA thioester retains the hydrogen-bonding
interaction of the proximal carbonyl of the acetylglutamyl anhydride with the side chain
of Asn347. This conformation prepares the intermediate for nucleophilic attack by the
carboxylate substrate (or product), forming the second mixed anhydride (or reforming the
first mixed anhydride) and the CoA thiolate. The transient tetrahedral oxyanion
intermediate would be stabilized by hydrogen-bonding interactions with Asn347 (Scheme
4.2). As the tetrahedral oxyanion intermediate decomposes, the leaving-group potential of
the CoA thiolate is likely increased by hydrogen-bonding interactions with HOH517 and
the backbone nitrogen of Val270. The accompanying acetate occupies the auxiliary
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binding site, forming hydrogen-bonding and/or electrostatic interactions with the side
chains of Ser71, Thr94, and Arg228.
Proposed roles of Asn347. Asn347 is appropriately located to prearrange Glu294 in
the reactive conformation, stabilize two of four tetrahedral oxyanion intermediates
(position 2, Scheme 4.2), and augment the leaving-group potential of the glutamyl
carboxylate. AarCH6-N347A exhibited significantly and globally reduced catalytic
activity but largely unaffected apparent substrate affinity. Both findings correlate with the
proposed roles of Asn347. Loss of catalytic activity by the mutant enzyme could
conceivably be attenuated by an advantageously positioned water between Glu294 and
Asp391.
Molecular modeling of Michaelis complexes and glutamylsuccinyl anhydride.
Molecular modeling and molecular mechanics calculations were employed to construct
the crystallographically unobserved Michaelis complexes and the single unobserved
covalent intermediate glutamylsuccinyl anhydride. When combined with crystallographic
results these techniques provide a complete structural description of the ground-state
complexes and intermediates in the SCACT reaction (Figure 4.16 and Scheme 4.3).
Modeled glutamylsuccinyl anhydride was restrained to be in much the same
conformation as the crystallographically observed acetylglutamyl anhydride, but the
position of the distal carboxylate and adjacent methylene group were optimized using
molecular mechanics calculations. Hydrogen-bonding interactions were formed with the
side chain of Ser71 and the backbone nitrogens of Ser71 and Thr36, while appropriate
hydrophobic contacts were created with the side chains of Phe35, Thr36, Ala70, Phe92,
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Leu114, Val270, and Val295. In this conformation the succinyl moiety possesses a nearly
trans geometry.
The Michaelis complex involving acetyl-CoA was modeled in the curled conformation
of dethiaacetyl-CoA. Hydrogen-bonding interactions were formed with the backbone
nitrogen of Gly388 and the distal amide nitrogen of the CoA moiety, while the terminal
methyl group was placed in contact with the side chains of Phe35, Thr36, Ala70, Phe92,
Leu114, Val270, and Val295. Energy minimization introduced small conformational
deviations relative to dethiaacetyl-CoA can be attributed to inherent differences in bond
lengths and bond angles involving carbon (dethiaacetyl-CoA) and sulfur (acetyl-CoA)
atoms.
The Michaelis complex involving succinyl-CoA was also modeled in the curled
conformation of acetyl-CoA, while the succinyl moiety was arranged in the extended
trans geometry of glutamylsuccinyl anhydride. Energy minimization retained all
hydrogen-bonding interactions and hydrophobic contacts observed for dethiaacetyl-CoA
and modeled for (acetyl-CoA and) glutamylsuccinyl anhydride.
Acetate and succinate were placed adjacent to the crystallographically observed
glutamyl-CoA thioester intermediate in modeled Michaelis complexes. Both carboxylates
were positioned according to the conformations of the corresponding mixed anhydrides
and then optimized using molecular mechanics calculations. All hydrogen-bonding
interactions and hydrophobic contacts from the initial complexes were retained after
energy minimization.
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Scheme 4.3. Abbreviated SCACT mechanism (reverse biosynthetic direction). The SCACT reaction proceeds through a series of anhydride, tetrahedral
oxyanion (not shown), and thioester intermediates. All individual steps and the overall reaction are fully reversible. B: acetyl-CoA, C: acetylglutamyl
anhydride and CoA thiolate, D: glutamyl-CoA thioester and acetate, E: glutamyl-CoA thioester and succinate, F: glutamylsuccinyl anhydride and CoA
thiolate, and G: succinyl-CoA. Labels correspond to panels in Figure 4.16.
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Figure 4.16. Structural characterization of the SCACT reaction (reverse biosynthetic direction). Crystallographically observed intermediates (ball-and-stick
representation) and modeled intermediates (stick representation) were combined to produce a complete structural description of the SCACT reaction. (A)
Unliganded. (B) Acetyl-CoA [and dethiaacetyl-CoA (black)]. (C) Acetylglutamyl anhydride and CoA thiolate. (D) Glutamyl-CoA thioester and acetate.
[Acetate is depicted in two positions. Position "2" was crystallographically observed (Figure 4.15). Position "1" was modeled.] (E) Glutamyl-CoA thioester
and succinate. (F) Glutamylsuccinyl anhydride and CoA thiolate. (G) Succinyl-CoA. Modeled intermediates were manually positioned within the active site
and equilibrium conformations were determined using molecular mechanics calculations. Atoms shown in ball-and-stick representation were "frozen" or
omitted during optimization. Yellow and red dotted lines indicate hydrogen bonds and possible paths of nucleophilic attack, respectively.
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Proposed roles of Ser71. Ser71 forms hydrogen-bonding interactions with acetate and
succinate in the auxiliary binding site and succinate, succinyl-CoA, and glutamylsuccinyl
anhydride in the primary binding site. AarCH6-S71A displayed moderately reduced
apparent binding affinity and greatly reduced catalytic activity, much greater than that
expected from the loss of a single noncatalytic hydrogen-bonding interaction. Catalytic
activity and apparent binding affinity were also reduced in reactions containing (acetylCoA and) propionate [kcat = 8 ± 1 s−1, Km = 900 ± 200 mM, and kcat/Km = (8 ± 2) × 100 M
−1

s−1], which should not directly interact with Ser(Ala)71 in the Michaelis complex, the

product complex, or any intervening covalent intermediate.
The specific activity of AarCH6-S71A oddly decreased in a nonlinear manner at low
enzyme concentrations. [Reaction times were shortened to allow for higher enzyme
concentrations in LCF/LCR assays.] Neither the wild-type enzyme nor any of the other
mutant enzymes exhibited this phenomenon. Deoligomerization of the dimeric biological
unit would be consistent with this observation; however, Ser71 is far-removed from the
subunit interface.
Introduction of the Ser71→Ala mutation allowed the primary succinate binding pocket
to collapse (AarCH6-S71A•CoA, PDB entry 4eu8, Tables 4.6 and 4.7; Figure 4.17).
Without the two hydrogen bonds between the side chain of Ser71 and the backbone
nitrogens of Thr36 and Gly37, the loop connecting β1 and α2 shifted toward Ala71. In the
resulting conformation, the side chain of Thr36 blocks a large portion of the reaction
pocket. While acetate and propionate are significantly smaller than succinate, the
relocated side chain of Thr36 may nonetheless interfere with binding of propionate and
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Figure 4.17. Collapse of the succinate binding pocket of AarCH6-S71A. Without the three structural
hydrogen-bonding interactions (yellow dotted lines) formed between the side chain of Ser71, the side
chain of Arg228, and the backbone nitrogens of Thr36 and Gly37, the loop connecting β1 and α2
shifts. In the resulting conformation, the side chain of Thr36 blocks a large portion of the succinate
binding pocket. CoA and all waters are omitted from the AarCH6 model (green, PDB entry 4eu5).
CoA (black), the catalytic water, and two placeholder waters are included from the AarCH6-S71A
model (orange, PDB entry 4eu8). The placeholder water HOH520 (Figure 4.16) was displaced by
Thr36.

inhibit ingress and egress into and from the reaction pocket of both propionate and
acetate.
Introduction of the Ser71→Ala mutation also removed a hydrogen bond between the
side chains of Ser71 and Arg228. Without this interaction, Arg228 was pulled from the
active site in both the closed and the open conformations (Figure 4.17). In the closed
conformation, repositioning of the domain linker (including Arg228) was accompanied
by a significant coordinated shift in the surface-exposed secondary structural elements in
the N-terminal domain (Figure 4.18). This previously unobserved motion may correlate
with the apparent deoligomerization of the AarCH6-S71A dimer.
Acid tolerance. Circular dichroism was used to monitor temperature-induced changes
in the secondary structures of AarC and AarCH6 as a function of pH (Figure 4.19). Both
proteins possessed maximal stability under slightly acidic conditions, decreasing
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Figure 4.18. Conformational motions in AarCH6-S71A. In the open conformation (light gray),
AarCH6-S71A (PDB entry 4eu8) displays only minor, local structural rearrangements relative to
AarCH6 (PDB entry 4eu5). In the closed conformation (dark gray), however, AarCH6-S71A exhibits
widespread, coordinated conformational shifts in the N-terminal domain. In both conformations, the
loss of the hydrogen-bonding interaction between Ser71 and Arg228 allows the side chain of Arg228
to be pulled from the active-site cleft. Dynamic regions (Rmsd ≥ 0.75 Å for Cα atoms) are
differentially colored (AarCH6, green; AarCH6-S71A, orange). CoA from the AarCH6-S71A model is
colored black.

gradually under alkaline conditions and relatively sharply under increasingly acidic
conditions (Figure 4.20). Under low pH conditions that would likely result in protonation
of histidine, the hexahistidine fusion protein was marginally less stable than the untagged
enzyme. Despite reduced stability at moderately acidic pH, AarC remained folded under
all conditions encountered in the A. aceti cytoplasm (pH 3.8 – 6.8 and ≤ 35 °C).
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Figure 4.19. Thermal denaturation of AarC and AarCH6 as a function of pH. Temperature-induced
changes in secondary structure were assessed by monitoring ellipticity at 222 nm. Melting
experiments were performed across a range of pH conditions: 3.5 (red), 4.0 (blue), 4.5 (green), 5.0
(orange), 5.5 (cyan), 6.5 (magenta), 7.5 (yellow), and 8.5 (lime). (A) AarC far-UV CD spectra. (B)
AarC melting profiles. (C) AarCH6 far-UV CD spectra. (D) AarCH6 melting profiles.

The acid stability of A. aceti proteins has been linked to an unusual but characteristic
charge decoration (10, 20, 21) shared by AarC (Figure 4.21). With the exception of the
positively charged active site and surrounding electrostatic gradient, the surface of AarC
appears largely neutral with only punctuate clusters of significant homogeneous charge.
The charge pattern in and around the active-site cleft may have evolved to funnel
negatively charged acyl-CoA and carboxylate substrates toward Glu294.
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Figure 4.20. Thermal denaturation of AarC and AarCH6 as a function of pH [2]. Melting
temperatures (Tm) were determined from changes in ellipticity at 222 nm. AarC (red triangles) and
AarCH6 (blue triangles) are maximally stable at slightly acidic pH. At low pH, the hexahistidine tag
appears to destabilize AarCH6.

Figure 4.21. Electrostatic surface of AarC (PDB entry 4eud). The protein surface is colored red for
negatively charged areas and blue for positively charged areas. The saturation of the colors is
proportional to the degree of electrostatic charge from −7 kT/e to +7 kT/e. The charge surface was
computed at pH 7 using the PDB2PQR web server and the APBS plugin for PyMOL. CoA and citrate
are depicted in stick representation.
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DISCUSSION
The identities of the covalent intermediates formed during the class I CoA-transferase
reaction were established over 35 years ago by William P. Jencks and colleagues (3-7).
Those same studies also predicted a protein conformational change upon formation of the
initial Michaelis complex (4) and a common binding pocket for the acyl moiety of the
acyl-CoA substrate, the first acylglutamyl anhydride intermediate, and the carboxylate
product (5). Subsequent efforts have unfortunately provided little additional insight. This
study continues the work of W. P. Jencks and provides the first complete structural
description of the ground-state complexes and intermediates in the class I CoAtransferase reaction.
Catalytic implications of the novel oxyanion hole. AarC employs a previously
unidentified oxyanion hole configuration composed of the backbone nitrogen of Gly388
and the distal amide nitrogen of CoA (position 1, Scheme 4.2). Unlike traditional
oxyanion holes in which the amide dipoles are prearranged (22), this novel oxyanion hole
synchronizes alignment of the amide dipoles and formation of the Michaelis complex.
This process inevitably decreases the affinity of the ground-state complex but should not
affect subsequent stabilization of the negatively charged transition state and tetrahedral
oxyanion intermediate. Furthermore, the reduced energetic gap between the Michaelis
complex and the Arrhenius complex should increase the rate of catalysis.
A mechanistic archetype for the class I CoA-transferase reaction. The reaction
mechanism proposed for AarC appears to be conserved across phylogenetically diverse
class I CoA-transferases. A structural alignment of distantly related enzymes with varied
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substrate preferences and backbone topologies revealed conservation or functional
replacement of all catalytic residues and the single catalytic water identified in AarC
(Val270, Glu294, Asn347, Gly388, and HOH517; Figure 4.22 and Table A.2). The more
dissimilar class I structures lack a catalytic asparagine but possess an apparent catalytic
glutamine in a different but functionally equivalent position. This common arrangement
of catalytic residues suggests that the novel oxyanion hole found in AarC is a general
feature of class I enzymes.
Many aspects of the class I mechanism may be shared by the phylogenetically and
structurally related class II CoA-transferases.

Asn

HOH

Glu
Gln

Val/Ile/Thr

Gly

Figure 4.22. Structural alignment of phylogenetically diverse class I CoA-transferases. CoAtransferase structures were aligned to AarC (PDB entry 4eud, chain A, black) using the Dali web
server (http://ekhidna.biocenter.helsinki.fi/dali_server) (42). Only proposed catalytic residues and a
single catalytic water are shown. Putative succinyl-CoA:acetate CoA-transferase from Pseudomonas
aeruginosa (PDB entry 2g39, chain A, green), putative succinyl-CoA:acetate CoA-transferase from
Porphyromonas gingivalis (PDB entry 2nvv, chain A, teal), 4-hydroxybutyrate CoA-transferse from
Clostridium aminobutyricum (4-HB-CoAT, PDB entry 3gk7, chain A, salmon), butyryl-CoA
transferase from Yersinia pestis (RipA, PDB entry 3qli, chain A, orange), succinyl-CoA:acetoacetate
CoA-transferase from pig heart (SCOT, PDB entry 3oxo, chain F, slate), short-chain-fatty-acid CoAtransferase from Escherichia coli (YdiF, PDB entry 2ahv, chain D, yellow), acetate CoA-transferase
from E. coli (ACT, PDB entry 1k6d, chain A, α-subunit only, gray), and glutaconate CoA-transferase
from Acidaminococcus fermentans (GCT, PDB entry 1poi, chain B, α- and β-subunits, magenta). The
biological units of most structures are homodimers with a single subunit comprising each active site.
The biological units of ACT and GCT, however, are heterotetramers with two subunits comprising
each active site: the catalytic glutamine is located in the α-subunit while all other catalytic residues
are located in the β-subunit. Conserved or functionally equivalent catalytic residues (Table A.2) are
provided in Appendix A.
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Roles of conformational dynamics in CoA transfer. Large rigid-body motions are a
common feature of transferase enzymes (23). The class I CoA-transferases RipA (24),
YdiF (8), 4-HB-CoAT (25), and SCOT (26-28) have been previously observed to undergo
significant rearrangements upon binding CoA. Four such motions have been proposed to
occur during CoA transfer, permitting substrate and product association and dissociation,
respectively, in the open form and protecting the labile anhydride intermediates from bulk
solvent and preventing dissociation of the CoA thiolate in the closed form (25). Using
truncated substrate analogues, W. P. Jencks further predicted that favorable binding
interactions between the protein and the unreactive portions of the acyl-CoA substrate
(e.g. the diphosphate moiety) are utilized to not only induce a conformational change in
the enzyme but also to accelerate CoA transfer (4, 29).
AarC seems to undergo a similar series of large rigid-body conformational changes
during transfer of CoA. Upon initially binding the acyl-CoA substrate, the active site
closes, sequestering Glu294 and the reactive thioester in the reaction pocket. This motion,
driven by electrostatic and hydrogen-bonding interactions with the diphosphate moiety
and pantetheine arm, "clamps" the reactive thioester against the nucleophilic glutamate
carboxylate. This restrictive conformation may increase the rate of catalysis by
decreasing the entropy that must be lost to form a new covalent bond and by creating
steric strain that would be relieved in the tetrahedral oxyanion intermediate and the
transition state (5). Additionally, closure of the active site appropriately positions the
backbone nitrogen and side chain of Val270 to increase the leaving-group potential of the
CoA thiolate and shield the transient mixed anhydride, respectively. The hydrogen-
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bonding interaction may also retain the active site in the closed conformation until the
glutamyl-CoA thioester is formed. Exchange of the resulting carboxylate product and
carboxylate substrate requires that the active site open. Opening may be aided by binding
of the carboxylate substrate in the auxiliary site as the side chain of Arg228 samples
positions both in and out of the active-site cleft. After the carboxylate substrate reaches
the reaction pocket, the active site closes, isolating the glutamyl-CoA thioester and the
carboxylate substrate. Again, closure may provide catalytic acceleration by inducing
steric strain that would be relieved in the transition state and decreasing the loss of
entropy required to form a new covalent bond. The hydrogen-bonding interaction with
the backbone nitrogen of Val270 may once more increase the leaving-group potential of
the CoA thiolate while the side chain shields the intermediary mixed anhydride. Before
the acyl-CoA product can dissociate, the active site must reopen. Opening of the active
site in both product complexes may be driven by the same reduced entropy and steric
strain that increases the rate of catalysis.
Rapid catalytic turnover appears largely dependent on conformational dynamics. While
Arg228 is inherently linked to the protein conformational equilibrium in AarC,
corresponding residues are not obvious in other class I CoA-transferases. This may in
part explain the comparatively low specific activity of most class I enzymes. [The
specific activity of AarC(H6) is among the highest of any characterized CoA-transferase.]
Furthermore, auxiliary carboxylate binding sites of any type are not obvious in other class
I CoA-transferases. Nonetheless, highly positively charged active-site clefts are
conserved across phylogenetically diverse class I enzymes (not shown) and may facilitate
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complexation of structurally varied but consistently negatively charged carboxylate
substrates.
Primary and secondary determinants of substrate specificity. Class I CoAtransferases are notoriously promiscuous (5, 8, 30-33). AarCH6, however, appears to be
unusually stringent. Only nine of twenty-four arguably structurally similar potential
alternate carboxylate substrates supported detectable CoA-transferase activity. None
supported activity greater than 10% of that produced by acetate or succinate. Separate
binding sites for the physiological carboxylate substrate and carboxylate product have
been considered previously (9). While two carboxylate binding sites were identified in
AarC (Figure 4.23), each seems able to accommodate either acetate or succinate and only
one site appears capable of involvement in the formation of Michaelis complexes.
Phe35, Thr36, Ala70, Ser71, Phe92, Leu114, Val270, Val295, Gly388, and the distal
amide nitrogen of CoA compose the primary binding site and form the periphery of the

Arg228

auxiliary
binding site

Ser71

reaction
pocket

Val270

Glu294

Glu294

active-site
cleft

Figure 4.23. Cartoon representation of the AarC active site. Two carboxylate binding sites were
identified in the funnel-shaped active-site cleft of AarC. The primary binding site (or reaction pocket)
contains the catalytic glutamate Glu294 and binds all Michaelis complexes and both covalent mixed
anhydride intermediates. In the closed conformation, the side chain of Val270 isolates the reaction
pocket from bulk solvent. The secondary binding site (or auxiliary binding site) binds only the
carboxylate substrate and product. Unlike the primary site, the secondary site remains accessible in
the closed conformation. Complex formation involving Arg228 may influence the protein
conformational equilibrium and facilitate opening of the active site. The side chain of Ser71 forms
hydrogen-bonding interactions with substrates in both binding sites. (38-42)
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reaction pocket (Figure 4.23). Acetate and succinate, acetylglutamyl anhydride and
glutamylsuccinyl anhydride, and the acyl moieties of acetyl-CoA and succinyl-CoA all
bind in the primary site. Succinate, glutamylsuccinyl anhydride, and the succinyl moiety
of succinyl-CoA form a common set of hydrogen-bonding interactions and hydrophobic
contacts. The same is true of acetate, acetylglutamyl anhydride, and the acetyl moiety of
acetyl-CoA. The latter group of hydrogen-bonding interactions and hydrophobic contacts
are a subset of the former. AarC accommodates both the succinyl and acetyl groups in the
same binding pocket.
Ser71, Thr94, and Arg228 compose the secondary (or auxiliary) binding site. This
accessory binding position is situated outside the reaction pocket and adjacent to the
gating residue Val270 (Figure 4.23). Both the physiological substrate acetate and the
failed alternate substrate citrate were crystallographically observed in this position,
suggesting the auxiliary site is relatively accessible and accommodating, providing little
additional stringency. The secondary binding site may nonetheless preconcentrate acetate
(or succinate) and influence the conformational equilibrium inherently linked to CoA
transfer. [Introduction of an Arg228→Glu mutation drastically altered the apparent
binding affinities of acetate and succinate (Table 4.10).]
Citrate is sterically precluded from entering the primary binding site and did not
support CoA-transferase activity. Citrate did, however, competitively inhibit SCACT
activity. By binding in the auxiliary site, many of the failed alternate substrates may be
able to do the same. Several of the previously performed alternate substrate screens
employed for class I CoA-transferases were based not upon the CoA-transferase activity
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supported by the alternate substrates but upon inhibition of the CoA-transferase activity
supported by the physiological substrates (24, 34). The results obtained with citrate
suggest that this method of screening alternate substrates could indicate falsely high
levels of promiscuity.
The stringency of AarCH6 seems to result primarily from interactions in the reaction
pocket. Hydrophobic residues create a largely rigid environment. Only the motion of
Val270 would seem to provide the flexibility required for extended, branched, or
substituted carboxylates to form Michaelis complexes. This accommodation, however,
would presumably be accompanied by reduced catalytic activity. In fact, while the
apparent binding affinities of all alternate dicarboxylate substrates, with the exception of
glutarate, surpassed that of acetate, the catalytic turnover supported by acetate was 20fold greater than that of any alternate dicarboxylate substrate.
Conclusion. AarC evolved to play a primary metabolic role under the selective
pressure induced by high concentrations of membrane-permeant acetic acid, producing a
CoA-transferase with relatively high substrate specificity and catalytic rapidity. A
previously uncharacterized oxyanion hole configuration is utilized to stabilize tetrahedral
oxyanion intermediates in what appears to be the archetypal mechanism for class I
enzymes. The protein conformational motions inherently linked to CoA transfer are
influenced by a previously unidentified auxiliary binding site that preconcentrates
carboxylate substrates.
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FUTURE DIRECTIONS
Molecular modeling and molecular mechanics calculations were used to generate the
glutamylsuccinyl anhydride intermediate, but the short-soak method used to produce the
crystallographically observed acetylglutamyl anhydride from acetyl-CoA should allow
the corresponding mixed anhydride to be formed from succinyl-CoA. Crystallographic
characterization could confirm the proposed hydrogen-bonding interactions with Thr36
and Ser71 and provide direct evidence for succinate complexation in the auxiliary
binding site.
AarCH6-N347A preserves modest SCACT activity despite lacking the hydrogen-bond
donor that stabilizes two of four tetrahedral oxyanion intermediates and increases the
leaving-group potential of the glutamyl carboxylate. Crystallographic characterization
would reveal if a water is present in the catalytically appropriate position between
Glu294 and Asp391, facilitating CoA transfer in the absence of Asn347.
Further study of the auxiliary binding site (Ser71, Thr94, and Arg228) would benefit
from the creation of more conservative mutants (e.g. AarCH6-T94V and AarCH6R228K). AarCH6-R228E is biased by an altered charge pattern in the active site, while
AarCH6-S71A is hindered by a collapsed succinate binding pocket. Kinetic
characterization of AarCH6-T94V and AarCH6-E228K would allow auxiliary binding
interactions to be examined without substantially altering electrostatic properties or
protein conformation.
AarCH6-E435D retained full solubility while both AarCH6-E435A and AarCH6E435Q were completely insoluble even when co-overproduced with GroEL/ES.
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Crystallographic characterization could reveal how AarCH6-E435D maintained stability:
if one or more waters played supporting structural roles, if a local and stabilizing
conformational change occurred, and if the latter, why this stable, variant conformation
was not adopted by AarCH6-E435A and AarCH6-E435Q.

REFERENCES
1.

Heider, J. (2001) A new family of CoA-transferases, FEBS Lett. 509, 345-349.

2.

Hersh, L. B., and Jencks, W. P. (1967) Coenzyme A transferase. Kinetics and
exchange reactions, J. Biol. Chem. 242, 3468-3480.

3.

Hersh, L. B., and Jencks, W. P. (1967) Coenzyme A transferase. Isolation and
properties of an enzyme-coenzyme A intermediate, J. Biol. Chem. 242, 3481-3486.

4.

White, H., Solomon, F., and Jencks, W. P. (1976) Utilization of the inactivation rate
of coenzyme A transferase by thiol reagents to determine properties of the enzymeCoA intermediate, J. Biol. Chem. 251, 1700-1707.

5.

White, H., and Jencks, W. P. (1976) Mechanism and specificity of succinyl-CoA:3ketoacid coenzyme A transferase, J. Biol. Chem. 251, 1688-1699.

6.

Pickart, C. M., and Jencks, W. P. (1979) Formation of stable anhydrides from CoA
transferases and hydroxamic acids, J. Biol. Chem. 254, 9120-9129.

7.

Solomon, F., and Jencks, W. P. (1969) Identification of an enzyme-γ-glutamyl
coenzyme A intermediate from coenzyme A transferase, J. Biol. Chem. 244,
1079-1081.

8.

Rangarajan, E. S., Li, Y., Ajamian, E., Iannuzzi, P., Kernaghan, S. D., Fraser, M. E.,
Cygler, M., and Matte, A. (2005) Crystallographic trapping of the glutamyl-CoA
thioester intermediate of family I CoA transferases, J. Biol. Chem. 280,
42919-42928.

9.

Macieira, S., Zhang, J., Velarde, M., Buckel, W., and Messerschmidt, A. (2009)
Crystal structure of 4-hydroxybutyrate CoA-transferase from Clostridium
aminobutyricum, Biol. Chem. 390, 1251-1263.

10. Francois, J. A., Starks, C. M., Sivanuntakorn, S., Jiang, H., Ransome, A. E., Nam, J.
W., Constantine, C. Z., and Kappock, T. J. (2006) Structure of a NADH-insensitive
134

hexameric citrate synthase that resists acid inactivation, Biochemistry 45,
13487-13499.
11. Francois, J. A., and Kappock, T. J. (2007) Alanine racemase from the acidophile
Acetobacter aceti, Protein Expr. Purif. 51, 39-48.
12. Otwinowski, Z., and Minor, W. (1997) Processing of X-ray diffraction data collected
in oscillation mode, Methods Enzymol. 276, 307-326.
13. Guex, N., and Peitsch, M. C. (1997) SWISS-MODEL and the Swiss-PdbViewer: an
environment for comparative protein modeling, Electrophoresis 18, 2714-2723.
14. Adams, P. D., Afonine, P. V., Bunkoczi, G., Chen, V. B., Davis, I. W., Echols, N.,
Headd, J. J., Hung, L. W., Kapral, G. J., Grosse-Kunstleve, R. W., McCoy, A. J.,
Moriarty, N. W., Oeffner, R., Read, R. J., Richardson, D. C., Richardson, J. S.,
Terwilliger, T. C., and Zwart, P. H. (2010) PHENIX: a comprehensive Python-based
system for macromolecular structure solution, Acta Crystallogr. D Biol. Crystallogr.
66, 213-221.
15. Emsley, P., Lohkamp, B., Scott, W. G., and Cowtan, K. (2010) Features and
development of Coot, Acta Crystallogr. D Biol. Crystallogr. 66, 486-501.
16. Kleywegt, G. J. (2007) Crystallographic refinement of ligand complexes, Acta
Crystallogr. D Biol. Crystallogr. 63, 94-100.
17. DeLano, W. L. (2002) The PyMOL molecular graphics system, DeLano Scientific,
San Carlos, CA, USA.
18. Carson, M., Johnson, D. H., McDonald, H., Brouillette, C., and DeLucas, L. J.
(2007) His-tag impact on structure, Acta Crystallogr. D Biol. Crystallogr. 63,
295-301.
19. Mack, M., and Buckel, W. (1997) Conversion of glutaconate CoA-transferase from
Acidaminococcus fermentans into an acyl-CoA hydrolase by site-directed
mutagenesis, FEBS Lett. 405, 209-212.
20. Settembre, E. C., Chittuluru, J. R., Mill, C. P., Kappock, T. J., and Ealick, S. E.
(2004) Acidophilic adaptations in the structure of Acetobacter aceti N5carboxyaminoimidazole ribonucleotide mutase (PurE), Acta Crystallogr. D Biol.
Crystallogr. 60, 1753-1760.
21. Mullins, E. A., Starks, C. M., Francois, J. A., Sael, L., Kihara, D., and Kappock, T. J.
(2012) Formyl-coenzyme A (CoA):oxalate CoA-transferase from the acidophile
Acetobacter aceti has a distinctive electrostatic surface and inherent acid stability,
Protein Sci. 21, 686-696.
135

22. Kamerlin, S. C. L., Chu, Z. T., and Warshel, A. (2010) On catalytic preorganization
in oxyanion holes: highlighting the problems with gas-phase modeling of oxyanion
holes and illustrating the need for complete enzyme models, J. Org. Chem. 75,
6391-6401.
23. Koike, R., Amemiya, T., Ota, M., and Kidera, A. (2008) Protein structural change
upon ligand binding correlates with enzymatic reaction mechanism, J. Mol. Biol.
379, 397-401.
24. Torres, R., Swift, R. V., Chim, N., Wheatley, N., Lan, B., Atwood, B. R., Pujol, C.,
Sankaran, B., Bliska, J. B., Amaro, R. E., and Goulding, C. W. (2011) Biochemical,
structural, and molecular dynamics analyses of the potential virulence factor RipA
from Yersenia pestis, PLoS One 6, 1-14.
25. Macieira, S., Zhang, J., Buckel, W., and Messerschmidt, A. (2012) Crystal structure
of the complex between 4-hydroxybutyrate CoA-transferase from Clostridium
aminobutyricum and CoA, Arch. Microbiol. 194, 157-166.
26. Tammam, S. D., Rochet, J., and Fraser, M. E. (2007) Identification of the cysteine
residue exposed by the conformational change in pig heart succinyl-CoA:3-ketoacid
coenzyme A transferase on binding coenzyme A, Biochemistry 46, 10852-10863.
27. Fraser, M. E., Hayakawa, K., and Brown, W. D. (2010) Catalytic role of the
conformational change in succinyl-CoA:3-oxoacid CoA transferase on binding CoA,
Biochemistry 49, 10319-10328.
28. Coker, S., Lloyd, A. J., Mitchell, E., Lewis, G. R., Coker, A. R., and ShoolinginJordan, P. M. (2010) The high-resolution structure of pig heart succinyl-CoA:3oxoacid coenzyme A transferase, Acta Crystallogr. D Biol. Crystallogr. D66,
797-805.
29. Whitty, A., Fierke, C. A., and Jencks, W. P. (1995) Role of binding energy with
coenzyme A in catalysis by 3-oxoacid coenzyme A transferase, Biochemistry 34,
11678-11689.
30. Selmer, T., Willanzheimer, A., and Hetzel, M. (2002) Propionate CoA-transferase
from Clostridium propionicum. Cloning of the gene and identification of glutamate
324 at the active site, Eur. J. Biochem. 269, 372-380.
31. Haller, T., Buckel, T., Rétey, J., and Gerlt, J. A. (2000) Discovering new enzymes
and metabolic pathways: conversion of succinate to propionate by Escherichia coli,
Biochemistry 39, 4622-4629.

136

32. Fleck, C. B., and Brock, M. (2008) Characterization of an acyl-CoA:carboxylate
CoA-transferase from Aspergillus nidulans involved in propionyl-CoA
detoxification, Mol. Microbiol. 68, 642-656.
33. Buckel, W., Dorn, U., and Semmler, R. (1981) Glutaconate CoA-transferase from
Acidaminococcus fermentans, Eur. J. Biochem. 118, 315-321.
34. Schweiger, G., and Buckel, W. (1984) On the dehydration of (R)-lactate in the
fermentation of alanine to propionate by Clostridium propionicum, FEBS 171, 79-84.
35. Miroux, B., and Walker, J. E. (1996) Over-production of proteins in Escherichia coli:
mutant hosts that allow synthesis of some membrane proteins and globular proteins
at high levels, J. Mol. Biol. 260, 289-298.
36. Laboratories, B. R. (1986) BRL pUC host: E. coli DH5α competent cells, Focus 8, 9.
37. Cole, P. A. (1996) Chaperone-assisted protein expression, Structure 4, 239-242.
38. Matthews, B. W. (1968) Solvent content of protein crystals, J. Mol. Biol. 33,
491-497.
39. Kantardjieff, K. A., and Rupp, B. (2003) Matthews coefficient probabilities:
improved estimates for unit cell contents of proteins, DNA, and protein-nucleic acid
complex crystals, Protein Sci. 12, 1865-1871.
40. Dolinsky, T. J., Czodrowski, P., Li, H., Nielsen, J. E., Jensen, J. H., Klebe, G., and
Baker, N. A. (2007) PDB2PQR: expanding and upgrading automated preparation of
biomolecular structures for molecular simulations, Nucleic Acids Res. 35, W522W525.
41. Baker, N. A., Sept, D., Joseph, S., Holst, M. J., and McCammon, J. A. (2001)
Electrostatics of nanosystems: application to microtubules and the ribosome, Proc.
Natl. Acad. Sci. USA 98, 10037-10041.
42. Holm, L., and Rosenström, P. (2010) Dali server: conservation mapping in 3D,
Nucleic Acids Res. 38, W545-W549.

137

Appendix A.
Supplemental material

ADDITIONAL FIGURES AND TABLES

Figure A.1. ESI-TOF-MS analysis of AarCH6 (55,846 ± 2 Da observed; 55,847 Da expected
[−Met1]).
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Figure A.2. ESI-TOF-MS analysis of AarCH6 following incubation with acetyl-CoA and treatment
with sodium borohydride (55,832 ± 2 Da observed; 55,833 Da expected [−Met1]).
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Figure A.3. MALDI-TOF-MS analysis of SixAH6 (19,821 ± 2 Da observed; 19,822 Da expected
[+Met1]). N-terminally processed SixAH6 lacking Met1 was not detected, consistent with the
extremely short in vivo half-life (~2 min) expected for a protein with an N-terminal arginine (Arg2).
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Figure A.4. ESI-TOF-MS analysis of AarCH6-S71A (55,831 Da observed; 55,831 Da expected
[−Met1]).
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Figure A.5. ESI-TOF-MS analysis of AarCH6-R228E (55,821 Da observed; 55,820 Da expected
[−Met1]).
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Figure A.6. ESI-TOF-MS analysis of AarCH6-E294A (55,789 Da observed; 55,789 Da expected
[−Met1]).
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Figure A.7. ESI-TOF-MS analysis of AarCH6-N347A (55,804 Da observed; 55,804 Da expected
[−Met1]). The minor peak does not correspond to the thioester intermediate (57,197 Da observed;
56,554 Da expected).
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Figure A.8. ESI-TOF-MS analysis of AarCH6-E435D (55,833 Da observed; 55,833 Da expected
[−Met1]).
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Figure A.9. ESI-TOF-MS analysis of AarC (54,695 Da observed; 54,695 Da expected [−Met1]).
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C1

C2

formate

acetate

glycolate

trifluoroacetate

glyoxylate

oxalate

C3

propionate

L-lactate

DL-lactate

pyruvate

malonate

C4

butyrate

acetoacetate

fumarate

D-malate

succinate

L-malate

maleate

oxaloacetate

C5

D-tartrate

L-tartrate

DL-methylsuccinate

glutarate

C6

α-ketoglutarate

citrate

DL-isocitrate

Figure A.10. Physiological and potential alternate carboxylate substrates for AarCH6. Compounds are
sorted by number of carbon atoms (C1 – C6). Compounds with black labels, including acetate and
succinate, supported detectable CoA-transferase activity in modified LCF/LCR assays.
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Table A.1. AarCH6 kinetic constants obtained with physiological and alternate carboxylate substrates
Sp. activity (U/mg)a

kcat (s−1)b

Km (mM)

kcat/Km (M−1 s−1)

formate

0.23

1.9

75

2.6 × 101

acetatec,d

66

280

70 (Ki = 1500)e

4.0 × 103

propionate

6.9

65
(65)d

240 (Ki = 1600)e
(310, Ki = 1400)d,e

2.7 × 102
(2.1 × 102)d

acetoacetatec,d

5.7

37
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2.8 × 102

succinatec

73

71

0.90

7.9 × 104

fumarate

0.75

0.89

5.4

1.6 × 102

D-malate

4.0
(0.010)f

12
(---)g

55
(---)g

2.2 × 102
(---)g

L-malate

0.44
(0.41)f

0.80
(0.74)f

20
(19)f

4.0 × 101
(3.9 × 101)f

oxaloacetate

0.060

0.083

9.4

8.8 × 100

DL-methylsuccinate

0.082

0.46

58

7.9 × 100

glutarate

0.029

0.27

290

9.3 × 10−1

Substrate

a

Alternate CoA-acceptors were screened in modified LCR assays as described in Chapter 4. The limit
of detection was ~0.01 U/mg. b Kinetic constants were obtained using modified LCR assays as
described in Chapter 4 unless otherwise noted. Saturation experiments were performed in duplicate. c
Kinetic constants were taken from Chapter 2. d Kinetic constants were obtained using modified LCF
assays containing 50 mM potassium phosphate, pH 8.0, 100 mM potassium chloride, 0.2 mM
succinyl-CoA, varying concentrations of carboxylate substrate, and 5 – 50 ng AarCH6. Saturation
experiments were performed in duplicate. e Data were fit to a substrate inhibition model. f Two acylCoA/acyl-isoCoA product pairs (likely constitutional isomers) were observed. g Under normal
substrate conversion conditions, formation of the minor product pair was too slow to be measured
relative to that of the major product pair.
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3-aminopropionate

glycylglycine

4-guanidinobutyrate

4-aminobutyrate

Figure A.11. Potential zwitterionic substrates for AarCH6-R228E. None of the compounds supported
detectable CoA-transferase activity in modified LCR and VisR assays.

150

Table A.2. Conserved or functionally equivalent catalytic residues in phylogenetically diverse class I
CoA-transferasesa
PDB id
(chain)

Z score
(identity)

Val270

Glu294

Asn347

Gly388

HOH517

2g39 (A)b

56.1 (48%)

Ile264

Glu288

Asn341

Gly382

HOH947

2nvv (A)c

53.2 (48%)

Val259

Glu284

Asn337

Gly378

---k

3gk7 (A)d

36.3 (24%)

Ile216

Glu238

Asn295

Gly336

HOH486

3qli (A)e

34.8 (25%)

Val227

Glu249

Asn306

Gly347

HOH466

3oxo (F)f

21.6 (18%)

Ile284

Glu305

Gln99

Gly386

---l

2ahv (D)g

21.3 (16%)

Val309

Glu333

Gln118

Gly401

HOH2682

1k6d (A)h

15.6 (18%)

---j

---j

Gln100

---j

---j

1poi (A)i

14.6 (14%)

Thr31 (B)j

Glu54 (B)j

Gln103

Gly137 (B)j

HOH270 (B)j

1poi (B)i

9.6 (18%)

Thr31

Glu54

Gln103 (A)j

Gly137

HOH270

a

Catalytic residues in AarC (bold) were determined through crystallographic, mutagenic, and kinetic
analyses as described in Chapter 4. Conserved or functionally equivalent residues in structurally
related class I CoA-transferases were identified by manual inspection of structures aligned to AarC
(PDB id 6tba, chain A) using the Dali web server. b Putative succinyl-CoA:acetate CoA-transferase
from Pseudomonas aeruginosa. c Putative succinyl-CoA:acetate CoA-transferase from
Porphyromonas gingivalis. d 4-hydroxybutyrate CoA-transferse from Clostridium aminobutyricum (4HB-CoAT). e Butyryl-CoA transferase from Yersinia pestis (RipA). f Succinyl-CoA:acetoacetate CoAtransferase from pig heart (SCOT). g Short-chain-fatty-acid CoA-transferase from Escherichia coli
(YdiF). h Acetate CoA-transferase from E. coli (ACT, α-subunit only). i Glutaconate CoA-transferase
from Acidaminococcus fermentans (GCT, α- and β-subunits). j Each active site in ACT and GCT is
composed of two heteromeric subunits. k Few waters were modeled due to the low resolution of the
dataset (2.7 Å). l Few waters were modeled (~55 per chain) despite the moderate resolution of the
dataset (2.3 Å).
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